16. Literaturverzeichnis – Oro- und Hypopharynxkarzinom
1. S3-Leitlinie Diagnostik und Therapie des Mundhöhlenkarzinoms, AWMF-Registernummer: 007/100OL, 2021. Version 3.0:, https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Mundhoehlenkarzinom/Version_3/LL_Mundhoehlenkarzinom_Langversion_3.0.pdf
2. S3-Leitlinie Diagnostik, Therapie und Nachsorge des Larynxkarzinoms, Langversion 1.1, AWMF-Registernummer: 017-076OL, 2019., https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Larynxkarzinom/Version1.1/LL_Larynxkarzinom_Langversion_1.1.pdf
3. Kreimer, AR, Johansson, M, Yanik, EL, Katki, HA, Check, DP, Lang Kuhs, KA, et.al. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer., J Natl Cancer Inst, 2017. 109 (8)(8):, https://pubmed.ncbi.nlm.nih.gov/28376197/
4. Morais, E, Kothari, S, Chen, YT, Roberts, CS, Gómez-Ulloa, D, Fenoll, R, et.al. The BROADEN study: The design of an observational study to assess the absolute burden of HPV-related head and neck cancers., Contemp Clin Trials, 2022. 115 (): p. 106631., https://pubmed.ncbi.nlm.nih.gov/34838716/
5. Dietz, Andreas., Kopf-Hals-Tumoren - Therapie des Larynx-/Hypopharynxkarzinoms unter besonderer Berücksichtigung des Larynxorganerhalts.UNI-MED Verlag, 2010.
6. Roesch-Ely, M, Leipold, A, Nees, M, Holzinger, D, Dietz, A, Flechtenmacher, C, et.al. Proteomic analysis of field cancerization in pharynx and oesophagus: a prospective pilot study., J Pathol, 2010. 221 (4)(4): p. 462-70., https://pubmed.ncbi.nlm.nih.gov/20593486/
7. Robert-Koch-Institut, Epidemiologisches Bulletin, 2018. 26:, https://www.rki.de/DE/Aktuelles/Publikationen/Epidemiologisches-Bulletin/2018/26_18.pdf?__blob=publicationFile&v=1
8. Ang, KK, Harris, J, Wheeler, R, Weber, R, Rosenthal, DI, Nguyen-Tân, PF, et.al. Human papillomavirus and survival of patients with oropharyngeal cancer., N Engl J Med, 2010. 363 (1)(1): p. 24-35., https://pubmed.ncbi.nlm.nih.gov/20530316/
9. Klussmann, JP, Weissenborn, SJ, Wieland, U, Dries, V, Eckel, HE, Pfister, HJ, et.al. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?, Med Microbiol Immunol, 2003. 192 (3)(3): p. 129-32., https://pubmed.ncbi.nlm.nih.gov/12920586./
10. Jansen, Lina, Moratin, Julius, Waldmann, Annika, Zaoui, Karim, Holleczek, Bernd, Nennecke, Alice, et.al. Mundhöhlen- und Pharynxkarzinome: Inzidenz, Mortalität und Überleben in Deutschland, 2021. 64(8): p. 941 - 950., https://doi.org/10.1007/s00103-021-03368-z
11. Guntinas-Lichius, O, Wendt, T, Buentzel, J, Esser, D, Lochner, P, Mueller, A, et.al. Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database., J Cancer Res Clin Oncol, 2010. 136 (1)(1): p. 55-63., https://pubmed.ncbi.nlm.nih.gov/19568769/
12. Petersen, JF, Timmermans, AJ, van Dijk, BAC, Overbeek, LIH, Smit, LA, Hilgers, FJM, et.al. Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands., Eur Arch Otorhinolaryngol, 2018. 275 (1)(1): p. 181-189., https://pubmed.ncbi.nlm.nih.gov/29080963/
13. Jakobsen, KK, Grønhøj, C, Jensen, DH, Karnov, KKS, Agander, TK, Specht, L, et.al. Increasing incidence and survival of head and neck cancers in Denmark: a nation-wide study from 1980 to 2014., Acta Oncol, 2018. 57 (9)(9): p. 1143-1151., https://pubmed.ncbi.nlm.nih.gov/29447088/
14. Menezes, FDS, Fernandes, GA, Antunes, JLF, Villa, LL, Toporcov, TN, Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: A systematic review of population-based studies., Oral Oncol, 2021. 115 (): p. 105177., https://pubmed.ncbi.nlm.nih.gov/33561611/
15. Klussmann, JP, Weissenborn, SJ, Wieland, U, Dries, V, Kolligs, J, Jungehuelsing, M, et.al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas., Cancer, 2001. 92 (11)(11): p. 2875-84., https://pubmed.ncbi.nlm.nih.gov/11753961/
16. Castellsagué, X, Alemany, L, Quer, M, Halec, G, Quirós, B, Tous, S, et.al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients., J Natl Cancer Inst, 2016. 108 (6)(6): p. djv403., https://pubmed.ncbi.nlm.nih.gov/26823521/
17. Reuschenbach, M, Tinhofer, I, Wittekindt, C, Wagner, S, Klussmann, JP, A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany., Cancer Med, 2019. 8 (4)(4): p. 1908-1918., https://pubmed.ncbi.nlm.nih.gov/30821126/
18. Bayer, O, Krüger, M, Koutsimpelas, D, Emrich, K, Ressing, M, Zeissig, SR, et.al. [Changes in Incidence and Mortality Trends of Head and Neck Cancer in Rhineland-Palatinate, 2000-2009]., Laryngorhinootologie, 2015. 94 (7)(7): p. 451-8., https://pubmed.ncbi.nlm.nih.gov/25429640/
19. Tinhofer, I, Jöhrens, K, Keilholz, U, Kaufmann, A, Lehmann, A, Weichert, W, et.al. Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence., Eur J Cancer, 2015. 51 (4)(4): p. 514-521., https://pubmed.ncbi.nlm.nih.gov/25623438/
20. Wittekindt, C, Wagner, S, Sharma, SJ, Würdemann, N, Knuth, J, Reder, H, et.al. [HPV - A different view on Head and Neck Cancer]., Laryngorhinootologie, 2018. 97 (S 01)(S 01): p. S48-S113., https://pubmed.ncbi.nlm.nih.gov/29905354/
21. Wittekindt, C, Wagner, S, Bushnak, A, Prigge, ES, von Knebel Doeberitz, M, Würdemann, N, et.al. Increasing Incidence rates of Oropharyngeal Squamous Cell Carcinoma in Germany and Significance of Disease Burden Attributed to Human Papillomavirus., Cancer Prev Res (Phila), 2019. 12 (6)(6): p. 375-382., https://pubmed.ncbi.nlm.nih.gov/31003993/
22. Liao, CI, Francoeur, AA, Kapp, DS, Caesar, MAP, Huh, WK, Chan, JK, Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017., JAMA Netw Open, 2022. 5 (3)(3): p. e222530., https://pubmed.ncbi.nlm.nih.gov/35294540/
23. Suchan, M, Wuerdemann, N, Sharma, SJ, Klussmann, JP, [HPV-related oropharyngeal squamous cell carcinoma-Incidence steadily rising]., HNO, 2021. 69 (7)(7): p. 599-608., https://pubmed.ncbi.nlm.nih.gov/34143237/
24. Dietz, A, Wichmann, G, Wiegand, S, [Update Treatment HPV-16-positive Oropharyngeal Carcinoma]., Laryngorhinootologie, 2021. 100 (10)(10): p. 832-844., https://pubmed.ncbi.nlm.nih.gov/34614529/
25. Maier, H, de Vries, N, Weidauer, H, [Occupation and cancer of the oral cavity, pharynx and larynx]., HNO, 1990. 38 (8)(8): p. 271-8., https://pubmed.ncbi.nlm.nih.gov/2228740/
26. Maier, H, Dietz, A, Gewelke, U, Seitz, HK, Heller, WD, [Tobacco- and alcohol-associated cancer risk of the upper respiratory and digestive tract]., Laryngorhinootologie, 1990. 69 (10)(10): p. 505-11., https://pubmed.ncbi.nlm.nih.gov/2252473/
27. Maier, H, Dietz, A, Zielinski, D, Jünemann, KH, Heller, WD, [Risk factors for squamous epithelial carcinoma of the mouth, the oropharynx, the hypopharynx and the larynx]., Dtsch Med Wochenschr, 1990. 115 (22)(22): p. 843-50., https://pubmed.ncbi.nlm.nih.gov/2347296/
28. Bosetti, C, Gallus, S, Trichopoulou, A, Talamini, R, Franceschi, S, Negri, E, et.al. Influence of the Mediterranean diet on the risk of cancers of the upper aerodigestive tract., Cancer Epidemiol Biomarkers Prev, 2003. 12 (10)(10): p. 1091-4., https://pubmed.ncbi.nlm.nih.gov/14578148/
29. Levi, F, Pasche, C, Lucchini, F, Chatenoud, L, Jacobs, DR, La Vecchia, C, Refined and whole grain cereals and the risk of oral, oesophageal and laryngeal cancer., Eur J Clin Nutr, 2000. 54 (6)(6): p. 487-9., https://pubmed.ncbi.nlm.nih.gov/10878650/
30. Uzcudun, AE, Retolaza, IR, Fernández, PB, Sánchez Hernández, JJ, Grande, AG, García, AG, et.al. Nutrition and pharyngeal cancer: results from a case-control study in Spain., Head Neck, 2002. 24 (9)(9): p. 830-40., https://pubmed.ncbi.nlm.nih.gov/12211047/
31. Franceschi, S, Favero, A, Conti, E, Talamini, R, Volpe, R, Negri, E, et.al. Food groups, oils and butter, and cancer of the oral cavity and pharynx., Br J Cancer, 1999. 80 (3-4)(3-4): p. 614-20., https://pubmed.ncbi.nlm.nih.gov/10408875/
32. Riechelmann, H, [Occupational exposure and cancer of the oral cavity and pharynx]., Laryngorhinootologie, 2002. 81 (8)(8): p. 573-9., https://pubmed.ncbi.nlm.nih.gov/12189574/
33. Dietz, A, Heller, WD, Maier, H, [Epidemiologic aspects of cancers of the head-neck area]., Offentl Gesundheitswes, 1991. 53 (10)(10): p. 674-80., https://pubmed.ncbi.nlm.nih.gov/1837600/
34. Dietz, A, Maier, H, [Occupational cancer]., HNO, 1997. 45 (7)(7): p. 495-7., https://pubmed.ncbi.nlm.nih.gov/9340325/
35. Maier, H, Gewelke, U, Dietz, A, Thamm, H, Heller, WD, Weidauer, H, [Laryngeal cancer and occupation--results of the Heidelberg laryngeal cancer study]., HNO, 1992. 40 (2)(2): p. 44-51., https://pubmed.ncbi.nlm.nih.gov/1568886/
36. Weichert, W, Ihrler, S, Boxberg, M, Agaimy, A, Mollenhauer, M, Hartmann, A, [Morphology of non cutaneous head and neck squamous cell carcinoma]., Pathologe, 2018. 39 (1)(1): p. 3-10., https://pubmed.ncbi.nlm.nih.gov/29209797/
37. Barnes, L, Eveson JW, Reichart P, Sidransky D (Eds.):, World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck TumoursIARC Press, 2005.
38. Agaimy, A, Hartmann, A, [Head and neck neoplasms : News from the WHO classification of 2017]., Pathologe, 2018. 39 (1)(1): p. 1-2., https://pubmed.ncbi.nlm.nih.gov/29387917/
39. El-Naggar, Adel K., El-Naggar, Ahmed, WHO classification of head and neck tumoursInternational Agency for Research on Cancer, Fourth edition., 2017.
40. Wichmann, G, Variation of HPV Subtypes with Focus on HPV-Infection and Cancer in the Head and Neck Region., Recent Results Cancer Res 206 (): p. 113-122., https://pubmed.ncbi.nlm.nih.gov/27699533/
41. Wagner, S, Würdemann, N, Hübbers, C, Reuschenbach, M, Prigge, ES, Wichmann, G, et.al. [HPV-associated head and neck cancer : mutational signature and genomic aberrations]., HNO, 2015. 63 (11)(11): p. 758-67., https://pubmed.ncbi.nlm.nih.gov/26507715/
42. Wichmann, G, Rosolowski, M, Krohn, K, Kreuz, M, Boehm, A, Reiche, A, et.al. The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer., Int J Cancer, 2015. 137 (12)(12): p. 2846-57., https://pubmed.ncbi.nlm.nih.gov/26095926/
43. Lechner, M, Liu, J, Masterson, L, Fenton, TR, HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management., Nat Rev Clin Oncol, 2022. 19 (5)(5): p. 306-327., https://pubmed.ncbi.nlm.nih.gov/35105976/
44. Andl, T, Kahn, T, Pfuhl, A, Nicola, T, Erber, R, Conradt, C, et.al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control., Cancer Res, 1998. 58 (1)(1): p. 5-13., https://pubmed.ncbi.nlm.nih.gov/9426048/
45. Klussmann, JP, Gültekin, E, Weissenborn, SJ, Wieland, U, Dries, V, Dienes, HP, et.al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus., Am J Pathol, 2003. 162 (3)(3): p. 747-53., https://pubmed.ncbi.nlm.nih.gov/12598309/
46. Shamseddine, AA, Burman, B, Lee, NY, Zamarin, D, Riaz, N, Tumor Immunity and Immunotherapy for HPV-Related Cancers., Cancer Discov, 2021. 11 (8)(8): p. 1896-1912., https://pubmed.ncbi.nlm.nih.gov/33990345/
47. Wagner, S, Böckmann, H, Gattenlöhner, S, Klussmann, JP, Wittekindt, C, [The innate immune system in oropharyngeal squamous cell carcinoma : Immune modulation by HPV]., HNO, 2018. 66 (4)(4): p. 301-307., https://pubmed.ncbi.nlm.nih.gov/29468275/
48. Reimers, N, Kasper, HU, Weissenborn, SJ, Stützer, H, Preuss, SF, Hoffmann, TK, et.al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer., Int J Cancer, 2007. 120 (8)(8): p. 1731-8., https://pubmed.ncbi.nlm.nih.gov/17236202/
49. Golusiński, Wojciech, Leemans, C. René, Dietz, Andreas, HPV infection in head and neck cancerSpringer, 2016.
50. Mehanna, H, Taberna, M, von Buchwald, C, Tous, S, Brooks, J, Mena, M, et.al. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis., Lancet Oncol, 2023. ():, https://pubmed.ncbi.nlm.nih.gov/36796393/
51. Rischin, D, Young, RJ, Fisher, R, Fox, SB, Le, QT, Peters, LJ, et.al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial., J Clin Oncol, 2010. 28 (27)(27): p. 4142-8., https://pubmed.ncbi.nlm.nih.gov/20697079/
52. Freitag, J, Wald, T, Kuhnt, T, Gradistanac, T, Kolb, M, Dietz, A, et.al. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma., Cancer, 2020. 126 (9)(9): p. 1856-1872., https://pubmed.ncbi.nlm.nih.gov/32032442/
53. Holmes, BJ, Westra, WH, The expanding role of cytopathology in the diagnosis of HPV-related squamous cell carcinoma of the head and neck., Diagn Cytopathol, 2014. 42 (1)(1): p. 85-93., https://pubmed.ncbi.nlm.nih.gov/23749770/
54. D'Souza, G, Kreimer, AR, Viscidi, R, Pawlita, M, Fakhry, C, Koch, WM, et.al. Case-control study of human papillomavirus and oropharyngeal cancer., N Engl J Med, 2007. 356 (19)(19): p. 1944-56., https://pubmed.ncbi.nlm.nih.gov/17494927/
55. Brenner, N, Mentzer, AJ, Hill, M, Almond, R, Allen, N, Pawlita, M, et.al. Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank., EBioMedicine, 2020. 62 (): p. 103123., https://pubmed.ncbi.nlm.nih.gov/33248371/
56. Giuliano, AR, Felsher, M, Waterboer, T, Mirghani, H, Mehanna, H, Roberts, C, et.al. Oral Human Papillomavirus Prevalence and Genotyping Among a Healthy Adult Population in the US., JAMA Otolaryngol Head Neck Surg, 2023. ():, https://pubmed.ncbi.nlm.nih.gov/37535349/
57. Wiegand, S, Wichmann, G, Golusinski, W, Leemans, CR, Klussmann, JP, Dietz, A, Highlights from the Second International Symposium on HPV infection in head and neck cancer., Eur Arch Otorhinolaryngol, 2018. 275 (6)(6): p. 1365-1373., https://pubmed.ncbi.nlm.nih.gov/29589141/
58. Doorbar, J, Griffin, H, Refining our understanding of cervical neoplasia and its cellular origins., Papillomavirus Res, 2019. 7 (): p. 176-179., https://pubmed.ncbi.nlm.nih.gov/30974183/
59. Hoffmann, M, Quabius, ES, Fabian, A, Laudien, M, Ambrosch, P, The interaction of smoking habit, SLPI and AnxA2 in HPV associated head and neck and other cancers., Cancer Treat Res Commun, 2021. 26 (): p. 100299., https://pubmed.ncbi.nlm.nih.gov/33387869/
60. Liu, C, Sadat, SH, Ebisumoto, K, Sakai, A, Panuganti, BA, Ren, S, et.al. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation., Clin Cancer Res, 2020. 26 (11)(11): p. 2693-2703., https://pubmed.ncbi.nlm.nih.gov/31932491/
61. Marks, MA, Chaturvedi, AK, Kelsey, K, Straif, K, Berthiller, J, Schwartz, SM, et.al. Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium., Cancer Epidemiol Biomarkers Prev, 2014. 23 (1)(1): p. 160-71., https://pubmed.ncbi.nlm.nih.gov/24351902/
62. Robert-Koch-Institut, Epidemiologisches Bulletin, Einfluss von Schulimpfprogrammen auf die HPV-Impfquote, 2022. 20/2022:, https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2022/Ausgaben/20_22.pdf?__blob=publicationFile
63. Robert-Koch-Institut, HVP-Impfung, Kurz & Knapp: Faktenblätter zum Impfen, 2019.
64. Gross, GE, Werner, RN, Avila Valle, GL, Bickel, M, Brockmeyer, NH, Doubek, K, et.al. German evidence and consensus-based (S3) guideline: Vaccination recommendations for the prevention of HPV-associated lesions., J Dtsch Dermatol Ges, 2021. 19 (3)(3): p. 479-494., https://pubmed.ncbi.nlm.nih.gov/33634583 /
65. Gross, G, Becker, N, Brockmeyer, NH, Esser, S, Freitag, U, Gebhardt, M, et.al. [Vaccination against HPV-associated neoplasias]., Laryngorhinootologie, 2014. 93 (12)(12): p. 848-56., https://pubmed.ncbi.nlm.nih.gov/25437625/
66. Kreimer, AR, Shiels, MS, Fakhry, C, Johansson, M, Pawlita, M, Brennan, P, et.al. Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research., Cancer, 2018. 124 (9)(9): p. 1859-1866., https://pubmed.ncbi.nlm.nih.gov/29499070/
67. Franceschi, S, Combes, JD, Dalstein, V, Caudroy, S, Clifford, G, Gheit, T, et.al. Deep brush-based cytology in tonsils resected for benign diseases., Int J Cancer, 2015. 137 (12)(12): p. 2994-9., https://pubmed.ncbi.nlm.nih.gov/26111735/
68. Eggersmann, TK, Baumeister, P, Kumbrink, J, Mayr, D, Schmoeckel, E, Thaler, CJ, et.al. Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients., Anticancer Res, 2020. 40 (4)(4): p. 2117-2123., https://pubmed.ncbi.nlm.nih.gov/32234904/
69. Kreimer, AR, Pierce Campbell, CM, Lin, HY, Fulp, W, Papenfuss, MR, Abrahamsen, M, et.al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study., Lancet, 2013. 382 (9895)(9895): p. 877-87., https://pubmed.ncbi.nlm.nih.gov/23827089/
70. Martin-Gomez, L, Fulp, WJ, Schell, MJ, Sirak, B, Abrahamsen, M, Isaacs-Soriano, KA, et.al. Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases., Oral Oncol, 2019. 92 (): p. 85-91., https://pubmed.ncbi.nlm.nih.gov/31010629/
71. Loermann, G, Kolb, M, Prascevic, D, Siemert, J, Wiegand, S, Zebralla, V, et.al. High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy-A Feasibility Study., J Clin Med, 2022. 11 (19)(19):, https://pubmed.ncbi.nlm.nih.gov/36233378/
72. Hibbert, J, Halec, G, Baaken, D, Waterboer, T, Brenner, N, Sensitivity and Specificity of Human Papillomavirus (HPV) 16 Early Antigen Serology for HPV-Driven Oropharyngeal Cancer: A Systematic Literature Review and Meta-Analysis., Cancers (Basel), 2021. 13 (12)(12):, https://pubmed.ncbi.nlm.nih.gov/34208476/
73. Kreimer, AR, Johansson, M, Waterboer, T, Kaaks, R, Chang-Claude, J, Drogen, D, et.al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer., J Clin Oncol, 2013. 31 (21)(21): p. 2708-15., https://pubmed.ncbi.nlm.nih.gov/23775966/
74. Kreimer, AR, Ferreiro-Iglesias, A, Nygard, M, Bender, N, Schroeder, L, Hildesheim, A, et.al. Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium., Ann Oncol, 2019. 30 (8)(8): p. 1335-1343., https://pubmed.ncbi.nlm.nih.gov/31185496/
75. Robbins, HA, Ferreiro-Iglesias, A, Waterboer, T, Brenner, N, Nygard, M, Bender, N, et.al. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium., J Clin Oncol, 2022. 40 (31)(31): p. 3613-3622., https://pubmed.ncbi.nlm.nih.gov/35700419/
76. Busch, CJ, Hoffmann, AS, Viarisio, D, Becker, BT, Rieckmann, T, Betz, C, et.al. Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology - A proof-of-concept study., EClinicalMedicine, 2022. 53 (): p. 101659., https://pubmed.ncbi.nlm.nih.gov/36147627/
77. Waterboer, T, Brenner, N, Klussmann, JP, Brennan, P, Wieland, U, Robbins, HA, Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test., EBioMedicine, 2020. 62 (): p. 103143., https://pubmed.ncbi.nlm.nih.gov/33249381/
78. Leung, E, Han, K, Zou, J, Zhao, Z, Zheng, Y, Wang, TT, et.al. HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA., Clin Cancer Res, 2021. 27 (21)(21): p. 5857-5868., https://pubmed.ncbi.nlm.nih.gov/34580115/
79. Rettig, EM, Faden, DL, Sandhu, S, Wong, K, Faquin, WC, Warinner, C, et.al. Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV-positive head and neck cancer., Int J Cancer, 2022. 151 (7)(7): p. 1081-1085., https://pubmed.ncbi.nlm.nih.gov/35262203/
80. Schroeder, L, Wichmann, G, Willner, M, Michel, A, Wiesenfarth, M, Flechtenmacher, C, et.al. Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor., Int J Cancer, 2018. 142 (7)(7): p. 1361-1368., https://pubmed.ncbi.nlm.nih.gov/29159804/
81. Faden, DL, Liquid biopsy for the diagnosis of HPV-associated head and neck cancer., Cancer Cytopathol, 2022. 130 (1)(1): p. 12-15., https://pubmed.ncbi.nlm.nih.gov/34375020/
82. Reder, H, Taferner, VF, Wittekindt, C, Bräuninger, A, Speel, EM, Gattenlöhner, S, et.al. Plasma Cell-Free Human Papillomavirus Oncogene E6 and E7 DNA Predicts Outcome in Oropharyngeal Squamous Cell Carcinoma., J Mol Diagn, 2020. 22 (11)(11): p. 1333-1343., https://pubmed.ncbi.nlm.nih.gov/32822851/
83. Dahlstrom, KR, Anderson, KS, Guo, M, Kwon, MC, Messick, CA, Pettaway, CA, et.al. Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial., Oral Oncol, 2021. 120 (): p. 105397., https://pubmed.ncbi.nlm.nih.gov/34182223/
84. Wichmann, G, Rudolph, J, Henger, S, Engel, C, Wirkner, K, Wenning, JR, et.al. Is High-Risk Sexual Behavior a Risk Factor for Oropharyngeal Cancer?, Cancers (Basel), 2023. 15 (13)(13):, https://pubmed.ncbi.nlm.nih.gov/37444466/
85. Quabius, ES, Fazel, A, Knieling, C, Gebhardt, S, Laudien, M, Moore, C, et.al. No association between HPV-status in tonsillar tissue and sexual behavior of the patients in a northern German population - Critical view of the link between HPV natural history and HPV-driven carcinogenesis., Papillomavirus Res, 2020. 10 (): p. 100207., https://pubmed.ncbi.nlm.nih.gov/32971320/
86. Reuschenbach, M, Wagner, S, Würdemann, N, Sharma, SJ, Prigge, ES, Sauer, M, et.al. [Human papillomavirus and squamous cell cancer of the head and neck region : Prognostic, therapeutic and prophylactic implications]., HNO, 2016. 64 (7)(7): p. 450-9., https://pubmed.ncbi.nlm.nih.gov/26864190/
87. Zimmermann, PH, Stuut, M, Wuerdemann, N, Möllenhoff, K, Suchan, M, Eckel, H, et.al. Upfront Surgery vs. Primary Chemoradiation in an Unselected, Bicentric Patient Cohort with Oropharyngeal Squamous Cell Carcinoma-A Matched-Pair Analysis., Cancers (Basel), 2021. 13 (21)(21):, https://pubmed.ncbi.nlm.nih.gov/34771428/
88. Wagner, S, Wittekindt, C, Sharma, SJ, Wuerdemann, N, Jüttner, T, Reuschenbach, M, et.al. Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer., Br J Cancer, 2017. 116 (12)(12): p. 1604-1611., https://pubmed.ncbi.nlm.nih.gov/28472822/
89. LaPak, KM, Burd, CE, The molecular balancing act of p16(INK4a) in cancer and aging., Mol Cancer Res, 2014. 12 (2)(2): p. 167-83., https://pubmed.ncbi.nlm.nih.gov/24136988/
90. Rayess, H, Wang, MB, Srivatsan, ES, Cellular senescence and tumor suppressor gene p16., Int J Cancer, 2012. 130 (8)(8): p. 1715-25., https://pubmed.ncbi.nlm.nih.gov/22025288/
91. Moody, CA, Laimins, LA, Human papillomavirus oncoproteins: pathways to transformation., Nat Rev Cancer, 2010. 10 (8)(8): p. 550-60., https://pubmed.ncbi.nlm.nih.gov/20592731/
92. Amin, Mahul B., Edge, Stephen B., AJCC cancer staging manualSpringer, American Joint Committee on Cancer cancer staging manual, 2017. 8th edition:
93. Fakhry, C, Lacchetti, C, Rooper, LM, Jordan, RC, Rischin, D, Sturgis, EM, et.al. Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline., J Clin Oncol, 2018. 36 (31)(31): p. 3152-3161., https://pubmed.ncbi.nlm.nih.gov/30188786/
94. Lewis, JS, Beadle, B, Bishop, JA, Chernock, RD, Colasacco, C, Lacchetti, C, et.al. Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists., Arch Pathol Lab Med, 2018. 142 (5)(5): p. 559-597., https://pubmed.ncbi.nlm.nih.gov/29251996/
95. Shelton, J, Purgina, BM, Cipriani, NA, Dupont, WD, Plummer, D, Lewis, JS, p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status., Mod Pathol, 2017. 30 (9)(9): p. 1194-1203., https://pubmed.ncbi.nlm.nih.gov/28621317/
96. Ennis, CM, Rohrbach, MR, Schwalbe, M, Mahajan, A, Hartig, GK, A Comparison of E6H4 and G175-405 p16-specific Monoclonal Antibodies in Oropharyngeal Squamous Cell Carcinoma., Appl Immunohistochem Mol Morphol, 2020. 28 (4)(4): p. 290-295., https://pubmed.ncbi.nlm.nih.gov/30664533/
97. Nauta, IH, Rietbergen, MM, van Bokhoven, AAJD, Bloemena, E, Lissenberg-Witte, BI, Heideman, DAM, et.al. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing., Ann Oncol, 2018. 29 (5)(5): p. 1273-1279., https://pubmed.ncbi.nlm.nih.gov/29438466/
98. Sathasivam, HP, Santambrogio, A, Andoniadou, CL, Robinson, M, Thavaraj, S, Prognostic utility of HPV specific testing in addition to p16 immunohistochemistry in oropharyngeal squamous cell carcinoma., Ann Oncol, 2018. 29 (10)(10): p. 2144-2145., https://pubmed.ncbi.nlm.nih.gov/30101315/
99. Augustin, JG, Lepine, C, Morini, A, Brunet, A, Veyer, D, Brochard, C, et.al. HPV Detection in Head and Neck Squamous Cell Carcinomas: What Is the Issue?, Front Oncol, 2020. 10 (): p. 1751., https://pubmed.ncbi.nlm.nih.gov/33042820/
100. Craig, SG, Anderson, LA, Schache, AG, Moran, M, Graham, L, Currie, K, et.al. Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach., Br J Cancer, 2019. 120 (8)(8): p. 827-833., https://pubmed.ncbi.nlm.nih.gov/30890775/
101. Rasmussen, JH, Grønhøj, C, Håkansson, K, Friborg, J, Andersen, E, Lelkaitis, G, et.al. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma., Ann Oncol, 2019. 30 (4)(4): p. 629-636., https://pubmed.ncbi.nlm.nih.gov/30657857/
102. Wagner, S, Prigge, ES, Wuerdemann, N, Reder, H, Bushnak, A, Sharma, SJ, et.al. Evaluation of p16, Br J Cancer, 2020. 123 (7)(7): p. 1114-1122., https://pubmed.ncbi.nlm.nih.gov/32624580/
103. Prigge, ES, Arbyn, M, von Knebel Doeberitz, M, Reuschenbach, M, Diagnostic accuracy of p16, Int J Cancer, 2017. 140 (5)(5): p. 1186-1198., https://pubmed.ncbi.nlm.nih.gov/27859245/
104. Holzinger, D, Flechtenmacher, C, Henfling, N, Kaden, I, Grabe, N, Lahrmann, B, et.al. Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway., Int J Cancer, 2013. 133 (6)(6): p. 1389-99., https://pubmed.ncbi.nlm.nih.gov/23457055/
105. Bussu, F, Ragin, C, Boscolo-Rizzo, P, Rizzo, D, Gallus, R, Delogu, G, et.al. HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice., Head Neck, 2019. 41 (4)(4): p. 1104-1111., https://pubmed.ncbi.nlm.nih.gov/30747478/
106. Chera, BS, Kumar, S, Beaty, BT, Marron, D, Jefferys, S, Green, R, et.al. Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer., Clin Cancer Res, 2019. 25 (15)(15): p. 4682-4690., https://pubmed.ncbi.nlm.nih.gov/31088830/
107. Haring, CT, Bhambhani, C, Brummel, C, Jewell, B, Bellile, E, Heft Neal, ME, et.al. Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma., Oncotarget, 2021. 12 (13)(13): p. 1214-1229., https://pubmed.ncbi.nlm.nih.gov/34194620/
108. Tanaka, H, Suzuki, M, Takemoto, N, Fukusumi, T, Eguchi, H, Takai, E, et.al. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary., Int J Cancer, 2022. 150 (1)(1): p. 174-186., https://pubmed.ncbi.nlm.nih.gov/34486724/
109. Cao, Y, Haring, CT, Brummel, C, Bhambhani, C, Aryal, M, Lee, C, et.al. Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma., Clin Cancer Res, 2022. 28 (2)(2): p. 350-359., https://pubmed.ncbi.nlm.nih.gov/34702772/
110. Mattox, AK, D'Souza, G, Khan, Z, Allen, H, Henson, S, Seiwert, TY, et.al. Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer., Oral Oncol, 2022. 128 (): p. 105805., https://pubmed.ncbi.nlm.nih.gov/35334415/
111. Haring, CT, Dermody, SM, Yalamanchi, P, Kang, SY, Old, MO, Chad Brenner, J, et.al. The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma., Oral Oncol, 2022. 126 (): p. 105776., https://pubmed.ncbi.nlm.nih.gov/35183912/
112. O'Sullivan, B, Huang, SH, Su, J, Garden, AS, Sturgis, EM, Dahlstrom, K, et.al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study., Lancet Oncol, 2016. 17 (4)(4): p. 440-451., https://pubmed.ncbi.nlm.nih.gov/26936027/
113. Huang, SH, Xu, W, Waldron, J, Siu, L, Shen, X, Tong, L, et.al. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas., J Clin Oncol, 2015. 33 (8)(8): p. 836-45., https://pubmed.ncbi.nlm.nih.gov/25667292/
114. Haughey, BH, Sinha, P, Kallogjeri, D, Goldberg, RL, Lewis, JS, Piccirillo, JF, et.al. Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx., Oral Oncol, 2016. 62 (): p. 11-19., https://pubmed.ncbi.nlm.nih.gov/27865363/
115. Huang, SH, O'Sullivan, B, Su, J, Bartlett, E, Kim, J, Waldron, JN, et.al. Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification., Radiother Oncol, 2020. 144 (): p. 13-22., https://pubmed.ncbi.nlm.nih.gov/31710939/
116. Boscolo-Rizzo, P, Dietz, A, The AJCC/UICC eighth edition for staging head and neck cancers: Is it wise to de-escalate treatment regimens in p16-positive oropharyngeal cancer patients?, Int J Cancer, 2017. 141 (7)(7): p. 1490-1491., https://pubmed.ncbi.nlm.nih.gov/28614904/
117. Becker, C, Hofauer, BG, Mansour, N, Ketterer, MC, Schulz, T, Knopf, A, [The 8th edition of the TNM staging system-a curse or a blessing for oropharyngeal carcinoma?], HNO, 2021. 69 (2)(2): p. 89-94., https://pubmed.ncbi.nlm.nih.gov/32385531/
118. Sharma, SJ, Wagner, S, Reder, HSF, Kroll, T, Wuerdemann, N, Klussmann, JP, et.al. The 8th edition AJCC/UICC TNM staging for p16-positive oropharyngeal carcinoma: is there space for improvement?, Eur Arch Otorhinolaryngol, 2018. 275 (12)(12): p. 3087-3091., https://pubmed.ncbi.nlm.nih.gov/30327906/
119. Slootweg, P. J. and J.R. Grandis, Tumours of the hypopharynx, larynx, trachea and parapharyngeal space, in WHO Classification of Head and Neck Tumours, 2017: Lyon. Fourth Edition: p. p. 77-104.
120. Agaimy, A, Weichert, W, [Grading of head and neck neoplasms]., Pathologe, 2016. 37 (4)(4): p. 285-92., https://pubmed.ncbi.nlm.nih.gov/27342593/
121. Byers, RM, El-Naggar, AK, Lee, YY, Rao, B, Fornage, B, Terry, NH, et.al. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue?, Head Neck, 1998. 20 (2)(2): p. 138-44., https://pubmed.ncbi.nlm.nih.gov/9484945/
122. Brasilino de Carvalho, M, Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx., Head Neck, 1998. 20 (1)(1): p. 16-21., https://pubmed.ncbi.nlm.nih.gov/9464947/
123. Tankéré, F, Camproux, A, Barry, B, Guedon, C, Depondt, J, Gehanno, P, Prognostic value of lymph node involvement in oral cancers: a study of 137 cases., Laryngoscope, 2000. 110 (12)(12): p. 2061-5., https://pubmed.ncbi.nlm.nih.gov/11129021/
124. Woolgar, JA, Rogers, SN, Lowe, D, Brown, JS, Vaughan, ED, Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread., Oral Oncol, 2003. 39 (2)(2): p. 130-7., https://pubmed.ncbi.nlm.nih.gov/12509965/
125. Suoglu, Y, Erdamar, B, Katircioglu, OS, Karatay, MC, Sunay, T, Extracapsular spread in ipsilateral neck and contralateral neck metastases in laryngeal cancer., Ann Otol Rhinol Laryngol, 2002. 111 (5 Pt 1)(5 Pt 1): p. 447-54., https://pubmed.ncbi.nlm.nih.gov/12018330/
126. Greenberg, JS, Fowler, R, Gomez, J, Mo, V, Roberts, D, El Naggar, AK, et.al. Extent of extracapsular spread: a critical prognosticator in oral tongue cancer., Cancer, 2003. 97 (6)(6): p. 1464-70., https://pubmed.ncbi.nlm.nih.gov/12627511/
127. Esposito, ED, Motta, S, Cassiano, B, Motta, G, Occult lymph node metastases in supraglottic cancers of the larynx., Otolaryngol Head Neck Surg, 2001. 124 (3)(3): p. 253-7., https://pubmed.ncbi.nlm.nih.gov/11240985/
128. Enepekides, DJ, Sultanem, K, Nguyen, C, Shenouda, G, Black, MJ, Rochon, L, Occult cervical metastases: immunoperoxidase analysis of the pathologically negative neck., Otolaryngol Head Neck Surg, 1999. 120 (5)(5): p. 713-7., https://pubmed.ncbi.nlm.nih.gov/10229598/
129. Ferlito, A, Partridge, M, Brennan, J, Hamakawa, H, Lymph node micrometastases in head and neck cancer: a review., Acta Otolaryngol, 2001. 121 (6)(6): p. 660-5., https://pubmed.ncbi.nlm.nih.gov/11678163/
130. Barzan, L, Montomoli, C, Di Carlo, R, Bertinazzi, M, Colangeli, R, Martini, A, et.al. Multicentre study on resection margins in carcinoma of the oral cavity, oro-hypopharynx and larynx., Acta Otorhinolaryngol Ital, 2022. 42 (2)(2): p. 126-139., https://pubmed.ncbi.nlm.nih.gov/35612504/
131. Looser, KG, Shah, JP, Strong, EW, The significance of "positive" margins in surgically resected epidermoid carcinomas., Head Neck Surg 1 (2)(2): p. 107-11., https://pubmed.ncbi.nlm.nih.gov/755803/
132. Scholl, P, Byers, RM, Batsakis, JG, Wolf, P, Santini, H, Microscopic cut-through of cancer in the surgical treatment of squamous carcinoma of the tongue. Prognostic and therapeutic implications., Am J Surg, 1986. 152 (4)(4): p. 354-60., https://pubmed.ncbi.nlm.nih.gov/3766863/
133. Kwok, P, Gleich, O, Hübner, G, Strutz, J, Prognostic importance of "clear versus revised margins" in oral and pharyngeal cancer., Head Neck, 2010. 32 (11)(11): p. 1479-84., https://pubmed.ncbi.nlm.nih.gov/20175196/
134. Jäckel, MC, Ambrosch, P, Martin, A, Steiner, W, Impact of re-resection for inadequate margins on the prognosis of upper aerodigestive tract cancer treated by laser microsurgery., Laryngoscope, 2007. 117 (2)(2): p. 350-6., https://pubmed.ncbi.nlm.nih.gov/17204985/
135. Haughey, BH, Sinha, P, Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer., Laryngoscope, 2012. 122 Suppl 2 (): p. S13-33., https://pubmed.ncbi.nlm.nih.gov/22926949/
136. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Head and Neck Cancers, Version 1.2023., Dezember 2022., https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1437
137. Rostoft, S, O'Donovan, A, Soubeyran, P, Alibhai, SMH, Hamaker, ME, Geriatric Assessment and Management in Cancer., J Clin Oncol, 2021. 39 (19)(19): p. 2058-2067., https://pubmed.ncbi.nlm.nih.gov/34043439/
138. Chow, WB, Rosenthal, RA, Merkow, RP, Ko, CY, Esnaola, NF, Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society., J Am Coll Surg, 2012. 215 (4)(4): p. 453-66., https://pubmed.ncbi.nlm.nih.gov/22917646/
139. Hernandez Torres, C, Hsu, T, Comprehensive Geriatric Assessment in the Older Adult with Cancer: A Review., Eur Urol Focus, 2017. 3 (4-5)(4-5): p. 330-339., https://pubmed.ncbi.nlm.nih.gov/29331624/
140. Mendoza, TR, Kehl, KL, Bamidele, O, Williams, LA, Shi, Q, Cleeland, CS, et.al. Assessment of baseline symptom burden in treatment-naïve patients with lung cancer: an observational study., Support Care Cancer, 2019. 27 (9)(9): p. 3439-3447., https://pubmed.ncbi.nlm.nih.gov/30661202/
141. Newcomb, RA, Nipp, RD, Waldman, LP, Greer, JA, Lage, DE, Hochberg, EP, et.al. Symptom burden in patients with cancer who are experiencing unplanned hospitalization., Cancer, 2020. 126 (12)(12): p. 2924-2933., https://pubmed.ncbi.nlm.nih.gov/32167594/
142. Bellera, CA, Rainfray, M, Mathoulin-Pélissier, S, Mertens, C, Delva, F, Fonck, M, et.al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool., Ann Oncol, 2012. 23 (8)(8): p. 2166-2172., https://pubmed.ncbi.nlm.nih.gov/22250183/
143. Stiel, S, Matthes, ME, Bertram, L, Ostgathe, C, Elsner, F, Radbruch, L, [Validation of the new version of the minimal documentation system (MIDOS) for patients in palliative care : the German version of the edmonton symptom assessment scale (ESAS)]., Schmerz, 2010. 24 (6)(6): p. 596-604., https://pubmed.ncbi.nlm.nih.gov/20882300/
144. Wiegand, S, Dietz, A, Wichmann, G, Kunz, V, [Frailty in Head and Neck Oncology]., Laryngorhinootologie, 2022. 101 (3)(3): p. 249-258., https://pubmed.ncbi.nlm.nih.gov/35226958/
145. Kunz, V, Wichmann, G, Lehmann-Laue, A, Mehnert-Theuerkauf, A, Dietz, A, Wiegand, S, Screening for distress, related problems and perceived need for psycho-oncological support in head and neck squamous cell carcinoma (HNSCC) patients: a retrospective cohort study., BMC Cancer, 2021. 21 (1)(1): p. 478., https://pubmed.ncbi.nlm.nih.gov/33926414/
146. Kunz, V, Wichmann, G, Wald, T, Pirlich, M, Zebralla, V, Dietz, A, et.al. Frailty Assessed with FRAIL Scale and G8 Questionnaire Predicts Severe Postoperative Complications in Patients Receiving Major Head and Neck Surgery., J Clin Med, 2022. 11 (16)(16):, https://pubmed.ncbi.nlm.nih.gov/36012953/
147. Goerres, GW, Schmid, DT, Schuknecht, B, Eyrich, GK, Bone invasion in patients with oral cavity cancer: comparison of conventional CT with PET/CT and SPECT/CT., Radiology, 2005. 237 (1)(1): p. 281-7., https://pubmed.ncbi.nlm.nih.gov/16118155/
148. Yen, TC, Chang, JT, Ng, SH, Chang, YC, Chan, SC, Wang, HM, et.al. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology., J Nucl Med, 2005. 46 (5)(5): p. 775-81., https://pubmed.ncbi.nlm.nih.gov/15872350;16724209/
149. Hafidh, MA, Lacy, PD, Hughes, JP, Duffy, G, Timon, CV, Evaluation of the impact of addition of PET to CT and MR scanning in the staging of patients with head and neck carcinomas., Eur Arch Otorhinolaryngol, 2006. 263 (9)(9): p. 853-9., https://pubmed.ncbi.nlm.nih.gov/16724209/
150. Wax, MK, Myers, LL, Gona, JM, Husain, SS, Nabi, HA, The role of positron emission tomography in the evaluation of the N-positive neck., Otolaryngol Head Neck Surg, 2003. 129 (3)(3): p. 163-7., https://pubmed.ncbi.nlm.nih.gov/12958562/
151. Krabbe, CA, Dijkstra, PU, Pruim, J, van der Laan, BF, van der Wal, JE, Gravendeel, JP, et.al. FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases., Oral Oncol, 2008. 44 (1)(1): p. 31-6., https://pubmed.ncbi.nlm.nih.gov/17306603/
152. Nahmias, C, Carlson, ER, Duncan, LD, Blodgett, TM, Kennedy, J, Long, MJ, et.al. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer., J Oral Maxillofac Surg, 2007. 65 (12)(12): p. 2524-35., https://pubmed.ncbi.nlm.nih.gov/18022480/
153. Seitz, O, Chambron-Pinho, N, Middendorp, M, Sader, R, Mack, M, Vogl, TJ, et.al. 18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen., Neuroradiology, 2009. 51 (10)(10): p. 677-86., https://pubmed.ncbi.nlm.nih.gov/19727695/
154. Wolmark, N, Mamounas, EP, Baehner, FL, Butler, SM, Tang, G, Jamshidian, F, et.al. Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor-Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14., J Clin Oncol, 2016. 34 (20)(20): p. 2350-8., https://pubmed.ncbi.nlm.nih.gov/27217450/
155. Dammann, F, Horger, M, Mueller-Berg, M, Schlemmer, H, Claussen, CD, Claussen, C, et.al. Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET., AJR Am J Roentgenol, 2005. 184 (4)(4): p. 1326-31., https://pubmed.ncbi.nlm.nih.gov/15788619/
156. Gu, DH, Yoon, DY, Park, CH, Chang, SK, Lim, KJ, Seo, YL, et.al. CT, MR, (18)F-FDG PET/CT, and their combined use for the assessment of mandibular invasion by squamous cell carcinomas of the oral cavity., Acta Radiol, 2010. 51 (10)(10): p. 1111-9., https://pubmed.ncbi.nlm.nih.gov/20929295/
157. Kyzas, PA, Evangelou, E, Denaxa-Kyza, D, Ioannidis, JP, 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis., J Natl Cancer Inst, 2008. 100 (10)(10): p. 712-20., https://pubmed.ncbi.nlm.nih.gov/18477804/
158. Ng, SH, Yen, TC, Liao, CT, Chang, JT, Chan, SC, Ko, SF, et.al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation., J Nucl Med, 2005. 46 (7)(7): p. 1136-43., https://pubmed.ncbi.nlm.nih.gov/16000282/
159. Ng, SH, Yen, TC, Chang, JT, Chan, SC, Ko, SF, Wang, HM, et.al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck., J Clin Oncol, 2006. 24 (27)(27): p. 4371-6., https://pubmed.ncbi.nlm.nih.gov/16983105/
160. Sumi, M, Kimura, Y, Sumi, T, Nakamura, T, Diagnostic performance of MRI relative to CT for metastatic nodes of head and neck squamous cell carcinomas., J Magn Reson Imaging, 2007. 26 (6)(6): p. 1626-33., https://pubmed.ncbi.nlm.nih.gov/17968896/
161. van den Brekel, MW, Castelijns, JA, Stel, HV, Golding, RP, Meyer, CJ, Snow, GB, Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study., Eur Arch Otorhinolaryngol, 1993. 250 (1)(1): p. 11-7., https://pubmed.ncbi.nlm.nih.gov/8466744/
162. Wiener, E, Pautke, C, Link, TM, Neff, A, Kolk, A, Comparison of 16-slice MSCT and MRI in the assessment of squamous cell carcinoma of the oral cavity., Eur J Radiol, 2006. 58 (1)(1): p. 113-8., https://pubmed.ncbi.nlm.nih.gov/16337355/
163. Takes, RP, Righi, P, Meeuwis, CA, Manni, JJ, Knegt, P, Marres, HA, et.al. The value of ultrasound with ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neck., Int J Radiat Oncol Biol Phys, 1998. 40 (5)(5): p. 1027-32., https://pubmed.ncbi.nlm.nih.gov/9539556/
164. Stokkel, MP, ten Broek, FW, Hordijk, GJ, Koole, R, van Rijk, PP, Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography., Ann Surg, 2000. 231 (2)(2): p. 229-34., https://pubmed.ncbi.nlm.nih.gov/10674615/
165. Adams, S, Baum, RP, Stuckensen, T, Bitter, K, Hör, G, Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer., Eur J Nucl Med, 1998. 25 (9)(9): p. 1255-60., https://pubmed.ncbi.nlm.nih.gov/9724374/
166. Andrle, J, Schartinger, VH, Schwentner, I, Deibl, M, Sprinzl, GM, Initial staging examinations for head and neck squamous cell carcinoma: are they appropriate?, J Laryngol Otol, 2009. 123 (8)(8): p. 885-8., https://pubmed.ncbi.nlm.nih.gov/19371453/
167. Arunachalam, PS, Putnam, G, Jennings, P, Messersmith, R, Robson, AK, Role of computerized tomography (CT) scan of the chest in patients with newly diagnosed head and neck cancers., Clin Otolaryngol Allied Sci, 2002. 27 (5)(5): p. 409-11., https://pubmed.ncbi.nlm.nih.gov/12383307/
168. Loh, KS, Brown, DH, Baker, JT, Gilbert, RW, Gullane, PJ, Irish, JC, A rational approach to pulmonary screening in newly diagnosed head and neck cancer., Head Neck, 2005. 27 (11)(11): p. 990-4., https://pubmed.ncbi.nlm.nih.gov/16136584/
169. Ghosh, SK, Roland, NJ, Kumar, A, Tandon, S, Lancaster, JL, Jackson, SR, et.al. Detection of synchronous lung tumors in patients presenting with squamous cell carcinoma of the head and neck., Head Neck, 2009. 31 (12)(12): p. 1563-70., https://pubmed.ncbi.nlm.nih.gov/19475554/
170. Bongers, V, Hobbelink, MG, van Rijk, PP, Hordijk, GJ, Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer., Cancer Biother Radiopharm, 2002. 17 (3)(3): p. 303-6., https://pubmed.ncbi.nlm.nih.gov/12136522/
171. Lonneux, M, Lawson, G, Ide, C, Bausart, R, Remacle, M, Pauwels, S, Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient., Laryngoscope, 2000. 110 (9)(9): p. 1493-7., https://pubmed.ncbi.nlm.nih.gov/10983949/
172. Nakamoto, Y, Tamai, K, Saga, T, Higashi, T, Hara, T, Suga, T, et.al. Clinical value of image fusion from MR and PET in patients with head and neck cancer., Mol Imaging Biol 11 (1)(1): p. 46-53., https://pubmed.ncbi.nlm.nih.gov/18769975/
173. Imaizumi, A, Yoshino, N, Yamada, I, Nagumo, K, Amagasa, T, Omura, K, et.al. A potential pitfall of MR imaging for assessing mandibular invasion of squamous cell carcinoma in the oral cavity., AJNR Am J Neuroradiol, 2006. 27 (1)(1): p. 114-22., https://pubmed.ncbi.nlm.nih.gov/16418368/
174. Van Cann, EM, Koole, R, Oyen, WJ, de Rooy, JW, de Wilde, PC, Slootweg, PJ, et.al. Assessment of mandibular invasion of squamous cell carcinoma by various modes of imaging: constructing a diagnostic algorithm., Int J Oral Maxillofac Surg, 2008. 37 (6)(6): p. 535-41., https://pubmed.ncbi.nlm.nih.gov/18406107/
175. Leslie, A, Fyfe, E, Guest, P, Goddard, P, Kabala, JE, Staging of squamous cell carcinoma of the oral cavity and oropharynx: a comparison of MRI and CT in T- and N-staging., J Comput Assist Tomogr 23 (1)(1): p. 43-9., https://pubmed.ncbi.nlm.nih.gov/10050806/
176. Rohde, M, Dyrvig, AK, Johansen, J, Sørensen, JA, Gerke, O, Nielsen, AL, et.al. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis., Eur J Cancer, 2014. 50 (13)(13): p. 2271-9., https://pubmed.ncbi.nlm.nih.gov/25011659/
177. van den Brekel, MW, Castelijns, JA, Stel, HV, Golding, RP, Meyer, CJ, Snow, GB, Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study., Eur Arch Otorhinolaryngol, 1993. 250 (1)(1): p. 11-7., https://pubmed.ncbi.nlm.nih.gov/8466744/
178. Schroeder, U, Dietlein, M, Wittekindt, C, Ortmann, M, Stuetzer, H, Vent, J, et.al. Is there a need for positron emission tomography imaging to stage the N0 neck in T1-T2 squamous cell carcinoma of the oral cavity or oropharynx?, Ann Otol Rhinol Laryngol, 2008. 117 (11)(11): p. 854-63., https://pubmed.ncbi.nlm.nih.gov/19102133/
179. Roh, JL, Yeo, NK, Kim, JS, Lee, JH, Cho, KJ, Choi, SH, et.al. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma., Oral Oncol, 2007. 43 (9)(9): p. 887-93., https://pubmed.ncbi.nlm.nih.gov/17207656/
180. Schwartz, DL, Ford, E, Rajendran, J, Yueh, B, Coltrera, MD, Virgin, J, et.al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma., Int J Radiat Oncol Biol Phys, 2005. 61 (1)(1): p. 129-36., https://pubmed.ncbi.nlm.nih.gov/15629603/
181. Jeong, HS, Baek, CH, Son, YI, Cho, DY, Chung, MK, Min, JY, et.al. Sentinel lymph node radiolocalization with 99mTc filtered tin colloid in clinically node-negative squamous cell carcinomas of the oral cavity., J Korean Med Sci, 2006. 21 (5)(5): p. 865-70., https://pubmed.ncbi.nlm.nih.gov/17043421/
182. Yamazaki, Y, Saitoh, M, Notani, K, Tei, K, Totsuka, Y, Takinami, S, et.al. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer., Ann Nucl Med, 2008. 22 (3)(3): p. 177-84., https://pubmed.ncbi.nlm.nih.gov/18498032/
183. Piao, Y, Bold, B, Tayier, A, Ishida, R, Omura, K, Okada, N, et.al. Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma., Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009. 108 (6)(6): p. 933-8., https://pubmed.ncbi.nlm.nih.gov/19846326/
184. Park, SI, Guenette, JP, Suh, CH, Hanna, GJ, Chung, SR, Baek, JH, et.al. The diagnostic performance of CT and MRI for detecting extranodal extension in patients with head and neck squamous cell carcinoma: a systematic review and diagnostic meta-analysis., Eur Radiol, 2021. 31 (4)(4): p. 2048-2061., https://pubmed.ncbi.nlm.nih.gov/32949282/
185. Hohlweg-Majert, B, Metzger, MC, Voss, PJ, Hölzle, F, Wolff, KD, Schulze, D, Preoperative cervical lymph node size evaluation in patients with malignant head/neck tumors: comparison between ultrasound and computer tomography., J Cancer Res Clin Oncol, 2009. 135 (6)(6): p. 753-9., https://pubmed.ncbi.nlm.nih.gov/18830710/
186. Thomsen, JB, Sørensen, JA, Grupe, P, Karstoft, J, Krogdahl, A, Staging N0 oral cancer: lymphoscintigraphy and conventional imaging., Acta Radiol, 2005. 46 (5)(5): p. 492-6., https://pubmed.ncbi.nlm.nih.gov/16224924/
187. To, EW, Tsang, WM, Cheng, J, Lai, E, Pang, P, Ahuja, AT, et.al. Is neck ultrasound necessary for early stage oral tongue carcinoma with clinically N0 neck?, Dentomaxillofac Radiol, 2003. 32 (3)(3): p. 156-9., https://pubmed.ncbi.nlm.nih.gov/12917280/
188. Borgemeester, MC, van den Brekel, MW, van Tinteren, H, Smeele, LE, Pameijer, FA, van Velthuysen, ML, et.al. Ultrasound-guided aspiration cytology for the assessment of the clinically N0 neck: factors influencing its accuracy., Head Neck, 2008. 30 (11)(11): p. 1505-13., https://pubmed.ncbi.nlm.nih.gov/18704967/
189. Brouwer, J, de Bree, R, Comans, EF, Castelijns, JA, Hoekstra, OS, Leemans, CR, Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?, Eur Arch Otorhinolaryngol, 2004. 261 (9)(9): p. 479-83., https://pubmed.ncbi.nlm.nih.gov/14685887/
190. Yen, TC, Chang, JT, Ng, SH, Chang, YC, Chan, SC, Wang, HM, et.al. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology., J Nucl Med, 2005. 46 (5)(5): p. 775-81., https://pubmed.ncbi.nlm.nih.gov/15872350/
191. Kave, M, Sadegi, K, Parooie, F, Salarzaei, M, Diagnostic Accuracy of Combined PET/CT with MRI, 18F-FDG PET/MRI, and 18F-FDG PET/CT in Patients with Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis., Contrast Media Mol Imaging, 2021. 2021 (): p. 6653117., https://pubmed.ncbi.nlm.nih.gov/34007251/
192. Kaanders, JH, Hordijk, GJ, Carcinoma of the larynx: the Dutch national guideline for diagnostics, treatment, supportive care and rehabilitation., Radiother Oncol, 2002. 63 (3)(3): p. 299-307., https://pubmed.ncbi.nlm.nih.gov/12142094/
193. Pauleit, D, Zimmermann, A, Stoffels, G, Bauer, D, Risse, J, Flüss, MO, et.al. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer., J Nucl Med, 2006. 47 (2)(2): p. 256-61., https://pubmed.ncbi.nlm.nih.gov/16455631/
194. Höing, B, Wittig, L, Weber, L, Stuck, BA, Mattheis, S, Hussain, T, et.al. Abdominal ultrasound in head and neck squamous cell carcinoma staging: yes or no?, Eur Arch Otorhinolaryngol, 2023. 280 (4)(4): p. 1885-1891., https://pubmed.ncbi.nlm.nih.gov/36357610/
195. Chen, PG, Schoeff, SS, Watts, CA, Reibel, JF, Levine, PA, Shonka, DC, et.al. Utility of abdominal imaging to assess for liver metastasis in patients with head and neck cancer and abnormal liver function tests., Am J Otolaryngol, 2014. 35 (2)(2): p. 137-40., https://pubmed.ncbi.nlm.nih.gov/24315629/
196. Haerle, SK, Schmid, DT, Ahmad, N, Hany, TF, Stoeckli, SJ, The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma., Oral Oncol, 2011. 47 (7)(7): p. 653-9., https://pubmed.ncbi.nlm.nih.gov/21658990/
197. Johansen, J, Eigtved, A, Buchwald, C, Theilgaard, SA, Hansen, HS, Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study., Laryngoscope, 2002. 112 (11)(11): p. 2009-14., https://pubmed.ncbi.nlm.nih.gov/12439171/
198. Regelink, G, Brouwer, J, de Bree, R, Pruim, J, van der Laan, BF, Vaalburg, W, et.al. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities., Eur J Nucl Med Mol Imaging, 2002. 29 (8)(8): p. 1024-30., https://pubmed.ncbi.nlm.nih.gov/12173016/
199. Richard, C, Prevot, N, Timoshenko, AP, Dumollard, JM, Dubois, F, Martin, C, et.al. Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial N staging?, Acta Otolaryngol, 2010. 130 (12)(12): p. 1421-4., https://pubmed.ncbi.nlm.nih.gov/20735322/
200. Minovi, A, Hertel, A, Ural, A, Hofmann, E, Draf, W, Bockmuehl, U, Is PET superior to MRI in the pretherapeutic evaluation of head and neck squamous cell carcinoma?, Kulak Burun Bogaz Ihtis Derg, 2007. 17 (6)(6): p. 324-8., https://pubmed.ncbi.nlm.nih.gov/18187997/
201. Ozer, E, Naiboğlu, B, Meacham, R, Ryoo, C, Agrawal, A, Schuller, DE, The value of PET/CT to assess clinically negative necks., Eur Arch Otorhinolaryngol, 2012. 269 (11)(11): p. 2411-4., https://pubmed.ncbi.nlm.nih.gov/22249837/
202. Mehanna, H, Wong, WL, McConkey, CC, Rahman, JK, Robinson, M, Hartley, AG, et.al. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer., N Engl J Med, 2016. 374 (15)(15): p. 1444-54., https://pubmed.ncbi.nlm.nih.gov/27007578/
203. Mehanna, H, Evans, M, Beasley, M, Chatterjee, S, Dilkes, M, Homer, J, et.al. Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines., J Laryngol Otol, 2016. 130 (S2)(S2): p. S90-S96., https://pubmed.ncbi.nlm.nih.gov/27841123/
204. Breik, O, Kumar, A, Birchall, J, Mortimore, S, Laugharne, D, Jones, K, Follow up imaging of oral, oropharyngeal and hypopharyngeal cancer patients: Comparison of PET-CT and MRI post treatment., J Craniomaxillofac Surg, 2020. 48 (7)(7): p. 672-679., https://pubmed.ncbi.nlm.nih.gov/32513432/
205. Davidson, J, Gilbert, R, Irish, J, Witterick, I, Brown, D, Birt, D, et.al. The role of panendoscopy in the management of mucosal head and neck malignancy-a prospective evaluation., Head Neck, 2000. 22 (5)(5): p. 449-54; discussion 454-5., https://pubmed.ncbi.nlm.nih.gov/10897102/
206. Di Martino, E, Rieger, M, Hassan, HA, Hausmann, R, Reinecke, T, Lohmann, M, et.al. [Multiple primary carcinomas in patients with head and neck malignancies]., Laryngorhinootologie, 2000. 79 (12)(12): p. 711-8., https://pubmed.ncbi.nlm.nih.gov/11199453/
207. Haughey, BH, Gates, GA, Arfken, CL, Harvey, J, Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol., Ann Otol Rhinol Laryngol, 1992. 101 (2 Pt 1)(2 Pt 1): p. 105-12., https://pubmed.ncbi.nlm.nih.gov/1531402/
208. Kim, MK, Deschler, DG, Hayden, RE, Flexible esophagoscopy as part of routine panendoscopy in ENT resident and fellowship training., Ear Nose Throat J, 2001. 80 (1)(1): p. 49-50., https://pubmed.ncbi.nlm.nih.gov/11209519/
209. Rodriguez-Bruno, K, Ali, MJ, Wang, SJ, Role of panendoscopy to identify synchronous second primary malignancies in patients with oral cavity and oropharyngeal squamous cell carcinoma., Head Neck, 2011. 33 (7)(7): p. 949-53., https://pubmed.ncbi.nlm.nih.gov/21674670/
210. Sjögren, EV, Snijder, S, van Beekum, J, Baatenburg de Jong, RJ, Second malignant neoplasia in early (TIS-T1) glottic carcinoma., Head Neck, 2006. 28 (6)(6): p. 501-7., https://pubmed.ncbi.nlm.nih.gov/16673414/
211. Stoeckli, SJ, Zimmermann, R, Schmid, S, Role of routine panendoscopy in cancer of the upper aerodigestive tract., Otolaryngol Head Neck Surg, 2001. 124 (2)(2): p. 208-12., https://pubmed.ncbi.nlm.nih.gov/11226943/
212. Guardiola, E, Chaigneau, L, Villanueva, C, Pivot, X, Is there still a role for triple endoscopy as part of staging for head and neck cancer?, Curr Opin Otolaryngol Head Neck Surg, 2006. 14 (2)(2): p. 85-8., https://pubmed.ncbi.nlm.nih.gov/16552264/
213. Koo, K, Harris, R, Wiesenfeld, D, Iseli, TA, A role for panendoscopy? Second primary tumour in early stage squamous cell carcinoma of the oral tongue., J Laryngol Otol, 2015. 129 Suppl 1 (): p. S27-31., https://pubmed.ncbi.nlm.nih.gov/25656280/
214. Hung, SH, Tsai, MC, Liu, TC, Lin, HC, Chung, SD, Routine endoscopy for esophageal cancer is suggestive for patients with oral, oropharyngeal and hypopharyngeal cancer., PLoS One, 2013. 8 (8)(8): p. e72097., https://pubmed.ncbi.nlm.nih.gov/23977217/
215. Sharma, SJ, Linke, JJ, Kroll, T, Wuerdemann, N, Klussmann, JP, Guntinas-Lichius, O, et.al. Rigid Triple Endoscopy Improves Clinical Staging of Primary Head and Neck Cancer., Oncol Res Treat, 2018. 41 (1-2)(1-2): p. 35-38., https://pubmed.ncbi.nlm.nih.gov/29402786/
216. McGarey, PO, O'Rourke, AK, Owen, SR, Shonka, DC, Reibel, JF, Levine, PA, et.al. Rigid Esophagoscopy for Head and Neck Cancer Staging and the Incidence of Synchronous Esophageal Malignant Neoplasms., JAMA Otolaryngol Head Neck Surg, 2016. 142 (1)(1): p. 40-5., https://pubmed.ncbi.nlm.nih.gov/26633039/
217. Wang, H, Zhang, Y, Bai, W, Wang, B, Wei, J, Ji, R, et.al. Feasibility of Immunohistochemical p16 Staining in the Diagnosis of Human Papillomavirus Infection in Patients With Squamous Cell Carcinoma of the Head and Neck: A Systematic Review and Meta-Analysis., Front Oncol, 2020. 10 (): p. 524928., https://pubmed.ncbi.nlm.nih.gov/33324540/
218. Schildhaus, HU, Weichert, W, [Predictive diagnostics for checkpoint inhibitors]., Pathologe, 2021. 42 (4)(4): p. 380-390., https://pubmed.ncbi.nlm.nih.gov/33956171/
219. Schilling, C, Stoeckli, SJ, Vigili, MG, de Bree, R, Lai, SY, Alvarez, J, et.al. Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer., Head Neck, 2019. 41 (8)(8): p. 2655-2664., https://pubmed.ncbi.nlm.nih.gov/30896058/
220. Liu, M, Wang, SJ, Yang, X, Peng, H, Diagnostic Efficacy of Sentinel Lymph Node Biopsy in Early Oral Squamous Cell Carcinoma: A Meta-Analysis of 66 Studies., PLoS One, 2017. 12 (1)(1): p. e0170322., https://pubmed.ncbi.nlm.nih.gov/28107500/
221. Fan, SF, Zeng, ZY, Peng, HW, Guo, ZM, Wang, SL, Zhang, Q, Sentinel lymph node biopsy versus elective neck dissection in patients with cT1-2N0 oral tongue squamous cell carcinoma., Oral Surg Oral Med Oral Pathol Oral Radiol, 2014. 117 (2)(2): p. 186-90., https://pubmed.ncbi.nlm.nih.gov/24332157/
222. Moya-Plana, A, Aupérin, A, Guerlain, J, Gorphe, P, Casiraghi, O, Mamelle, G, et.al. Sentinel node biopsy in early oral squamous cell carcinomas: Long-term follow-up and nodal failure analysis., Oral Oncol, 2018. 82 (): p. 187-194., https://pubmed.ncbi.nlm.nih.gov/29909896/
223. Schiefke, F, Akdemir, M, Weber, A, Akdemir, D, Singer, S, Frerich, B, Function, postoperative morbidity, and quality of life after cervical sentinel node biopsy and after selective neck dissection., Head Neck, 2009. 31 (4)(4): p. 503-12., https://pubmed.ncbi.nlm.nih.gov/19156833/
224. van den Bosch, S, Czerwinski, M, Govers, T, Takes, RP, de Bree, R, Al-Mamgani, A, et.al. Diagnostic test accuracy of sentinel lymph node biopsy in squamous cell carcinoma of the oropharynx, larynx, and hypopharynx: A systematic review and meta-analysis., Head Neck, 2022. 44 (11)(11): p. 2621-2632., https://pubmed.ncbi.nlm.nih.gov/36047597/
225. Thompson, CF, St John, MA, Lawson, G, Grogan, T, Elashoff, D, Mendelsohn, AH, Diagnostic value of sentinel lymph node biopsy in head and neck cancer: a meta-analysis., Eur Arch Otorhinolaryngol, 2013. 270 (7)(7): p. 2115-22., https://pubmed.ncbi.nlm.nih.gov/23263205/
226. Werner, JA, Dünne, AA, Ramaswamy, A, Folz, BJ, Brandt, D, Külkens, C, et.al. Number and location of radiolabeled, intraoperatively identified sentinel nodes in 48 head and neck cancer patients with clinically staged N0 and N1 neck., Eur Arch Otorhinolaryngol, 2002. 259 (2)(2): p. 91-6., https://pubmed.ncbi.nlm.nih.gov/11954940/
227. Parzeller, Markus, Wenk, Maren, Zedler, Barbara, Rothschild, Markus, Aufklärung und Einwilligung bei ärztlichen Eingriffen, 2007. 104(9): p. A-576-86., https://www.aerzteblatt.de/archiv/aufklaerung-und-einwilligung-bei-aerztlichen-eingriffen-118d685b-d154-4ab1-a48f-88f14371f78e
228. Halbe, Bernd, Aufklärungspflicht Teil 2: Strafbarkeit von Ärzten bei unzureichender Patientenaufklärung, 2017. 114(19): p. A-962 / B-802 / C-784., https://www.aerzteblatt.de/archiv/aufklaerungspflicht-teil-2-strafbarkeit-von-aerzten-bei-unzureichender-patientenaufklaerung-a57781d3-44d2-4b4b-a7b0-aa2c81953680
229. Bundesgesetzblatt, Gesetz zur Verbesserung der Rechte von Patientinnen und Patienten vom 20. Februar 2013, 2013., http://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/Patientenrechtegesetz_BGBl.pdf
230. Gaissmaier, W, Gigerenzer, G, Statistical illiteracy undermines informed shared decision making., Z Evid Fortbild Qual Gesundhwes, 2008. 102 (7)(7): p. 411-3., https://pubmed.ncbi.nlm.nih.gov/19209567/
231. Gigerenzer, G, Gaissmaier, W, Kurz-Milcke, E, Schwartz, LM, Woloshin, S, Helping Doctors and Patients Make Sense of Health Statistics., Psychol Sci Public Interest, 2007. 8 (2)(2): p. 53-96., https://pubmed.ncbi.nlm.nih.gov/26161749/
232. Nichols, AC, Theurer, J, Prisman, E, Read, N, Berthelet, E, Tran, E, et.al. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial., J Clin Oncol, 2022. 40 (8)(8): p. 866-875., https://pubmed.ncbi.nlm.nih.gov/34995124/
233. Palma, DA, Prisman, E, Berthelet, E, Tran, E, Hamilton, S, Wu, J, et.al. Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial., JAMA Oncol, 2022. 8 (6)(6): p. 1-7., https://pubmed.ncbi.nlm.nih.gov/35482348/
234. Lefebvre, JL, Chevalier, D, Luboinski, B, Kirkpatrick, A, Collette, L, Sahmoud, T, Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group., J Natl Cancer Inst, 1996. 88 (13)(13): p. 890-9., https://pubmed.ncbi.nlm.nih.gov/8656441/
235. Yoshida, EJ, Luu, M, Mallen-St Clair, J, Mita, AC, Scher, KS, Lu, DJ, et.al. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?, Cancer, 2020. 126 (1)(1): p. 58-66., https://pubmed.ncbi.nlm.nih.gov/31536144/
236. Cheraghlou, S, Yu, PK, Otremba, MD, Park, HS, Bhatia, A, Zogg, CK, et.al. Treatment deintensification in human papillomavirus-positive oropharynx cancer: Outcomes from the National Cancer Data Base., Cancer, 2018. 124 (4)(4): p. 717-726., https://pubmed.ncbi.nlm.nih.gov/29243245/
237. Nichols, AC, Theurer, J, Prisman, E, Read, N, Berthelet, E, Tran, E, et.al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial., Lancet Oncol, 2019. 20 (10)(10): p. 1349-1359., https://pubmed.ncbi.nlm.nih.gov/31416685/
238. Baliga, S, Kabarriti, R, Jiang, J, Mehta, V, Guha, C, Kalnicki, S, et.al. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy., Oral Oncol, 2018. 86 (): p. 75-80., https://pubmed.ncbi.nlm.nih.gov/30409323/
239. Kelly, JR, Park, HS, An, Y, Yarbrough, WG, Contessa, JN, Decker, R, et.al. Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer., Oral Oncol, 2018. 79 (): p. 64-70., https://pubmed.ncbi.nlm.nih.gov/29598952/
240. Patel, EJ, Zhu, AW, Oliver, JR, Cornwell, M, Jacobson, AS, Hu, KS, et.al. Treatment of Early Stage Tonsil Cancer in the Age of Human Papillomavirus-Associated Malignancies., Otolaryngol Head Neck Surg, 2021. 165 (1)(1): p. 104-112., https://pubmed.ncbi.nlm.nih.gov/33290171/
241. Park, DA, Lee, MJ, Kim, SH, Lee, SH, Comparative safety and effectiveness of transoral robotic surgery versus open surgery for oropharyngeal cancer: A systematic review and meta-analysis., Eur J Surg Oncol, 2020. 46 (4 Pt A)(4 Pt A): p. 644-649., https://pubmed.ncbi.nlm.nih.gov/31627931/
242. Park, YM, Byeon, HK, Chung, HP, Choi, EC, Kim, SH, Comparison study of transoral robotic surgery and radical open surgery for hypopharyngeal cancer., Acta Otolaryngol, 2013. 133 (6)(6): p. 641-8., https://pubmed.ncbi.nlm.nih.gov/23448352/
243. Ford, SE, Brandwein-Gensler, M, Carroll, WR, Rosenthal, EL, Magnuson, JS, Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status., Otolaryngol Head Neck Surg, 2014. 151 (4)(4): p. 606-11., https://pubmed.ncbi.nlm.nih.gov/25049265/
244. Hammoudi, K, Pinlong, E, Kim, S, Bakhos, D, Morinière, S, Transoral robotic surgery versus conventional surgery in treatment for squamous cell carcinoma of the upper aerodigestive tract., Head Neck, 2015. 37 (9)(9): p. 1304-9., https://pubmed.ncbi.nlm.nih.gov/24816480/
245. Slama, K, Slouka, D, Slipka, J, Fischer, S, Short-term postoperative distress associated with open vs. transoral robotic surgery (TORS) in patients with T1-T2 carcinomas of the tongue base and supraglottis., Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2016. 160 (3)(3): p. 423-8., https://pubmed.ncbi.nlm.nih.gov/26996243/
246. Cheraghlou, S, Yu, PK, Otremba, MD, Park, HS, Bhatia, A, Zogg, CK, et.al. Treatment deintensification in human papillomavirus-positive oropharynx cancer: Outcomes from the National Cancer Data Base., Cancer, 2018. 124 (4)(4): p. 717-726., https://pubmed.ncbi.nlm.nih.gov/29243245/
247. Zenga, J, Wilson, M, Adkins, DR, Gay, HA, Haughey, BH, Kallogjeri, D, et.al. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma., JAMA Otolaryngol Head Neck Surg, 2015. 141 (12)(12): p. 1118-27., https://pubmed.ncbi.nlm.nih.gov/25902372/
248. Yeh, DH, Tam, S, Fung, K, MacNeil, SD, Yoo, J, Winquist, E, et.al. Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma - A systematic review of the literature., Eur J Surg Oncol, 2015. 41 (12)(12): p. 1603-14., https://pubmed.ncbi.nlm.nih.gov/26461255/
249. de Almeida, JR, Genden, EM, Robotic assisted reconstruction of the oropharynx., Curr Opin Otolaryngol Head Neck Surg, 2012. 20 (4)(4): p. 237-45., https://pubmed.ncbi.nlm.nih.gov/22894991/
250. Knecht, R, Bussmann, L, Möckelmann, N, Lörincz, BB, [Is (chemo)radiotherapy really the future standard in the treatment of oropharyngeal carcinoma?]., HNO, 2016. 64 (4)(4): p. 221-6., https://pubmed.ncbi.nlm.nih.gov/26992383/
251. Lörincz, BB, Jowett, N, Knecht, R, Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective., Head Neck, 2016. 38 Suppl 1 (): p. E2190-6., https://pubmed.ncbi.nlm.nih.gov/25833809/
252. Weinstein, GS, O'Malley, BW, Snyder, W, Sherman, E, Quon, H, Transoral robotic surgery: radical tonsillectomy., Arch Otolaryngol Head Neck Surg, 2007. 133 (12)(12): p. 1220-6., https://pubmed.ncbi.nlm.nih.gov/18086963/
253. Lang, S, Mattheis, S, Kansy, B, TORS in HPV-Positive Tumors-The New Standard?, Recent Results Cancer Res, 2017. 206 (): p. 207-218., https://pubmed.ncbi.nlm.nih.gov/27699541/
254. Gangwani, K, Shetty, L, Seshagiri, R, Kulkarni, D, Comparison of TORS with Conventional Surgery for Oropharyngeal Carcinomas in T1-T4 Lesions., Ann Maxillofac Surg, 2019. 9 (2)(2): p. 387-392., https://pubmed.ncbi.nlm.nih.gov/31909020/
255. Mattheis, S, Hasskamp, P, Holtmann, L, Schäfer, C, Geisthoff, U, Dominas, N, et.al. Flex Robotic System in transoral robotic surgery: The first 40 patients., Head Neck, 2017. 39 (3)(3): p. 471-475., https://pubmed.ncbi.nlm.nih.gov/27792258/
256. Ford, SE, Brandwein-Gensler, M, Carroll, WR, Rosenthal, EL, Magnuson, JS, Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status., Otolaryngol Head Neck Surg, 2014. 151 (4)(4): p. 606-11., https://pubmed.ncbi.nlm.nih.gov/25049265/
257. Biron, VL, O'Connell, DA, Barber, B, Clark, JM, Andrews, C, Jeffery, CC, et.al. Transoral robotic surgery with radial forearm free flap reconstruction: case control analysis., J Otolaryngol Head Neck Surg, 2017. 46 (1)(1): p. 20., https://pubmed.ncbi.nlm.nih.gov/28292318/
258. Richmon, JD, Quon, H, Gourin, CG, The effect of transoral robotic surgery on short-term outcomes and cost of care after oropharyngeal cancer surgery., Laryngoscope, 2014. 124 (1)(1): p. 165-71., https://pubmed.ncbi.nlm.nih.gov/23945993/
259. Liu, H, Wang, Y, Wu, C, Sun, X, Li, L, Li, C, et.al. Robotic compared with open operations for cancers of the head and neck: a systematic review and meta-analysis., Br J Oral Maxillofac Surg, 2019. 57 (10)(10): p. 967-976., https://pubmed.ncbi.nlm.nih.gov/31522917/
260. Hutcheson, KA, Holsinger, FC, Kupferman, ME, Lewin, JS, Functional outcomes after TORS for oropharyngeal cancer: a systematic review., Eur Arch Otorhinolaryngol, 2015. 272 (2)(2): p. 463-71., https://pubmed.ncbi.nlm.nih.gov/24643851/
261. Yom, SS, Torres-Saavedra, P, Caudell, JJ, Waldron, JN, Gillison, ML, Xia, P, et.al. Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)., J Clin Oncol, 2021. 39 (9)(9): p. 956-965., https://pubmed.ncbi.nlm.nih.gov/33507809/
262. Zech, HB, Betz, CS, Hoffmann, TK, Klussmann, JP, Deitmer, T, Guntinas-Lichius, O, [Radiation or Surgery for HPV-positive oropharyngeal cancer? The ORATOR2 Trial - Comparing apples and oranges]., Laryngorhinootologie, 2023. 102 (3)(3): p. 169-176., https://pubmed.ncbi.nlm.nih.gov/36858059/
263. Nichols, AC, Lang, P, Prisman, E, Berthelet, E, Tran, E, Hamilton, S, et.al. Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial., BMC Cancer, 2020. 20 (1)(1): p. 125., https://pubmed.ncbi.nlm.nih.gov/32059705/
264. Davies, JC, Husain, Z, Day, TA, Graboyes, EM, Eskander, A, Perioperative Mortality Risk in Patients Undergoing Transoral Robotic Surgery for T1-T2 Oropharyngeal Squamous Cell Carcinoma: A National Cancer Database Study., Front Oncol, 2021. 11 (): p. 808465., https://pubmed.ncbi.nlm.nih.gov/35071012/
265. Hoffmann, TK, [ORATOR study : Surgery or radiotherapy for oropharyngeal carcinoma in the context of HPV?]., HNO, 2020. 68 (4)(4): p. 278-279., https://pubmed.ncbi.nlm.nih.gov/32060569/
266. Hoffmann, TK, [The ORATOR trials-an update : Primary surgery or radiotherapy for HPV-associated oropharyngeal cancer]., HNO, 2022. 70 (8)(8): p. 579-580., https://pubmed.ncbi.nlm.nih.gov/35727350/
267. Amin, JD, Kallen, ME, Hatten, KM, Radical Tonsillectomy and Superior Pharyngeal Constrictor Anatomy: A Cadaveric and Oncologic Specimen Assessment., ORL J Otorhinolaryngol Relat Spec, 2020. 82 (6)(6): p. 318-326., https://pubmed.ncbi.nlm.nih.gov/32659762/
268. Hinni, ML, Zarka, MA, Hoxworth, JM, Margin mapping in transoral surgery for head and neck cancer., Laryngoscope, 2013. 123 (5)(5): p. 1190-8., https://pubmed.ncbi.nlm.nih.gov/23382042/
269. Stelmes, JJ, Gregoire, V, Poorten, VV, Golusiñski, W, Szewczyk, M, Jones, T, et.al. Organ Preservation and Late Functional Outcome in Oropharyngeal Carcinoma: Rationale of EORTC 1420, the "Best of" Trial., Front Oncol, 2019. 9 (): p. 999., https://pubmed.ncbi.nlm.nih.gov/31696052/
270. de Almeida, JR, Li, R, Magnuson, JS, Smith, RV, Moore, E, Lawson, G, et.al. Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional Study., JAMA Otolaryngol Head Neck Surg, 2015. 141 (12)(12): p. 1043-1051., https://pubmed.ncbi.nlm.nih.gov/26402479/
271. Holcomb, AJ, Herberg, M, Strohl, M, Ochoa, E, Feng, AL, Abt, NB, et.al. Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma., Head Neck, 2021. 43 (8)(8): p. 2434-2444., https://pubmed.ncbi.nlm.nih.gov/33856083/
272. Pool, C, Weaver, T, Zhu, J, Goldenberg, D, Goyal, N, Surgical Margin Determination in the Era of HPV-Positive Oropharyngeal Cancer., Laryngoscope, 2021. 131 (10)(10): p. E2650-E2654., https://pubmed.ncbi.nlm.nih.gov/33797105/
273. Preuss, SF, Quante, G, Semrau, R, Mueller, RP, Klussmann, JP, Guntinas-Lichius, O, An analysis of surgical complications, morbidity, and cost calculation in patients undergoing multimodal treatment for operable oropharyngeal carcinoma., Laryngoscope, 2007. 117 (1)(1): p. 101-5., https://pubmed.ncbi.nlm.nih.gov/17135978/
274. Paleri, V, Simon, C, Gorphe, P, Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus-Associated Oropharyngeal Cancer., JAMA Oncol, 2022. 8 (10)(10): p. 1512-1513., https://pubmed.ncbi.nlm.nih.gov/35980619/
275. Simon, C, Caballero, C, Gregoire, V, Thurnher, D, Koivunen, P, Ceruse, P, et.al. Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' study., Eur J Cancer, 2018. 103 (): p. 69-77., https://pubmed.ncbi.nlm.nih.gov/30216847/
276. Laccourreye, O, Malinvaud, D, Garcia, D, Ménard, M, Hans, S, Cauchois, R, et.al. Postoperative hemorrhage after transoral oropharyngectomy for cancer of the lateral oropharynx., Ann Otol Rhinol Laryngol, 2015. 124 (5)(5): p. 361-7., https://pubmed.ncbi.nlm.nih.gov/25385839/
277. Salassa, JR, Hinni, ML, Grant, DG, Hayden, RE, Postoperative bleeding in transoral laser microsurgery for upper aerodigestive tract tumors., Otolaryngol Head Neck Surg, 2008. 139 (3)(3): p. 453-9., https://pubmed.ncbi.nlm.nih.gov/18722230/
278. Esriti, A, Maurer, J, Mann, W, [Postoperative bleeding after laser surgery in head and neck tumors]., Laryngorhinootologie, 2004. 83 (2)(2): p. 102-7., https://pubmed.ncbi.nlm.nih.gov/14999585/
279. Pollei, TR, Hinni, ML, Moore, EJ, Hayden, RE, Olsen, KD, Casler, JD, et.al. Analysis of postoperative bleeding and risk factors in transoral surgery of the oropharynx., JAMA Otolaryngol Head Neck Surg, 2013. 139 (11)(11): p. 1212-8., https://pubmed.ncbi.nlm.nih.gov/24113922/
280. Dietz, Andreas, Fischer, Milos, Magill, Christina, Haughey, Bruce, Principles and New Approaches in Surgical Reconstruction2016/08/23. p. 575 - 589., 10.1007/978-3-, 319-27601-4_32
281. Remmert, Stephan, Wiederherstellung der HNO-Funktion durch plastisch-rekonstruktive Chirurgie : : Expertise Plastische ChirurgieGeorg Thieme Verlag, 2018., 10.1055/b-005-143303
282. Lang, Stephan H., Bootz, Friedrich, , Remmert Stephan, Lappenplastiken und Transplantate im Kopf-Hals-BereichGeorg Thieme Verlag, Expertise Plastische Chirurgie, 2018.
283. Hoffmann, Thomas, Hoffmann, Jürgen, Hänggi, Daniel, Klußmann, Jens Peter, Springer-Verlag Gmb, H., Rekonstruktive Kopf-Hals-ChirurgieSpringer Berlin, 2023.
284. Takahashi, M, Hwang, M, Misiukiewicz, K, Gupta, V, Miles, BA, Bakst, R, et.al. Quality of Life Analysis of HPV-Positive Oropharyngeal Cancer Patients in a Randomized Trial of Reduced-Dose Versus Standard Chemoradiotherapy: 5-Year Follow-Up., Front Oncol, 2022. 12 (): p. 859992., https://pubmed.ncbi.nlm.nih.gov/35463348/
285. Ferris, RL, Flamand, Y, Weinstein, GS, Li, S, Quon, H, Mehra, R, et.al. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)., J Clin Oncol, 2022. 40 (2)(2): p. 138-149., https://pubmed.ncbi.nlm.nih.gov/34699271/
286. Gupta, T, Sinha, S, Ghosh-Laskar, S, Budrukkar, A, Mummudi, N, Swain, M, et.al. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial., Radiat Oncol, 2020. 15 (1)(1): p. 218., https://pubmed.ncbi.nlm.nih.gov/32938468/
287. Vergeer, MR, Doornaert, PA, Rietveld, DH, Leemans, CR, Slotman, BJ, Langendijk, JA, Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program., Int J Radiat Oncol Biol Phys, 2009. 74 (1)(1): p. 1-8., https://pubmed.ncbi.nlm.nih.gov/19111400/
288. Anand, AK, Chaudhoory, AR, Shukla, A, Negi, PS, Sinha, SN, Babu, AA, et.al. Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer., Br J Radiol, 2008. 81 (971)(971): p. 865-71., https://pubmed.ncbi.nlm.nih.gov/18941046/
289. van der Laan, HP, Christianen, ME, Bijl, HP, Schilstra, C, Langendijk, JA, The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: an in silico planning comparative study., Radiother Oncol, 2012. 103 (1)(1): p. 76-81., https://pubmed.ncbi.nlm.nih.gov/22112778/
290. Christianen, ME, van der Schaaf, A, van der Laan, HP, Verdonck-de Leeuw, IM, Doornaert, P, Chouvalova, O, et.al. Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: Clinical validation according to the model-based approach., Radiother Oncol, 2016. 118 (2)(2): p. 298-303., https://pubmed.ncbi.nlm.nih.gov/26700602/
291. Wopken, K, Bijl, HP, van der Schaaf, A, van der Laan, HP, Chouvalova, O, Steenbakkers, RJ, et.al. Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer., Radiother Oncol, 2014. 113 (1)(1): p. 95-101., https://pubmed.ncbi.nlm.nih.gov/25443500/
292. Kierkels, RG, Korevaar, EW, Steenbakkers, RJ, Janssen, T, van't Veld, AA, Langendijk, JA, et.al. Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans., Radiother Oncol, 2014. 112 (3)(3): p. 430-6., https://pubmed.ncbi.nlm.nih.gov/25220369/
293. Ashour, MG, Shouman, TH, Hassouna, AH, Mokhtar, MH, Emad El Din, R, Youssef, AA, et.al. Swallowing sparing intensity modulated radiotherapy versus standard parotid sparing intensity-modulated radiotherapy for treatment of head and neck cancer: a randomized clinical trial., Acta Oncol, 2022. 61 (2)(2): p. 134-140., https://pubmed.ncbi.nlm.nih.gov/35000532/
294. Gawryszuk, A, Bijl, HP, Holwerda, M, Halmos, GB, Wedman, J, Witjes, MJH, et.al. Functional Swallowing Units (FSUs) as organs-at-risk for radiotherapy. PART 1: Physiology and anatomy., Radiother Oncol, 2019. 130 (): p. 62-67., https://pubmed.ncbi.nlm.nih.gov/30420235/
295. Gawryszuk, A, Bijl, HP, Holwerda, M, Halmos, GB, Wedman, J, Witjes, MJH, et.al. Functional Swallowing Units (FSUs) as organs-at-risk for radiotherapy. PART 2: Advanced delineation guidelines for FSUs., Radiother Oncol, 2019. 130 (): p. 68-74., https://pubmed.ncbi.nlm.nih.gov/30551889/
296. Grégoire, V, Evans, M, Le, QT, Bourhis, J, Budach, V, Chen, A, et.al. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines., Radiother Oncol, 2018. 126 (1)(1): p. 3-24., https://pubmed.ncbi.nlm.nih.gov/29180076/
297. Grégoire, V, Ang, K, Budach, W, Grau, C, Hamoir, M, Langendijk, JA, et.al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines., Radiother Oncol, 2014. 110 (1)(1): p. 172-81., https://pubmed.ncbi.nlm.nih.gov/24183870/
298. Biau, J, Lapeyre, M, Troussier, I, Budach, W, Giralt, J, Grau, C, et.al. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update., Radiother Oncol, 2019. 134 (): p. 1-9., https://pubmed.ncbi.nlm.nih.gov/31005201/
299. Suwinski, R, Sowa, A, Rutkowski, T, Wydmanski, J, Tarnawski, R, Maciejewski, B, Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients., Int J Radiat Oncol Biol Phys, 2003. 56 (2)(2): p. 399-412., https://pubmed.ncbi.nlm.nih.gov/12738315/
300. Roberts, SA, Hendry, JH, The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data., Radiother Oncol, 1993. 29 (1)(1): p. 69-74., https://pubmed.ncbi.nlm.nih.gov/8295990/
301. Huang, J, Barbera, L, Brouwers, M, Browman, G, Mackillop, WJ, Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review., J Clin Oncol, 2003. 21 (3)(3): p. 555-63., https://pubmed.ncbi.nlm.nih.gov/12560449/
302. Mehanna, H, Robinson, M, Hartley, A, Kong, A, Foran, B, Fulton-Lieuw, T, et.al. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial., Lancet, 2019. 393 (10166)(10166): p. 51-60., https://pubmed.ncbi.nlm.nih.gov/30449623/
303. Rischin, D, King, M, Kenny, L, Porceddu, S, Wratten, C, Macann, A, et.al. Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group Study., Int J Radiat Oncol Biol Phys, 2021. 111 (4)(4): p. 876-886., https://pubmed.ncbi.nlm.nih.gov/34098030/
304. Gillison, ML, Trotti, AM, Harris, J, Eisbruch, A, Harari, PM, Adelstein, DJ, et.al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial., Lancet, 2019. 393 (10166)(10166): p. 40-50., https://pubmed.ncbi.nlm.nih.gov/30449625/
305. Bonner, JA, Harari, PM, Giralt, J, Azarnia, N, Shin, DM, Cohen, RB, et.al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck., N Engl J Med, 2006. 354 (6)(6): p. 567-78., https://pubmed.ncbi.nlm.nih.gov/16467544/
306. Rosenthal, DI, Harari, PM, Giralt, J, Bell, D, Raben, D, Liu, J, et.al. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab., J Clin Oncol, 2016. 34 (12)(12): p. 1300-8., https://pubmed.ncbi.nlm.nih.gov/26712222/
307. Seiwert, TY, Foster, CC, Blair, EA, Karrison, TG, Agrawal, N, Melotek, JM, et.al. OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer., Ann Oncol, 2019. 30 (10)(10): p. 1673., https://pubmed.ncbi.nlm.nih.gov/31168601/
308. Denis, F, Garaud, P, Bardet, E, Alfonsi, M, Sire, C, Germain, T, et.al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma., J Clin Oncol, 2004. 22 (1)(1): p. 69-76., https://pubmed.ncbi.nlm.nih.gov/14657228/
309. Bourhis, J, Sire, C, Graff, P, Grégoire, V, Maingon, P, Calais, G, et.al. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial., Lancet Oncol, 2012. 13 (2)(2): p. 145-53., https://pubmed.ncbi.nlm.nih.gov/22261362/
310. Olmi, P, Crispino, S, Fallai, C, Torri, V, Rossi, F, Bolner, A, et.al. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial., Int J Radiat Oncol Biol Phys, 2003. 55 (1)(1): p. 78-92., https://pubmed.ncbi.nlm.nih.gov/12504039/
311. Fallai, C, Bolner, A, Signor, M, Gava, A, Franchin, G, Ponticelli, P, et.al. Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx., Tumori, 2006. 92 (1)(1): p. 41-54., https://pubmed.ncbi.nlm.nih.gov/16683383/
312. Semrau, R, Mueller, RP, Stuetzer, H, Staar, S, Schroeder, U, Guntinas-Lichius, O, et.al. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer., Int J Radiat Oncol Biol Phys, 2006. 64 (5)(5): p. 1308-16., https://pubmed.ncbi.nlm.nih.gov/16464538/
313. Budach, V, Stromberger, C, Poettgen, C, Baumann, M, Budach, W, Grabenbauer, G, et.al. Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial., Int J Radiat Oncol Biol Phys, 2015. 91 (5)(5): p. 916-24., https://pubmed.ncbi.nlm.nih.gov/25670541/
314. Keane, TJ, Cummings, BJ, O'Sullivan, B, Payne, D, Rawlinson, E, MacKenzie, R, et.al. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma., Int J Radiat Oncol Biol Phys, 1993. 25 (4)(4): p. 613-8., https://pubmed.ncbi.nlm.nih.gov/8454478/
315. Patil, VM, Noronha, V, Menon, N, Singh, A, Ghosh-Laskar, S, Budrukkar, A, et.al. Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation., J Clin Oncol, 2023. (): p. JCO2200980., https://pubmed.ncbi.nlm.nih.gov/36706347/
316. Ruo Redda, MG, Ragona, R, Ricardi, U, Beltramo, G, Rampino, M, Gabriele, P, et.al. Radiotherapy alone or with concomitant daily low-dose carboplatin in locally advanced, unresectable head and neck cancer: definitive results of a phase III study with a follow-up period of up to ten years., Tumori, 2010. 96 (2)(2): p. 246-53., https://pubmed.ncbi.nlm.nih.gov/20572581/
317. Jeremic, B, Shibamoto, Y, Stanisavljevic, B, Milojevic, L, Milicic, B, Nikolic, N, Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial., Radiother Oncol, 1997. 43 (1)(1): p. 29-37., https://pubmed.ncbi.nlm.nih.gov/9165134/
318. Fountzilas, G, Ciuleanu, E, Dafni, U, Plataniotis, G, Kalogera-Fountzila, A, Samantas, E, et.al. Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study., Med Oncol, 2004. 21 (2)(2): p. 95-107., https://pubmed.ncbi.nlm.nih.gov/15299181/
319. Grau, C, Prakash Agarwal, J, Jabeen, K, Rab Khan, A, Abeyakoon, S, Hadjieva, T, et.al. Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial., Radiother Oncol, 2003. 67 (1)(1): p. 17-26., https://pubmed.ncbi.nlm.nih.gov/12758236/
320. Dobrowsky, W, Naudé, J, Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers., Radiother Oncol, 2000. 57 (2)(2): p. 119-24., https://pubmed.ncbi.nlm.nih.gov/11054514/
321. Weissberg, JB, Son, YH, Papac, RJ, Sasaki, C, Fischer, DB, Lawrence, R, et.al. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer., Int J Radiat Oncol Biol Phys, 1989. 17 (1)(1): p. 3-9., https://pubmed.ncbi.nlm.nih.gov/2501243/
322. Vlacich, G, Diaz, R, Thorpe, SW, Murphy, BA, Kirby, W, Sinard, RJ, et.al. Intensity-modulated radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer: toxicities and efficacy., Oncologist, 2012. 17 (5)(5): p. 673-81., https://pubmed.ncbi.nlm.nih.gov/22550060/
323. Nassif, S, Wichmann, J, Strube, D, Vassis, S, Christiansen, H, Steinmann, D, Cisplatin , In Vivo, 2022. 36 (2)(2): p. 821-832., https://pubmed.ncbi.nlm.nih.gov/35241538/
324. Roskies, M, Kay-Rivest, E, Mascarella, MA, Sultanem, K, Mlynarek, A, Hier, M, Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy., J Otolaryngol Head Neck Surg, 2016. 45 (1)(1): p. 50., https://pubmed.ncbi.nlm.nih.gov/27724969/
325. Maring, S, Elsayad, K, Stenner, M, Rudack, C, Haverkamp, U, Rehkämper, J, et.al. Efficacy of Carboplatin/Paclitaxel-Based Radiochemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck., Oncol Res Treat, 2018. 41 (12)(12): p. 736-743., https://pubmed.ncbi.nlm.nih.gov/30419553/
326. Suntharalingam, M, Haas, ML, Conley, BA, Egorin, MJ, Levy, S, Sivasailam, S, et.al. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck., Int J Radiat Oncol Biol Phys, 2000. 47 (1)(1): p. 49-56., https://pubmed.ncbi.nlm.nih.gov/10758304/
327. Agarwala, SS, Cano, E, Heron, DE, Johnson, J, Myers, E, Sandulache, V, et.al. Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer., Ann Oncol, 2007. 18 (7)(7): p. 1224-9., https://pubmed.ncbi.nlm.nih.gov/17675395/
328. Chougule, PB, Akhtar, MS, Rathore, R, Koness, J, McRae, R, Nigri, P, et.al. Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53)., Head Neck, 2008. 30 (3)(3): p. 289-96., https://pubmed.ncbi.nlm.nih.gov/17657799/
329. Jain, RK, Kirar, P, Gupta, G, Dubey, S, Gupta, SK, Goyal, J, A comparative study of low dose weekly paclitaxel versus cisplatin with concurrent radiation in the treatment of locally advanced head and neck cancers., Indian J Cancer, 2009. 46 (1)(1): p. 50-3., https://pubmed.ncbi.nlm.nih.gov/19282567/
330. Bonner, JA, Harari, PM, Giralt, J, Cohen, RB, Jones, CU, Sur, RK, et.al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival., Lancet Oncol, 2010. 11 (1)(1): p. 21-8., https://pubmed.ncbi.nlm.nih.gov/19897418/
331. Lacas, B, Carmel, A, Landais, C, Wong, SJ, Licitra, L, Tobias, JS, et.al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group., Radiother Oncol, 2021. 156 (): p. 281-293., https://pubmed.ncbi.nlm.nih.gov/33515668/
332. Shama, M, Al-Qurayshi, Z, Dahl, M, Amdur, RJ, Bates, J, Mendenhall, W, et.al. Human Papillomavirus-Negative Oropharyngeal Cancer Survival Outcomes Based on Primary Treatment: National Cancer Database Analysis., Otolaryngol Head Neck Surg, 2022. 167 (1)(1): p. 100-108., https://pubmed.ncbi.nlm.nih.gov/34546828/
333. Amini, A, Jones, BL, McDermott, JD, Serracino, HS, Jimeno, A, Raben, D, et.al. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base., Cancer, 2016. 122 (10)(10): p. 1533-43., https://pubmed.ncbi.nlm.nih.gov/26969811/
334. Zandberg, DP, Cullen, K, Bentzen, SM, Goloubeva, OG, Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database., Oral Oncol, 2018. 86 (): p. 132-140., https://pubmed.ncbi.nlm.nih.gov/30409293/
335. Petrelli, F, Coinu, A, Riboldi, V, Borgonovo, K, Ghilardi, M, Cabiddu, M, et.al. Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: a systematic review and meta-analysis of published studies., Oral Oncol, 2014. 50 (11)(11): p. 1041-8., https://pubmed.ncbi.nlm.nih.gov/25176576/
336. Nguyen-Tan, PF, Zhang, Q, Ang, KK, Weber, RS, Rosenthal, DI, Soulieres, D, et.al. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity., J Clin Oncol, 2014. 32 (34)(34): p. 3858-66., https://pubmed.ncbi.nlm.nih.gov/25366680/
337. Bensadoun, RJ, Bénézery, K, Dassonville, O, Magné, N, Poissonnet, G, Ramaïoli, A, et.al. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC)., Int J Radiat Oncol Biol Phys, 2006. 64 (4)(4): p. 983-94., https://pubmed.ncbi.nlm.nih.gov/16376489/
338. Brizel, DM, Albers, ME, Fisher, SR, Scher, RL, Richtsmeier, WJ, Hars, V, et.al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer., N Engl J Med, 1998. 338 (25)(25): p. 1798-804., https://pubmed.ncbi.nlm.nih.gov/9632446/
339. Ghadjar, P, Simcock, M, Studer, G, Allal, AS, Ozsahin, M, Bernier, J, et.al. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94)., Int J Radiat Oncol Biol Phys, 2012. 82 (2)(2): p. 524-31., https://pubmed.ncbi.nlm.nih.gov/21300466/
340. Lacas, B, Bourhis, J, Overgaard, J, Zhang, Q, Grégoire, V, Nankivell, M, et.al. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis., Lancet Oncol, 2017. 18 (9)(9): p. 1221-1237., https://pubmed.ncbi.nlm.nih.gov/28757375/
341. Petit, C, Lacas, B, Pignon, JP, Le, QT, Grégoire, V, Grau, C, et.al. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis., Lancet Oncol, 2021. 22 (5)(5): p. 727-736., https://pubmed.ncbi.nlm.nih.gov/33862002/
342. Kao, J, Lavaf, A, Teng, MS, Huang, D, Genden, EM, Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage., Int J Radiat Oncol Biol Phys, 2008. 71 (2)(2): p. 362-70., https://pubmed.ncbi.nlm.nih.gov/18164833/
343. Tupchong, L, Scott, CB, Blitzer, PH, Marcial, VA, Lowry, LD, Jacobs, JR, et.al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03., Int J Radiat Oncol Biol Phys, 1991. 20 (1)(1): p. 21-8., https://pubmed.ncbi.nlm.nih.gov/1993628/
344. Langendijk, JA, Ferlito, A, Takes, RP, Rodrigo, JP, Suárez, C, Strojan, P, et.al. Postoperative strategies after primary surgery for squamous cell carcinoma of the head and neck., Oral Oncol, 2010. 46 (8)(8): p. 577-85., https://pubmed.ncbi.nlm.nih.gov/20400361/
345. Mohr, C, Bohndorf, W, Gremmel, H, Härle, F, Hausamen, JE, Hirche, H, et.al. Preoperative radiochemotherapy and radical surgery of advanced head and neck cancers--results of a prospective, multicenter DOSAK study., Recent Results Cancer Res, 1994. 134 (): p. 155-63., https://pubmed.ncbi.nlm.nih.gov/8153431/
346. Gooi, Z, Chan, JY, Fakhry, C, The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer., Laryngoscope, 2016. 126 (4)(4): p. 894-900., https://pubmed.ncbi.nlm.nih.gov/26845348/
347. Soliman, SI, Faraji, F, Pang, J, Mell, LK, Califano, JA, Orosco, RK, Adjuvant Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Carcinoma with Adverse Pathological Features., Cancers (Basel), 2022. 14 (18)(18):, https://pubmed.ncbi.nlm.nih.gov/36139676/
348. Caudell, JJ, Gillison, ML, Maghami, E, Spencer, S, Pfister, DG, Adkins, D, et.al. NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022., J Natl Compr Canc Netw, 2022. 20 (3)(3): p. 224-234., https://pubmed.ncbi.nlm.nih.gov/35276673/
349. Cooper, JS, Zhang, Q, Pajak, TF, Forastiere, AA, Jacobs, J, Saxman, SB, et.al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck., Int J Radiat Oncol Biol Phys, 2012. 84 (5)(5): p. 1198-205., https://pubmed.ncbi.nlm.nih.gov/22749632/
350. Bernier, J, Domenge, C, Ozsahin, M, Matuszewska, K, Lefèbvre, JL, Greiner, RH, et.al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer., N Engl J Med, 2004. 350 (19)(19): p. 1945-52., https://pubmed.ncbi.nlm.nih.gov/15128894/
351. Fietkau, R., Lautenschläger, C., Sauer, R., Dunst, J., Becker, A., Baumann, M., et.al. Postoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: Results of the German phase III trial ARO 96–3, Journal of Clinical Oncology, 2006. 24(18_suppl): p. 5507-5507., https://ascopubs.org/doi/abs/10.1200/jco.2006.24.18_suppl.5507
352. Goel, AN, Sangar, S, Mukdad, L, Heaton, CM, Ryan, WR, Wang, MB, et.al. Patterns of care and survival impact of adjuvant chemoradiotherapy for oropharyngeal cancer with intermediate-risk features., Head Neck, 2019. 41 (9)(9): p. 3177-3186., https://pubmed.ncbi.nlm.nih.gov/31107584/
353. An, Y, Park, HS, Kelly, JR, Stahl, JM, Yarbrough, WG, Burtness, BA, et.al. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma., Cancer, 2017. 123 (14)(14): p. 2762-2772., https://pubmed.ncbi.nlm.nih.gov/28323338/
354. Day, AT, Yang, AM, Tanamal, P, Blackwell, JM, Wang, E, Sumer, BD, et.al. Extracapsular extension, pathologic node status, and adjuvant treatment in primary surgery patients with human papillomavirus-mediated oropharyngeal cancer: National hospital-based retrospective cohort analysis., Head Neck, 2021. 43 (11)(11): p. 3345-3363., https://pubmed.ncbi.nlm.nih.gov/34331477/
355. Ajmani, GS, Nocon, CC, Wang, CH, Bhayani, MK, Assessment of adjuvant therapy in resected head and neck cancer with high-risk features., Oral Oncol, 2017. 74 (): p. 15-20., https://pubmed.ncbi.nlm.nih.gov/29103745/
356. Iyer, NG, Dogan, S, Palmer, F, Rahmati, R, Nixon, IJ, Lee, N, et.al. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer., Ann Surg Oncol, 2015. 22 (13)(13): p. 4411-21., https://pubmed.ncbi.nlm.nih.gov/25801358/
357. Shevach, J, Bossert, A, Bakst, RL, Liu, J, Misiukiewicz, K, Beyda, J, et.al. Extracapsular extension is associated with worse distant control and progression-free survival in patients with lymph node-positive human papillomavirus-related oropharyngeal carcinoma., Oral Oncol, 2017. 74 (): p. 56-61., https://pubmed.ncbi.nlm.nih.gov/29103752/
358. Sunkara, PR, Graff, JT, Cramer, JD, Association of Surgical Margin Distance With Survival in Patients With Resected Head and Neck Squamous Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial., JAMA Otolaryngol Head Neck Surg, 2023. ():, https://pubmed.ncbi.nlm.nih.gov/36821132/
359. Fenlon, JB, Hutten, RJ, Weil, CR, Lloyd, S, Cannon, DM, Kerrigan, K, et.al. Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins., Head Neck, 2022. 44 (3)(3): p. 606-614., https://pubmed.ncbi.nlm.nih.gov/34931386/
360. Kiyota, N, Tahara, M, Mizusawa, J, Kodaira, T, Fujii, H, Yamazaki, T, et.al. Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial., J Clin Oncol, 2022. 40 (18)(18): p. 1980-1990., https://pubmed.ncbi.nlm.nih.gov/35230884/
361. Haffty, BG, Son, YH, Sasaki, CT, Papac, R, Fischer, D, Rockwell, S, et.al. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials., Int J Radiat Oncol Biol Phys, 1993. 27 (2)(2): p. 241-50., https://pubmed.ncbi.nlm.nih.gov/7691784/
362. Moore, EJ, Van Abel, KM, Routman, DM, Lohse, CM, Price, KAR, Neben-Wittich, M, et.al. Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy., Head Neck, 2021. 43 (1)(1): p. 229-237., https://pubmed.ncbi.nlm.nih.gov/32969095/
363. Vos, JL, Elbers, JBW, Krijgsman, O, Traets, JJH, Qiao, X, van der Leun, AM, et.al. Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma., Nat Commun, 2021. 12 (1)(1): p. 7348., https://pubmed.ncbi.nlm.nih.gov/34937871/
364. Leidner, R, Crittenden, M, Young, K, Xiao, H, Wu, Y, Couey, MA, et.al. Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma., J Immunother Cancer, 2021. 9 (5)(5):, https://pubmed.ncbi.nlm.nih.gov/33963014/
365. Amin, N, Maroun, CA, El Asmar, M, Alkhatib, HH, Guller, M, Herberg, ME, et.al. Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: Systematic review., Head Neck, 2022. 44 (2)(2): p. 562-571., https://pubmed.ncbi.nlm.nih.gov/34825751/
366. Kamran, SC, Qureshi, MM, Jalisi, S, Salama, A, Grillone, G, Truong, MT, Primary surgery versus primary radiation-based treatment for locally advanced oropharyngeal cancer., Laryngoscope, 2018. 128 (6)(6): p. 1353-1364., https://pubmed.ncbi.nlm.nih.gov/28988426/
367. Ko, HC, Chen, S, Wieland, AM, Yu, M, Baschnagel, AM, Hartig, GK, et.al. Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database., Head Neck, 2017. 39 (11)(11): p. 2159-2170., https://pubmed.ncbi.nlm.nih.gov/28737019/
368. Pignon, JP, le Maître, A, Maillard, E, Bourhis, J, Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients., Radiother Oncol, 2009. 92 (1)(1): p. 4-14., https://pubmed.ncbi.nlm.nih.gov/19446902/
369. Blanchard, P, Baujat, B, Holostenco, V, Bourredjem, A, Baey, C, Bourhis, J, et.al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site., Radiother Oncol, 2011. 100 (1)(1): p. 33-40., https://pubmed.ncbi.nlm.nih.gov/21684027/
370. Amini, A, Jasem, J, Jones, BL, Robin, TP, McDermott, JD, Bhatia, S, et.al. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base., Oral Oncol, 2016. 56 (): p. 1-7., https://pubmed.ncbi.nlm.nih.gov/27086480/
371. Ko, HC, Chen, S, Wieland, AM, Yu, M, Baschnagel, AM, Hartig, GK, et.al. Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database., Head Neck, 2017. 39 (11)(11): p. 2159-2170., https://pubmed.ncbi.nlm.nih.gov/28737019/
372. Mahmoud, O, Sung, K, Civantos, FJ, Thomas, GR, Samuels, MA, Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus., Head Neck, 2018. 40 (4)(4): p. 710-721., https://pubmed.ncbi.nlm.nih.gov/29244238/
373. Misiukiewicz, K, Gupta, V, Miles, BA, Bakst, R, Genden, E, Selkridge, I, et.al. Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trial., Oral Oncol, 2019. 95 (): p. 170-177., https://pubmed.ncbi.nlm.nih.gov/31345387/
374. Forastiere, AA, Goepfert, H, Maor, M, Pajak, TF, Weber, R, Morrison, W, et.al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer., N Engl J Med, 2003. 349 (22)(22): p. 2091-8., https://pubmed.ncbi.nlm.nih.gov/14645636/
375. Forastiere, AA, Zhang, Q, Weber, RS, Maor, MH, Goepfert, H, Pajak, TF, et.al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer., J Clin Oncol, 2013. 31 (7)(7): p. 845-52., https://pubmed.ncbi.nlm.nih.gov/23182993/
376. Cooper, JS, Pajak, TF, Forastiere, AA, Jacobs, J, Campbell, BH, Saxman, SB, et.al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck., N Engl J Med, 2004. 350 (19)(19): p. 1937-44., https://pubmed.ncbi.nlm.nih.gov/15128893/
377. Gonzalez-Angulo, AM, Litton, JK, Broglio, KR, Meric-Bernstam, F, Rakkhit, R, Cardoso, F, et.al. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller., J Clin Oncol, 2009. 27 (34)(34): p. 5700-6., https://pubmed.ncbi.nlm.nih.gov/19884543/
378. Licitra, L, Locati, LD, Cavina, R, Garassino, I, Mattavelli, F, Pizzi, N, et.al. Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer., Ann Oncol, 2003. 14 (3)(3): p. 367-72., https://pubmed.ncbi.nlm.nih.gov/12598339/
379. Pignon, JP, Bourhis, J, Domenge, C, Designé, L, Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer., Lancet, 2000. 355 (9208)(9208): p. 949-55., https://pubmed.ncbi.nlm.nih.gov/10768432/
380. Moore LK, , Luetjen-Drecoll E, Embryologie, Lehrbuch und Atlas der Entwicklungsgeschichte des MenschenSchattauer-Verlag, 1993.
381. Schilling, MK, Eichenberger, M, Maurer, CA, Greiner, R, Zbären, P, Büchler, MW, Long-term survival of patients with stage IV hypopharyngeal cancer: impact of fundus rotation gastroplasty., World J Surg, 2002. 26 (5)(5): p. 561-5., https://pubmed.ncbi.nlm.nih.gov/12098046/
382. Roesch-Ely, M, Nees, M, Karsai, S, Ruess, A, Bogumil, R, Warnken, U, et.al. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer., Oncogene, 2007. 26 (1)(1): p. 54-64., https://pubmed.ncbi.nlm.nih.gov/16819514/
383. Li, Y, Ou, X, Hu, C, Prevalence and prognostic impact of synchronous distant metastases in patients with hypopharynx squamous cell carcinomas: a SEER-based study., J Cancer, 2019. 10 (3)(3): p. 620-626., https://pubmed.ncbi.nlm.nih.gov/30719159/
384. Li, Y, Hu, C, Clinical manifestations of hypopharynx squamous cell carcinoma and treatment outcomes according to age at diagnosis., Int J Clin Pract, 2021. 75 (5)(5): p. e14059., https://pubmed.ncbi.nlm.nih.gov/33529411/
385. Burbure, N, Handorf, E, Ridge, JA, Bauman, J, Liu, JC, Giri, A, et.al. Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer., Head Neck, 2021. 43 (10)(10): p. 3042-3052., https://pubmed.ncbi.nlm.nih.gov/34165223/
386. Eckel, HE, Bradley, PJ, Treatment Options for Hypopharyngeal Cancer., Adv Otorhinolaryngol, 2019. 83 (): p. 47-53., https://pubmed.ncbi.nlm.nih.gov/30943512/
387. Eckel, HE, Staar, S, Volling, P, Sittel, C, Damm, M, Jungehuelsing, M, Surgical treatment for hypopharynx carcinoma: feasibility, mortality, and results., Otolaryngol Head Neck Surg, 2001. 124 (5)(5): p. 561-9., https://pubmed.ncbi.nlm.nih.gov/11337663/
388. Eckel, HE, Bradley, PJ, Natural History of Treated and Untreated Hypopharyngeal Cancer., Adv Otorhinolaryngol, 2019. 83 (): p. 27-34., https://pubmed.ncbi.nlm.nih.gov/30943503/
389. Gatta, G, Botta, L, Sánchez, MJ, Anderson, LA, Pierannunzio, D, Licitra, L, Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study., Eur J Cancer, 2015. 51 (15)(15): p. 2130-2143., https://pubmed.ncbi.nlm.nih.gov/26421817/
390. Vilaseca, I, Blanch, JL, Bernal-Sprekelsen, M, Transoral laser surgery for hypopharyngeal carcinomas., Curr Opin Otolaryngol Head Neck Surg, 2012. 20 (2)(2): p. 97-102., https://pubmed.ncbi.nlm.nih.gov/22249171/
391. Vilaseca-González, I, Bernal-Sprekelsen, M, Blanch-Alejandro, JL, Moragas-Lluis, M, Complications in transoral CO2 laser surgery for carcinoma of the larynx and hypopharynx., Head Neck, 2003. 25 (5)(5): p. 382-8., https://pubmed.ncbi.nlm.nih.gov/12692875/
392. Bernal-Sprekelsen, M, Dazert, S, Sudhoff, H, Blanch, JL, Vilaseca, I, [Complications of transoral laser surgery for malignant tumors of the larynx and hypopharynx]., Laryngorhinootologie, 2009. 88 (1)(1): p. 28-34., https://pubmed.ncbi.nlm.nih.gov/19205077/
393. Bernal-Sprekelsen, M, Blanch, JL, Caballero-Borrego, M, Vilaseca, I, The learning curve in transoral laser microsurgery for malignant tumors of the larynx and hypopharynx: parameters for a levelled surgical approach., Eur Arch Otorhinolaryngol, 2013. 270 (2)(2): p. 623-8., https://pubmed.ncbi.nlm.nih.gov/22996081/
394. Pradier, O, Christiansen, H, Schmidberger, H, Martin, A, Jäckel, MC, Steiner, W, et.al. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck., Int J Radiat Oncol Biol Phys, 2005. 63 (5)(5): p. 1368-77., https://pubmed.ncbi.nlm.nih.gov/16169679/
395. Weiss, BG, Ihler, F, Wolff, HA, Schneider, S, Canis, M, Steiner, W, et.al. Transoral laser microsurgery for treatment for hypopharyngeal cancer in 211 patients., Head Neck, 2017. 39 (8)(8): p. 1631-1638., https://pubmed.ncbi.nlm.nih.gov/28474378/
396. Steiner, W, [Therapy of hypopharyngeal cancer. Part III: The concept of minimally invasive therapy of cancers of the upper aerodigestive tract with special reference to hypopharyngeal cancer and trans-oral laser microsurgery]., HNO, 1994. 42 (2)(2): p. 104-12., https://pubmed.ncbi.nlm.nih.gov/8163394/
397. Martin, A, Jäckel, MC, Christiansen, H, Mahmoodzada, M, Kron, M, Steiner, W, Organ preserving transoral laser microsurgery for cancer of the hypopharynx., Laryngoscope, 2008. 118 (3)(3): p. 398-402., https://pubmed.ncbi.nlm.nih.gov/18091337/
398. Steiner, W, Stenglein, C, Fietkau, R, Sauerbrei, W, [Therapy of hypopharyngeal cancer. Part IV: Long-term results of transoral laser microsurgery of hypopharyngeal cancer]., HNO, 1994. 42 (3)(3): p. 147-56., https://pubmed.ncbi.nlm.nih.gov/7513680/
399. Rudert, HH, Höft, S, Transoral carbon-dioxide laser resection of hypopharyngeal carcinoma., Eur Arch Otorhinolaryngol, 2003. 260 (4)(4): p. 198-206., https://pubmed.ncbi.nlm.nih.gov/12709803/
400. Hall, SF, Griffiths, R, Did the addition of concomitant chemotherapy to radiotherapy improve outcomes in hypopharyngeal cancer? A population-based study., Curr Oncol, 2016. 23 (4)(4): p. 266-72., https://pubmed.ncbi.nlm.nih.gov/27536177/
401. Machiels, JP, René Leemans, C, Golusinski, W, Grau, C, Licitra, L, Gregoire, V, Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up., Ann Oncol, 2020. 31 (11)(11): p. 1462-1475., https://pubmed.ncbi.nlm.nih.gov/33239190/
402. Bernier, J, Cooper, JS, Pajak, TF, van Glabbeke, M, Bourhis, J, Forastiere, A, et.al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)., Head Neck, 2005. 27 (10)(10): p. 843-50., https://pubmed.ncbi.nlm.nih.gov/16161069/
403. Kim, YJ, Lee, R, Surgery vs. radiotherapy for locally advanced hypopharyngeal cancer in the contemporary era: A population-based study., Cancer Med, 2018. 7 (12)(12): p. 5889-5900., https://pubmed.ncbi.nlm.nih.gov/30479063/
404. Hochfelder, CG, Mehta, V, Kabarriti, R, McGinn, AP, Castellucci, E, Ow, TJ, Survival analysis of patients with advanced hypopharyngeal cancer comparing patients who received primary surgery to those who received chemoradiation: An analysis of the NCDB., Oral Oncol, 2021. 121 (): p. 105470., https://pubmed.ncbi.nlm.nih.gov/34418696/
405. Fan, Y, Li, S, Xia, X, Yu, S, Zhu, X, Zhu, Y, et.al. Oncological outcomes from surgical vs. non-surgical treatments for advanced hypopharyngeal squamous cell carcinoma: a surveillance, epidemiology, and end results-based study., Clin Transl Oncol, 2022. 24 (12)(12): p. 2379-2387., https://pubmed.ncbi.nlm.nih.gov/35882729/
406. Chen, AY, Hudgins, PA, Pitfalls in the staging squamous cell carcinoma of the hypopharynx., Neuroimaging Clin N Am, 2013. 23 (1)(1): p. 67-79., https://pubmed.ncbi.nlm.nih.gov/23199662/
407. Pameijer, FA, Mukherji, SK, Balm, AJ, van der Laan, BF, Imaging of squamous cell carcinoma of the hypopharynx., Semin Ultrasound CT MR, 1998. 19 (6)(6): p. 476-91., https://pubmed.ncbi.nlm.nih.gov/9861665/
408. Nemec, SF, Formanek, M, Noebauer-Huhmann, IM, Krestan, CR, Frühwald, J, Peloschek, P, et.al. [Pathological changes of the hypopharynx in the focus of imaging]., Radiologe, 2009. 49 (1)(1): p. 36-42., https://pubmed.ncbi.nlm.nih.gov/19023556/
409. Peracchia, A, Bonavina, L, Botturi, M, Pagani, M, Via, A, Saino, G, Current status of surgery for carcinoma of the hypopharynx and cervical esophagus., Dis Esophagus, 2001. 14 (2)(2): p. 95-7., https://pubmed.ncbi.nlm.nih.gov/11553216/
410. Kleinsasser,O., Tumoren des Larynx und des HypopharynxThieme, 1987., https://www.ncbi.nlm.nih.gov/nlmcatalog/8807243
411. Remmert, S, [Major defect reconstruction in the head and neck region]., Laryngorhinootologie, 2004. 83 (12)(12): p. 858-61., https://pubmed.ncbi.nlm.nih.gov/15611908/
412. Schwager, K, Hoppe, F, Hagen, R, Brunner, FX, Free-flap reconstruction for laryngeal preservation after partial laryngectomy in patients with extended tumors of the oropharynx and hypopharynx., Eur Arch Otorhinolaryngol, 1999. 256 (6)(6): p. 280-2., https://pubmed.ncbi.nlm.nih.gov/10456275/
413. Hagen, R, [Functional long-term results following hemipharyngo-hemilaryngectomy and microvascular reconstruction using the radial forearm flap]., Laryngorhinootologie, 2002. 81 (3)(3): p. 233-42., https://pubmed.ncbi.nlm.nih.gov/11967777/
414. Tai, SK, Chang, SY, Contralateral hemilaryngotracheal flap reconstruction of the hypopharynx in pyriform carcinoma resection., Laryngoscope, 1999. 109 (2 Pt 1)(2 Pt 1): p. 221-5., https://pubmed.ncbi.nlm.nih.gov/10890770/
415. Chu, PY, Chang, SY, Reconstruction of the hypopharynx after surgical treatment of squamous cell carcinoma., J Chin Med Assoc, 2009. 72 (7)(7): p. 351-5., https://pubmed.ncbi.nlm.nih.gov/19581140/
416. Bootz, F, Keiner, S, [Reconstructive procedures for restoring the hypopharynx after tumor excision]., HNO, 1998. 46 (2)(2): p. 87-9., https://pubmed.ncbi.nlm.nih.gov/9556705/
417. Disa, JJ, Pusic, AL, Mehrara, BJ, Reconstruction of the hypopharynx with the free jejunum transfer., J Surg Oncol, 2006. 94 (6)(6): p. 466-70., https://pubmed.ncbi.nlm.nih.gov/17061270/
418. Theile, DR, Robinson, DW, Theile, DE, Coman, WB, Free jejunal interposition reconstruction after pharyngolaryngectomy: 201 consecutive cases., Head Neck, 1995. 17 (2)(2): p. 83-8., https://pubmed.ncbi.nlm.nih.gov/7558817/
419. Reece, GP, Schusterman, MA, Miller, MJ, Kroll, SS, Robb, GL, Baldwin, BJ, et.al. Morbidity and functional outcome of free jejunal transfer reconstruction for circumferential defects of the pharynx and cervical esophagus., Plast Reconstr Surg, 1995. 96 (6)(6): p. 1307-16., https://pubmed.ncbi.nlm.nih.gov/7480227/
420. Couch, ME, Laryngopharyngectomy with reconstruction., Otolaryngol Clin North Am, 2002. 35 (5)(5): p. 1097-114., https://pubmed.ncbi.nlm.nih.gov/12587250/
421. Remmert, S, Müller, G, Weerda, H, [Revascularized over-long jejunum segments in single stage reconstruction of voice and deglutition function after total laryngopharyngectomy]., HNO, 1993. 41 (10)(10): p. 485-90., https://pubmed.ncbi.nlm.nih.gov/8226121/
422. Remmert, S, Ahrens, KH, Sommer, K, Müller, G, Weerda, H, [Voice rehabilitation with the jejunum speech siphon: the biventer rein, a modification for prevention of aspiration]., Laryngorhinootologie, 1994. 73 (2)(2): p. 84-7., https://pubmed.ncbi.nlm.nih.gov/8161415/
423. Zbären, P, Greiner, R, Kengelbacher, M, Stoma recurrence after laryngectomy: an analysis of risk factors., Otolaryngol Head Neck Surg, 1996. 114 (4)(4): p. 569-75., https://pubmed.ncbi.nlm.nih.gov/8643266/
424. Sheng, X, Zhang, S, Song, X, Chen, L, Luo, X, [Meta-analysis on the risk factors for stomal recurrence after total laryngectomy]., Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2013. 27 (18)(18): p. 995-9., https://pubmed.ncbi.nlm.nih.gov/24459925/
425. Basheeth, N, O'Leary, G, Khan, H, Sheahan, P, Oncologic outcomes of total laryngectomy: impact of margins and preoperative tracheostomy., Head Neck, 2015. 37 (6)(6): p. 862-9., https://pubmed.ncbi.nlm.nih.gov/24623609/
426. Imauchi, Y, Ito, K, Takasago, E, Nibu, K, Sugasawa, M, Ichimura, K, Stomal recurrence after total laryngectomy for squamous cell carcinoma of the larynx., Otolaryngol Head Neck Surg, 2002. 126 (1)(1): p. 63-6., https://pubmed.ncbi.nlm.nih.gov/11821768/
427. Esteller, E, Agüero, A, Martel, M, López, M, Quer, M, León, X, Stomal recurrence in head and neck cancer patients with temporary tracheostomy., Auris Nasus Larynx, 2014. 41 (5)(5): p. 467-70., https://pubmed.ncbi.nlm.nih.gov/24602695/
428. Onakoya, PA, Nwaorgu, OG, Kokong, DD, Adeosun, AA, Ayodele, KJ, Stomal recurrence post laryngectomy in University College Hospital, Ibadan., Afr J Med Med Sci, 2004. 33 (1)(1): p. 65-8., https://pubmed.ncbi.nlm.nih.gov/15490797/
429. Schariatzadeh, R, Pezier, TF, Studer, G, Schmid, S, Huber, GF, Does airway intervention before primary nonsurgical therapy for T3/T4 laryngeal squamous cell carcinoma impact on oncological or functional outcomes?, Swiss Med Wkly, 2015. 145 (): p. w14213., https://pubmed.ncbi.nlm.nih.gov/26715377/
430. Spiro, RH, Bains, MS, Shah, JP, Strong, EW, Gastric transposition for head and neck cancer: a critical update., Am J Surg, 1991. 162 (4)(4): p. 348-52., https://pubmed.ncbi.nlm.nih.gov/1951887/
431. Harrison, DF, Thompson, AE, Pharyngolaryngoesophagectomy with pharyngogastric anastomosis for cancer of the hypopharynx: review of 101 operations., Head Neck Surg, 1986. 8 (6)(6): p. 418-28., https://pubmed.ncbi.nlm.nih.gov/3721884/
432. Dudhat, SB, Mistry, RC, Fakih, AR, Complications following gastric transposition after total laryngo-pharyngectomy., Eur J Surg Oncol, 1999. 25 (1)(1): p. 82-5., https://pubmed.ncbi.nlm.nih.gov/10188861/
433. Böttger, T, Bumb, P, Dutkowski, P, Schlick, T, Junginger, T, Carcinoma of the hypopharynx and the cervical oesophagus: a surgical challenge., Eur J Surg, 1999. 165 (10)(10): p. 940-6., https://pubmed.ncbi.nlm.nih.gov/10574101/
434. Bentzen, SM, Trotti, A, Evaluation of early and late toxicities in chemoradiation trials., J Clin Oncol, 2007. 25 (26)(26): p. 4096-103., https://pubmed.ncbi.nlm.nih.gov/17827459/
435. Quon, H, Leong, T, Haselow, R, Leipzig, B, Cooper, J, Forastiere, A, Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: an intergroup trial of the Eastern Cooperative Oncology Group (E2382)., Int J Radiat Oncol Biol Phys, 2011. 81 (3)(3): p. 719-25., https://pubmed.ncbi.nlm.nih.gov/20888709/
436. Adelstein, DJ, Li, Y, Adams, GL, Wagner, H, Kish, JA, Ensley, JF, et.al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer., J Clin Oncol, 2003. 21 (1)(1): p. 92-8., https://pubmed.ncbi.nlm.nih.gov/12506176/
437. Merlano, M, Benasso, M, Corvò, R, Rosso, R, Vitale, V, Blengio, F, et.al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck., J Natl Cancer Inst, 1996. 88 (9)(9): p. 583-9., https://pubmed.ncbi.nlm.nih.gov/8609658/
438. Langendijk, JA, Hoebers, FJP, de Jong, MA, Doornaert, P, Terhaard, CHJ, Steenbakkers, RJHM, et.al. National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer., Int J Part Ther, 2021. 8 (1)(1): p. 354-365., https://pubmed.ncbi.nlm.nih.gov/34285961/
439. Christianen, ME, Verdonck-de Leeuw, IM, Doornaert, P, Chouvalova, O, Steenbakkers, RJ, Koken, PW, et.al. Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation., Radiother Oncol, 2015. 117 (1)(1): p. 139-44., https://pubmed.ncbi.nlm.nih.gov/26320608/
440. Kanayama, N, Kierkels, RGJ, van der Schaaf, A, Steenbakkers, RJHM, Yoshioka, Y, Nishiyama, K, et.al. External validation of a multifactorial normal tissue complication probability model for tube feeding dependence at 6 months after definitive radiotherapy for head and neck cancer., Radiother Oncol, 2018. 129 (2)(2): p. 403-408., https://pubmed.ncbi.nlm.nih.gov/30301559/
441. Wopken, K, Bijl, HP, van der Schaaf, A, Christianen, ME, Chouvalova, O, Oosting, SF, et.al. Development and validation of a prediction model for tube feeding dependence after curative (chemo-) radiation in head and neck cancer., PLoS One, 2014. 9 (4)(4): p. e94879., https://pubmed.ncbi.nlm.nih.gov/24736318/
442. Van den Bosch, L, van der Schaaf, A, van der Laan, HP, Hoebers, FJP, Wijers, OB, van den Hoek, JGM, et.al. Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment., Radiother Oncol, 2021. 157 (): p. 147-154., https://pubmed.ncbi.nlm.nih.gov/33545258/
443. Lefebvre, JL, Rolland, F, Tesselaar, M, Bardet, E, Leemans, CR, Geoffrois, L, et.al. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy., J Natl Cancer Inst, 2009. 101 (3)(3): p. 142-52., https://pubmed.ncbi.nlm.nih.gov/19176454/
444. Lefebvre, JL, Pointreau, Y, Rolland, F, Alfonsi, M, Baudoux, A, Sire, C, et.al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study., J Clin Oncol, 2013. 31 (7)(7): p. 853-9., https://pubmed.ncbi.nlm.nih.gov/23341517/
445. Dietz, A, Wichmann, G, Kuhnt, T, Pfreundner, L, Hagen, R, Scheich, M, et.al. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II., Ann Oncol, 2018. 29 (10)(10): p. 2105-2114., https://pubmed.ncbi.nlm.nih.gov/30412221/
446. Pointreau, Y, Garaud, P, Chapet, S, Sire, C, Tuchais, C, Tortochaux, J, et.al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation., J Natl Cancer Inst, 2009. 101 (7)(7): p. 498-506., https://pubmed.ncbi.nlm.nih.gov/19318632/
447. Blanchard, P, Bourhis, J, Lacas, B, Posner, MR, Vermorken, JB, Cruz Hernandez, JJ, et.al. Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group., J Clin Oncol, 2013. 31 (23)(23): p. 2854-60., https://pubmed.ncbi.nlm.nih.gov/23835714/
448. Fietkau, R, Hecht, M, Hofner, B, Lubgan, D, Iro, H, Gefeller, O, et.al. Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial., Radiother Oncol, 2020. 144 (): p. 209-217., https://pubmed.ncbi.nlm.nih.gov/32044419/
449. Robbins, KT, Shaha, AR, Medina, JE, Califano, JA, Wolf, GT, Ferlito, A, et.al. Consensus statement on the classification and terminology of neck dissection., Arch Otolaryngol Head Neck Surg, 2008. 134 (5)(5): p. 536-8., https://pubmed.ncbi.nlm.nih.gov/18490577/
450. Koyfman, SA, Ismaila, N, Crook, D, D'Cruz, A, Rodriguez, CP, Sher, DJ, et.al. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline., J Clin Oncol, 2019. 37 (20)(20): p. 1753-1774., https://pubmed.ncbi.nlm.nih.gov/30811281/
451. Gleysteen, J, Troob, S, Light, T, Brickman, D, Clayburgh, D, Andersen, P, et.al. The impact of prophylactic external carotid artery ligation on postoperative bleeding after transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma., Oral Oncol, 2017. 70 (): p. 1-6., https://pubmed.ncbi.nlm.nih.gov/28622885/
452. Kubik, M, Mandal, R, Albergotti, W, Duvvuri, U, Ferris, RL, Kim, S, Effect of transcervical arterial ligation on the severity of postoperative hemorrhage after transoral robotic surgery., Head Neck, 2017. 39 (8)(8): p. 1510-1515., https://pubmed.ncbi.nlm.nih.gov/28570011/
453. Kovács, AF, Döbert, N, Gaa, J, Menzel, C, Bitter, K, Positron emission tomography in combination with sentinel node biopsy reduces the rate of elective neck dissections in the treatment of oral and oropharyngeal cancer., J Clin Oncol, 2004. 22 (19)(19): p. 3973-80., https://pubmed.ncbi.nlm.nih.gov/15459220/
454. Salazar-Fernandez, CI, Gallana-Alvarez, S, Pereira, S, Cambill, T, Infante-Cossio, P, Herce-Lopez, J, Sentinel Lymph Node Biopsy in Oral and Oropharyngeal Squamous Cell Carcinoma: Statistical Validation and Impact of Micrometastasis Involvement on the Neck Dissection Decision., J Oral Maxillofac Surg, 2015. 73 (7)(7): p. 1403-9., https://pubmed.ncbi.nlm.nih.gov/25861693/
455. Gupta, T, Maheshwari, G, Kannan, S, Nair, S, Chaturvedi, P, Agarwal, JP, Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharyngeal squamous cell carcinoma: Evidence-base for practice and implications for research., Oral Oncol, 2022. 124 (): p. 105642., https://pubmed.ncbi.nlm.nih.gov/34861565/
456. Coskun, HH, Medina, JE, Robbins, KT, Silver, CE, Strojan, P, Teymoortash, A, et.al. Current philosophy in the surgical management of neck metastases for head and neck squamous cell carcinoma., Head Neck, 2015. 37 (6)(6): p. 915-26., https://pubmed.ncbi.nlm.nih.gov/24623715/
457. Ferlito, A, Rinaldo, A, Silver, CE, Gourin, CG, Shah, JP, Clayman, GL, et.al. Elective and therapeutic selective neck dissection., Oral Oncol, 2006. 42 (1)(1): p. 14-25., https://pubmed.ncbi.nlm.nih.gov/15979381/
458. Gross, BC, Olsen, SM, Lewis, JE, Kasperbauer, JL, Moore, EJ, Olsen, KD, et.al. Level IIB lymph node metastasis in oropharyngeal squamous cell carcinoma., Laryngoscope, 2013. 123 (11)(11): p. 2700-5., https://pubmed.ncbi.nlm.nih.gov/23686577/
459. Knopf, A, Jacob, S, Bier, H, Scherer, EQ, Bilateral versus ipsilateral neck dissection in oral and oropharyngeal cancer with contralateral cN0 neck., Eur Arch Otorhinolaryngol, 2020. 277 (11)(11): p. 3161-3168., https://pubmed.ncbi.nlm.nih.gov/32449025/
460. Olzowy, B, Tsalemchuk, Y, Schotten, KJ, Reichel, O, Harréus, U, Frequency of bilateral cervical metastases in oropharyngeal squamous cell carcinoma: a retrospective analysis of 352 cases after bilateral neck dissection., Head Neck, 2011. 33 (2)(2): p. 239-43., https://pubmed.ncbi.nlm.nih.gov/20848445/
461. Pitman, KT, Rationale for elective neck dissection., Am J Otolaryngol, 2000. 21 (1)(1): p. 31-7., https://pubmed.ncbi.nlm.nih.gov/10668674/
462. Weiss, MH, Harrison, LB, Isaacs, RS, Use of decision analysis in planning a management strategy for the stage N0 neck., Arch Otolaryngol Head Neck Surg, 1994. 120 (7)(7): p. 699-702., https://pubmed.ncbi.nlm.nih.gov/8018319/
463. Crumley, RL, Smith, JD, Postoperative chylous fistula prevention and management., Laryngoscope, 1976. 86 (6)(6): p. 804-13., https://pubmed.ncbi.nlm.nih.gov/933672/
464. de Gier, HH, Balm, AJ, Bruning, PF, Gregor, RT, Hilgers, FJ, Systematic approach to the treatment of chylous leakage after neck dissection., Head Neck, 1996. 18 (4)(4): p. 347-51., https://pubmed.ncbi.nlm.nih.gov/8780946/
465. de Jong, AA, Manni, JJ, Phrenic nerve paralysis following neck dissection., Eur Arch Otorhinolaryngol, 1991. 248 (3)(3): p. 132-4., https://pubmed.ncbi.nlm.nih.gov/2029390/
466. Leipzig, B, Suen, JY, English, JL, Barnes, J, Hooper, M, Functional evaluation of the spinal accessory nerve after neck dissection., Am J Surg, 1983. 146 (4)(4): p. 526-30., https://pubmed.ncbi.nlm.nih.gov/6625099/
467. Psychogios, G, Mantsopoulos, K, Agaimy, A, Koch, M, Zenk, J, Waldfahrer, F, et.al. Prognostic factors in limited (T1-2, N0-1) oropharyngeal carcinoma treated with surgery ± adjuvant therapy., Head Neck, 2013. 35 (12)(12): p. 1752-8., https://pubmed.ncbi.nlm.nih.gov/23468305/
468. Shin, YS, Kim, SH, Koh, YW, Hong, HJ, Seol, JH, Choi, EC, Necessity of level IV dissection in cN0 hypopharyngeal carcinoma., Acta Otolaryngol, 2011. 131 (6)(6): p. 665-9., https://pubmed.ncbi.nlm.nih.gov/21395474/
469. Terrell, JE, Welsh, DE, Bradford, CR, Chepeha, DB, Esclamado, RM, Hogikyan, ND, et.al. Pain, quality of life, and spinal accessory nerve status after neck dissection., Laryngoscope, 2000. 110 (4)(4): p. 620-6., https://pubmed.ncbi.nlm.nih.gov/10764008/
470. Finegersh, A, Moss, WJ, Saddawi-Konefka, R, Faraji, F, Coffey, CS, Califano, JA, et.al. Meta-analysis of risk of occult lymph node metastasis in the irradiated, clinically N0 neck., Head Neck, 2020. 42 (9)(9): p. 2355-2363., https://pubmed.ncbi.nlm.nih.gov/32432819/
471. Walvekar, RR, Li, RJ, Gooding, WE, Gibson, MK, Heron, D, Johnson, JT, et.al. Role of surgery in limited (T1-2, N0-1) cancers of the oropharynx., Laryngoscope, 2008. 118 (12)(12): p. 2129-34., https://pubmed.ncbi.nlm.nih.gov/18948826/
472. Hosal, AS, Carrau, RL, Johnson, JT, Myers, EN, Selective neck dissection in the management of the clinically node-negative neck., Laryngoscope, 2000. 110 (12)(12): p. 2037-40., https://pubmed.ncbi.nlm.nih.gov/11129016/
473. Psychogios, G, Mantsopoulos, K, Bohr, C, Koch, M, Zenk, J, Iro, H, Incidence of occult cervical metastasis in head and neck carcinomas: development over time., J Surg Oncol, 2013. 107 (4)(4): p. 384-7., https://pubmed.ncbi.nlm.nih.gov/22833224/
474. Psychogios, G, Mantsopoulos, K, Kuenzel, J, Koch, M, Zenk, J, Harreus, U, et.al. Primary surgical treatment of T2 oropharyngeal carcinoma., J Surg Oncol, 2012. 105 (7)(7): p. 719-23., https://pubmed.ncbi.nlm.nih.gov/22213267/
475. Layland, MK, Sessions, DG, Lenox, J, The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+., Laryngoscope, 2005. 115 (4)(4): p. 629-39., https://pubmed.ncbi.nlm.nih.gov/15805872/
476. Lee, SY, Lim, YC, Song, MH, Lee, JS, Koo, BS, Choi, EC, Level IIb lymph node metastasis in elective neck dissection of oropharyngeal squamous cell carcinoma., Oral Oncol, 2006. 42 (10)(10): p. 1017-21., https://pubmed.ncbi.nlm.nih.gov/16757201/
477. Candela, FC, Kothari, K, Shah, JP, Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx., Head Neck, 1990. 12 (3)(3): p. 197-203., https://pubmed.ncbi.nlm.nih.gov/2358329/
478. Byers, RM, Modified neck dissection. A study of 967 cases from 1970 to 1980., Am J Surg, 1985. 150 (4)(4): p. 414-21., https://pubmed.ncbi.nlm.nih.gov/4051103/
479. Ferlito, A, Shaha, AR, Rinaldo, A, The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx., Oral Oncol, 2002. 38 (1)(1): p. 3-5., https://pubmed.ncbi.nlm.nih.gov/11755814/
480. Böscke, R, Cakir, BD, Hoffmann, AS, Wiegand, S, Quetz, J, Meyer, JE, Outcome after elective neck dissection and observation for the treatment of the clinically node-negative neck (cN0) in squamous cell carcinoma of the oropharynx., Eur Arch Otorhinolaryngol, 2014. 271 (3)(3): p. 567-74., https://pubmed.ncbi.nlm.nih.gov/23661061/
481. Shah, JP, Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract., Am J Surg, 1990. 160 (4)(4): p. 405-9., https://pubmed.ncbi.nlm.nih.gov/2221244/
482. Da Mosto, MC, Zanetti, F, Boscolo-Rizzo, P, Pattern of lymph node metastases in squamous cell carcinoma of the tonsil: implication for selective neck dissection., Oral Oncol, 2009. 45 (3)(3): p. 212-7., https://pubmed.ncbi.nlm.nih.gov/18710821/
483. Gross, BC, Olsen, SM, Lewis, JE, Kasperbauer, JL, Moore, EJ, Olsen, KD, et.al. Level IIB lymph node metastasis in laryngeal and hypopharyngeal squamous cell carcinoma: single-institution case series and review of the literature., Laryngoscope, 2013. 123 (12)(12): p. 3032-6., https://pubmed.ncbi.nlm.nih.gov/23686866/
484. Jose, J, Coatesworth, AP, Johnston, C, MacLennan, K, Cervical node metastases in oropharyngeal squamous cell carcinoma: prospective analysis of prevalence and distribution., J Laryngol Otol, 2002. 116 (11)(11): p. 925-8., https://pubmed.ncbi.nlm.nih.gov/12487673/
485. Lim, YC, Koo, BS, Lee, JS, Lim, JY, Choi, EC, Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck., Laryngoscope, 2006. 116 (7)(7): p. 1148-52., https://pubmed.ncbi.nlm.nih.gov/16826050/
486. Lim, YC, Lee, SY, Lim, JY, Shin, HA, Lee, JS, Koo, BS, et.al. Management of contralateral N0 neck in tonsillar squamous cell carcinoma., Laryngoscope, 2005. 115 (9)(9): p. 1672-5., https://pubmed.ncbi.nlm.nih.gov/16148715/
487. O'Brien, CJ, Traynor, SJ, McNeil, E, McMahon, JD, Chaplin, JM, The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx., Arch Otolaryngol Head Neck Surg, 2000. 126 (3)(3): p. 360-5., https://pubmed.ncbi.nlm.nih.gov/10722009/
488. Ogura, JH, Biller, HF, Calcaterra, TC, Davis, WH, Surgical treatment of carcinoma of the larynx, pharynx, base of tongue and cervical esophagus., Int Surg, 1969. 52 (1)(1): p. 29-40., https://pubmed.ncbi.nlm.nih.gov/5788668/
489. Shin, HA, Lim, YC, Jeong, HM, Choi, EC, Role of primary surgery for early-stage (T1-2N0) squamous cell carcinoma of the oropharynx., Oral Oncol, 2009. 45 (12)(12): p. 1063-6., https://pubmed.ncbi.nlm.nih.gov/19717331/
490. Woolgar, JA, Histological distribution of cervical lymph node metastases from intraoral/oropharyngeal squamous cell carcinomas., Br J Oral Maxillofac Surg, 1999. 37 (3)(3): p. 175-80., https://pubmed.ncbi.nlm.nih.gov/10454023/
491. Woolgar, JA, The topography of cervical lymph node metastases revisited: the histological findings in 526 sides of neck dissection from 439 previously untreated patients., Int J Oral Maxillofac Surg, 2007. 36 (3)(3): p. 219-25., https://pubmed.ncbi.nlm.nih.gov/17239562/
492. Plonowska, KA, Strohl, MP, Wang, SJ, Ha, PK, George, JR, Heaton, CM, et.al. Human Papillomavirus-Associated Oropharyngeal Cancer: Patterns of Nodal Disease., Otolaryngol Head Neck Surg, 2019. 160 (3)(3): p. 502-509., https://pubmed.ncbi.nlm.nih.gov/30274544/
493. Lop, J, Rigó, A, Codina, A, de Juan, J, Quer, M, León, X, Prognostic significance of extranodal extension in head and neck squamous cell carcinoma cN0 patients with occult metastatic neck nodes., Acta Otorrinolaringol Esp (Engl Ed), 2018. 69 (3)(3): p. 156-164., https://pubmed.ncbi.nlm.nih.gov/29033121/
494. Divi, V, Harris, J, Harari, PM, Cooper, JS, McHugh, J, Bell, D, et.al. Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)., Cancer, 2016. 122 (22)(22): p. 3464-3471., https://pubmed.ncbi.nlm.nih.gov/27419843/
495. Lim, YC, Lee, JS, Koo, BS, Kim, SH, Kim, YH, Choi, EC, Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation., Laryngoscope, 2006. 116 (3)(3): p. 461-5., https://pubmed.ncbi.nlm.nih.gov/16540910/
496. O'Sullivan, B, Warde, P, Grice, B, Goh, C, Payne, D, Liu, FF, et.al. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region., Int J Radiat Oncol Biol Phys, 2001. 51 (2)(2): p. 332-43., https://pubmed.ncbi.nlm.nih.gov/11567806/
497. Shoushtari, AN, Meeneghan, M, Treharne, GC, Reibel, JF, Levine, PA, Moskaluk, CA, et.al. Clinical nodal staging of T1-2 tonsillar squamous cell carcinoma stratified by p16 status and implications for ipsilateral neck irradiation., Cancer J, 2010. 16 (3)(3): p. 284-7., https://pubmed.ncbi.nlm.nih.gov/20526108/
498. Tritter, AG, Mehta, V, Samuelson, M, deGravelle, G, Ma, X, Medlin-Moore, T, et.al. Incidence of contralateral-bilateral nodes in the human papillomavirus era., Laryngoscope, 2017. 127 (6)(6): p. 1328-1333., https://pubmed.ncbi.nlm.nih.gov/27905120/
499. Zenga, J, Jackson, RS, Graboyes, EM, Sinha, P, Lindberg, M, Martin, EJ, et.al. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma., Laryngoscope, 2017. 127 (3)(3): p. 623-630., https://pubmed.ncbi.nlm.nih.gov/27634021/
500. Amsbaugh, MJ, Yusuf, M, Cash, E, Silverman, C, Wilson, E, Bumpous, J, et.al. Distribution of Cervical Lymph Node Metastases From Squamous Cell Carcinoma of the Oropharynx in the Era of Risk Stratification Using Human Papillomavirus and Smoking Status., Int J Radiat Oncol Biol Phys, 2016. 96 (2)(2): p. 349-353., https://pubmed.ncbi.nlm.nih.gov/27598805/
501. Lindberg, R, Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts., Cancer, 1972. 29 (6)(6): p. 1446-9., https://pubmed.ncbi.nlm.nih.gov/5031238/
502. McMullen, CP, Garneau, J, Weimar, E, Ali, S, Farinhas, JM, Yu, E, et.al. Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection., Oral Oncol, 2019. 93 (): p. 96-100., https://pubmed.ncbi.nlm.nih.gov/31109703/
503. Stanford-Moore, GB, Ochoa, E, Larson, A, Han, M, Hoppe, K, Ryan, WR, Patterns of Nodal Metastases and Predictors of Occult Disease in HPV-Associated Oropharynx Cancer., Otolaryngol Head Neck Surg, 2021. 164 (3)(3): p. 624-630., https://pubmed.ncbi.nlm.nih.gov/32894979/
504. Bauwens, L, Baltres, A, Fiani, DJ, Zrounba, P, Buiret, G, Fleury, B, et.al. Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma., Radiother Oncol, 2021. 157 (): p. 122-129., https://pubmed.ncbi.nlm.nih.gov/33545255/
505. Kato, MG, Ellis, MA, Nguyen, SA, Day, TA, Predictors of contralateral-bilateral nodal disease in oropharyngeal cancer: A National Cancer Data Base Study., Head Neck, 2018. 40 (2)(2): p. 338-348., https://pubmed.ncbi.nlm.nih.gov/28963823/
506. León, X, Venegas, MDP, Casasayas, M, Rodríguez, C, Neumann, ED, Holgado, A, et.al. Prognostic value of the nodal yield in elective neck dissections in patients with head and neck carcinomas., Eur Arch Otorhinolaryngol, 2022. 279 (2)(2): p. 883-889., https://pubmed.ncbi.nlm.nih.gov/33938992/
507. Shah, JP, Shaha, AR, Spiro, RH, Strong, EW, Carcinoma of the hypopharynx., Am J Surg, 1976. 132 (4)(4): p. 439-43., https://pubmed.ncbi.nlm.nih.gov/1015533/
508. Olzowy, B, Hillebrand, M, Harréus, U, Frequency of bilateral cervical metastases in hypopharyngeal squamous cell carcinoma: a retrospective analysis of 203 cases after bilateral neck dissection., Eur Arch Otorhinolaryngol, 2017. 274 (11)(11): p. 3965-3970., https://pubmed.ncbi.nlm.nih.gov/28840308/
509. Majoufre, C, Faucher, A, Laroche, C, De Bonfils, C, Siberchicot, F, Renaud-Salis, JL, et.al. Supraomohyoid neck dissection in cancer of the oral cavity., Am J Surg, 1999. 178 (1)(1): p. 73-7., https://pubmed.ncbi.nlm.nih.gov/10456709/
510. Amar, A, Dedivitis, RA, Rapoport, A, Quarteiro, AL, Indication of elective contralateral neck dissection in squamous cell carcinoma of the hypopharynx., Braz J Otorhinolaryngol, 2009. 75 (4)(4): p. 493-6., https://pubmed.ncbi.nlm.nih.gov/19784415/
511. Johnson, JT, Bacon, GW, Myers, EN, Wagner, RL, Medial vs lateral wall pyriform sinus carcinoma: implications for management of regional lymphatics., Head Neck, 1994. 16 (5)(5): p. 401-5., https://pubmed.ncbi.nlm.nih.gov/7960736/
512. Kowalski, LP, Santos, CR, Magrin, J, Scopel, A, Factors influencing contralateral metastasis and prognosis from pyriform sinus carcinoma., Am J Surg, 1995. 170 (5)(5): p. 440-5., https://pubmed.ncbi.nlm.nih.gov/7485728/
513. Ye, LL, Rao, J, Fan, XW, Kong, FF, Hu, CS, Ying, HM, The prognostic value of tumor depth for cervical lymph node metastasis in hypopharyngeal and supraglottic carcinomas., Head Neck, 2019. 41 (7)(7): p. 2116-2122., https://pubmed.ncbi.nlm.nih.gov/30689266/
514. Koo, BS, Lim, YC, Lee, JS, Kim, YH, Kim, SH, Choi, EC, Management of contralateral N0 neck in pyriform sinus carcinoma., Laryngoscope, 2006. 116 (7)(7): p. 1268-72., https://pubmed.ncbi.nlm.nih.gov/16826073/
515. Spector, JG, Sessions, DG, Haughey, BH, Chao, KS, Simpson, J, El Mofty, S, et.al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx., Laryngoscope, 2001. 111 (6)(6): p. 1079-87., https://pubmed.ncbi.nlm.nih.gov/11404625/
516. Rivière, D, Mancini, J, Santini, L, Giovanni, A, Dessi, P, Fakhry, N, Lymph-node metastasis following total laryngectomy and total pharyngolaryngectomy for laryngeal and hypopharyngeal squamous cell carcinoma: Frequency, distribution and risk factors., Eur Ann Otorhinolaryngol Head Neck Dis, 2018. 135 (3)(3): p. 163-166., https://pubmed.ncbi.nlm.nih.gov/29277379/
517. Sanabria, A, Kowalski, LP, Shaha, AR, Silver, CE, Werner, JA, Mandapathil, M, et.al. Salvage surgery for head and neck cancer: a plea for better definitions., Eur Arch Otorhinolaryngol, 2014. 271 (6)(6): p. 1347-50., https://pubmed.ncbi.nlm.nih.gov/24532050/
518. Abel, T, Bruhin, E, Sommerhalder, K, Jordan, S, Health Literacy / Gesundheitskompetenz, 2018., https://leitbegriffe.bzga.de/alphabetisches-verzeichnis/health-literacy-gesundheitskompetenz/
519. Best, AL, Logan, RG, Vázquez-Otero, C, Fung, W, Chee, V, Thompson, EL, et.al. Application of a Health Literacy Framework to Explore Patients' Knowledge of the Link between HPV and Cancer., J Health Commun, 2018. 23 (8)(8): p. 695-702., https://pubmed.ncbi.nlm.nih.gov/30153087/
520. Lakra, S, Kaur, G, Mehta, A, Kaushal, V, Atri, R, Sunder, , Knowledge and awareness of oral cancer patients regarding its etiology, prevention, and treatment., Indian J Dent Res, 2020. 31 (4)(4): p. 625-628., https://pubmed.ncbi.nlm.nih.gov/33107467/
521. Macek, MD, Haynes, D, Wells, W, Bauer-Leffler, S, Cotten, PA, Parker, RM, Measuring conceptual health knowledge in the context of oral health literacy: preliminary results., J Public Health Dent, 2010. 70 (3)(3): p. 197-204., https://pubmed.ncbi.nlm.nih.gov/20337901/
522. Nguyen, NP, Nguyen, LM, Thomas, S, Hong-Ly, B, Chi, A, Vos, P, et.al. Oral sex and oropharyngeal cancer: The role of the primary care physicians., Medicine (Baltimore), 2016. 95 (28)(28): p. e4228., https://pubmed.ncbi.nlm.nih.gov/27428229/
523. Rettig, E, Kiess, AP, Fakhry, C, The role of sexual behavior in head and neck cancer: implications for prevention and therapy., Expert Rev Anticancer Ther, 2015. 15 (1)(1): p. 35-49., https://pubmed.ncbi.nlm.nih.gov/25193346/
524. Riley, JL, Pomery, EA, Dodd, VJ, Muller, KE, Guo, Y, Logan, HL, Disparities in knowledge of mouth or throat cancer among rural Floridians., J Rural Health, 2013. 29 (3)(3): p. 294-303., https://pubmed.ncbi.nlm.nih.gov/23802931/
525. Shimpi, N, Jethwani, M, Bharatkumar, A, Chyou, PH, Glurich, I, Acharya, A, Patient awareness/knowledge towards oral cancer: a cross-sectional survey., BMC Oral Health, 2018. 18 (1)(1): p. 86., https://pubmed.ncbi.nlm.nih.gov/29764414/
526. Verhees, F, Demers, I, Schouten, LJ, Lechner, M, Speel, EM, Kremer, B, Public awareness of the association between human papillomavirus and oropharyngeal cancer., Eur J Public Health, 2021. 31 (5)(5): p. 1021-1025., https://pubmed.ncbi.nlm.nih.gov/34233355/
527. Wong, TJ, Li, Q, Dodd, V, Wang, W, Bian, J, Guo, Y, Oral cancer knowledge and screening behavior among smokers and non-smokers in rural communities., BMC Cancer, 2021. 21 (1)(1): p. 430., https://pubmed.ncbi.nlm.nih.gov/33879128/
528. Lima, AM, Meira, IA, Soares, MS, Bonan, PR, Mélo, CB, Piagge, CS, Delay in diagnosis of oral cancer: a systematic review., Med Oral Patol Oral Cir Bucal, 2021. 26 (6)(6): p. e815-e824., https://pubmed.ncbi.nlm.nih.gov/34704975/
529. D'Souza, V, Blouin, E, Zeitouni, A, Muller, K, Allison, PJ, Do multimedia based information services increase knowledge and satisfaction in head and neck cancer patients?, Oral Oncol, 2013. 49 (9)(9): p. 943-949., https://pubmed.ncbi.nlm.nih.gov/23870712/
530. D'Souza, V, Blouin, E, Zeitouni, A, Muller, K, Allison, PJ, Multimedia information intervention and its benefits in partners of the head and neck cancer patients., Eur J Cancer Care (Engl), 2017. 26 (4)(4):, https://pubmed.ncbi.nlm.nih.gov/26777257/
531. Henry, M, Arnovitz, E, Frenkiel, S, Hier, M, Zeitouni, A, Kost, K, et.al. Psychosocial outcomes of human papillomavirus (HPV)- and non-HPV-related head and neck cancers: A longitudinal study., Psychooncology, 2022. 31 (2)(2): p. 185-197., https://pubmed.ncbi.nlm.nih.gov/35122670/
532. Rieke, K, Schmid, KK, Lydiatt, W, Houfek, J, Boilesen, E, Watanabe-Galloway, S, Depression and survival in head and neck cancer patients., Oral Oncol, 2017. 65 (): p. 76-82., https://pubmed.ncbi.nlm.nih.gov/28109472/
533. Wang, TJ, Lu, MH, Kuo, PL, Chen, YW, Lee, SC, Liang, SY, Influences of facial disfigurement and social support for psychosocial adjustment among patients with oral cancer in Taiwan: a cross-sectional study., BMJ Open, 2018. 8 (11)(11): p. e023670., https://pubmed.ncbi.nlm.nih.gov/30478118/
534. You, EL, Henry, M, Zeitouni, AG, Human papillomavirus-associated oropharyngeal cancer: review of current evidence and management., Curr Oncol, 2019. 26 (2)(2): p. 119-123., https://pubmed.ncbi.nlm.nih.gov/31043814/
535. Brennan, K, Hall, S, Yoo, J, Rohland, S, Theurer, J, Peng, P, Routine follow-up care for head and neck cancer after curative treatment: A 3-year experience of measuring patients' self-reported needs, preferences, quality of life and attitudes towards follow-up., Eur J Cancer Care (Engl), 2022. 31 (3)(3): p. e13581., https://pubmed.ncbi.nlm.nih.gov/35343002/
536. Fitzgerald, CWR, Long, SM, McLean, AT, Cracchiolo, JR, Patient-reported outcomes in human papillomavirus-related oropharyngeal cancer., J Surg Oncol, 2021. 124 (6)(6): p. 967-976., https://pubmed.ncbi.nlm.nih.gov/34599762/
537. Nelke, KH, Pawlak, W, Gerber, H, Leszczyszyn, J, Head and neck cancer patients' quality of life., Adv Clin Exp Med, 2014. 23 (6)(6): p. 1019-27., https://pubmed.ncbi.nlm.nih.gov/25618131/
538. Weaver, R, O'Connor, M, Golding, RM, Gibson, C, White, R, Jackson, M, et.al. "My life's not my own": A qualitative study into the expectations of head and neck cancer carers., Support Care Cancer, 2022. 30 (5)(5): p. 4073-4080., https://pubmed.ncbi.nlm.nih.gov/35066666/
539. Wang, TF, Li, YJ, Chen, LC, Chou, C, Yang, SC, Correlation Between Postoperative Health-Related Quality of Life and Care Needs of Oral Cancer Patients., Cancer Nurs, 2020. 43 (1)(1): p. 12-21., https://pubmed.ncbi.nlm.nih.gov/30433894/
540. Morales, CZ, McDowell, L, Lisy, K, Piper, A, Jefford, M, Return to Work in Survivors of Human Papillomavirus-Associated Oropharyngeal Cancer: An Australian Experience., Int J Radiat Oncol Biol Phys, 2020. 106 (1)(1): p. 146-156., https://pubmed.ncbi.nlm.nih.gov/31521718/
541. Blumenberg, Petra, Krebs, Moritz, Schiemann, Doris, Stehling, Heiko, Stomberg, Dalien, Büscher, Andreas, Expertenstandard Entlassungsmanagement in der Pflege : [einschliesslich Kommentierung und Literaturstudie]Fachhochschule Osnabrück, Schriftenreihe des Deutschen Netzwerks für Qualitätsentwicklung in der Pflege, 2019.
542. Casswell, G, Gough, K, Drosdowsky, A, Bressel, M, Coleman, A, Shrestha, S, et.al. Sexual Health and Interpersonal Relationships After Chemoradiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A Cross-sectional Study., Int J Radiat Oncol Biol Phys, 2021. 110 (2)(2): p. 382-393., https://pubmed.ncbi.nlm.nih.gov/33171200/
543. Thompson, LMA, Donovan, KA, Discussions About Sexual Health: An Unmet Need Among Patients With Human Papillomavirus-Related Oropharyngeal Cancer., Int J Radiat Oncol Biol Phys, 2021. 110 (2)(2): p. 394-395., https://pubmed.ncbi.nlm.nih.gov/33989575/
544. You, EL, Henry, M, Zeitouni, AG, Human papillomavirus-associated oropharyngeal cancer: review of current evidence and management., Curr Oncol, 2019. 26 (2)(2): p. 119-123., https://pubmed.ncbi.nlm.nih.gov/31043814)/
545. Pingili, S, Ahmed, J, Sujir, N, Shenoy, N, Ongole, R, Evaluation of Malnutrition and Quality of Life in Patients Treated for Oral and Oropharyngeal Cancer., ScientificWorldJournal, 2021. 2021 (): p. 9936715., https://pubmed.ncbi.nlm.nih.gov/34381320/
546. Brewczyński, A, Jabłońska, B, Mrowiec, S, Składowski, K, Rutkowski, T, Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status., Nutrients, 2020. 13 (1)(1):, https://pubmed.ncbi.nlm.nih.gov/33375430/
547. Alhambra Expósito, MR, Herrera-Martínez, AD, Manzano García, G, Espinosa Calvo, M, Bueno Serrano, CM, Gálvez Moreno, MÁ, Early nutrition support therapy in patients with head-neck cancer., Nutr Hosp, 2018. 35 (3)(3): p. 505-510., https://pubmed.ncbi.nlm.nih.gov/29974754/
548. Gellrich, NC, Handschel, J, Holtmann, H, Krüskemper, G, Oral cancer malnutrition impacts weight and quality of life., Nutrients, 2015. 7 (4)(4): p. 2145-60., https://pubmed.ncbi.nlm.nih.gov/25825828/
549. Harrowfield, J, Isenring, E, Kiss, N, Laing, E, Lipson-Smith, R, Britton, B, The Impact of Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) on Nutritional Outcomes., Nutrients, 2021. 13 (2)(2):, https://pubmed.ncbi.nlm.nih.gov/33557340/
550. Harms, A, Kansara, S, Stach, C, Richardson, PA, Chen, G, Lai, S, et.al. Swallowing Function in Survivors of Oropharyngeal Cancer Is Associated With Advanced T Classification., Ann Otol Rhinol Laryngol, 2019. 128 (8)(8): p. 696-703., https://pubmed.ncbi.nlm.nih.gov/30913911/
551. Talwar, B, Donnelly, R, Skelly, R, Donaldson, M, Nutritional management in head and neck cancer: United Kingdom National Multidisciplinary Guidelines., J Laryngol Otol, 2016. 130 (S2)(S2): p. S32-S40., https://pubmed.ncbi.nlm.nih.gov/27841109/
552. Yao, CMKL, Hutcheson, KA, Quality of Life Implications After Transoral Robotic Surgery for Oropharyngeal Cancers., Otolaryngol Clin North Am, 2020. 53 (6)(6): p. 1117-1129., https://pubmed.ncbi.nlm.nih.gov/32917421/
553. Jo, S, Yeo, MS, Shin, YK, Shin, KH, Kim, SH, Kim, HR, et.al. Therapeutic Singing as a Swallowing Intervention in Head and Neck Cancer Patients With Dysphagia., Integr Cancer Ther, 2021. 20 (): p. 15347354211065040., https://pubmed.ncbi.nlm.nih.gov/34903088/
554. Nugent, B, Lewis, S, O'Sullivan, JM, Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy., Cochrane Database Syst Rev, 2013. 2013 (1)(1): p. CD007904., https://pubmed.ncbi.nlm.nih.gov/23440820/
555. Galbiatti, AL, Padovani-Junior, JA, Maníglia, JV, Rodrigues, CD, Pavarino, ÉC, Goloni-Bertollo, EM, Head and neck cancer: causes, prevention and treatment., Braz J Otorhinolaryngol, 2013. 79 (2)(2): p. 239-47., https://pubmed.ncbi.nlm.nih.gov/23670332/
556. Petersen, PE, Oral cancer prevention and control--the approach of the World Health Organization., Oral Oncol, 2009. 45 (4-5)(4-5): p. 454-60., https://pubmed.ncbi.nlm.nih.gov/18804412/
557. Zygogianni, AG, Kyrgias, G, Karakitsos, P, Psyrri, A, Kouvaris, J, Kelekis, N, et.al. Oral squamous cell cancer: early detection and the role of alcohol and smoking., Head Neck Oncol, 2011. 3 (): p. 2., https://pubmed.ncbi.nlm.nih.gov/21211041/
558. Conlon, MSC, Santi, SA, Meigs, ML, Davidson, SM, Saunders, D, Cigarette-smoking characteristics and interest in cessation in patients with head-and-neck cancer., Curr Oncol, 2020. 27 (5)(5): p. e478-e485., https://pubmed.ncbi.nlm.nih.gov/33173387/
559. Goldstein, BY, Chang, SC, Hashibe, M, La Vecchia, C, Zhang, ZF, Alcohol consumption and cancers of the oral cavity and pharynx from 1988 to 2009: an update., Eur J Cancer Prev, 2010. 19 (6)(6): p. 431-65., https://pubmed.ncbi.nlm.nih.gov/20679896/
560. Al Feghali, KA, Ghanem, AI, Burmeister, C, Chang, SS, Ghanem, T, Keller, C, et.al. Impact of smoking on pathological features in oral cavity squamous cell carcinoma., J Cancer Res Ther, 2019. 15 (3)(3): p. 582-588., https://pubmed.ncbi.nlm.nih.gov/31169224/
561. Montero, PH, Patel, SG, Cancer of the oral cavity., Surg Oncol Clin N Am, 2015. 24 (3)(3): p. 491-508., https://pubmed.ncbi.nlm.nih.gov/25979396/
562. Braakhuis, BJ, Tabor, MP, Leemans, CR, van der Waal, I, Snow, GB, Brakenhoff, RH, Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions., Head Neck, 2002. 24 (2)(2): p. 198-206., https://pubmed.ncbi.nlm.nih.gov/11891950/
563. Rohde, M, Rosenberg, T, Pareek, M, Nankivell, P, Sharma, N, Mehanna, H, et.al. Definition of locally recurrent head and neck squamous cell carcinoma: a systematic review and proposal for the Odense-Birmingham definition., Eur Arch Otorhinolaryngol, 2020. 277 (6)(6): p. 1593-1599., https://pubmed.ncbi.nlm.nih.gov/32266461/
564. Leith, JT, Michelson, S, Tumor radiocurability: relationship to intrinsic tumor heterogeneity and to the tumor bed effect., Invasion Metastasis, 1990. 10 (6)(6): p. 329-51., https://pubmed.ncbi.nlm.nih.gov/2265986/
565. Milas, L, Hunter, N, Peters, LJ, The tumor bed effect: dependence of tumor take, growth rate, and metastasis on the time interval between irradiation and tumor cell transplantation., Int J Radiat Oncol Biol Phys, 1987. 13 (3)(3): p. 379-83., https://pubmed.ncbi.nlm.nih.gov/3558028/
566. Haveman, J, Rodermond, H, van Bree, C, Wondergem, J, Franken, NA, Residual late radiation damage in mouse stromal tissue assessed by the tumor bed effect., J Radiat Res, 2007. 48 (2)(2): p. 107-12., https://pubmed.ncbi.nlm.nih.gov/17299252/
567. Milas, L, Hirata, H, Hunter, N, Peters, LJ, Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas., Cancer Res, 1988. 48 (8)(8): p. 2116-20., https://pubmed.ncbi.nlm.nih.gov/3349483/
568. Ang, KK, Jiang, GL, Feng, Y, Stephens, LC, Tucker, SL, Price, RE, Extent and kinetics of recovery of occult spinal cord injury., Int J Radiat Oncol Biol Phys, 2001. 50 (4)(4): p. 1013-20., https://pubmed.ncbi.nlm.nih.gov/11429229/
569. Zafereo, ME, Hanasono, MM, Rosenthal, DI, Sturgis, EM, Lewin, JS, Roberts, DB, et.al. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx., Cancer, 2009. 115 (24)(24): p. 5723-33., https://pubmed.ncbi.nlm.nih.gov/19760612/
570. Zafereo, M, Surgical salvage of recurrent cancer of the head and neck., Curr Oncol Rep, 2014. 16 (5)(5): p. 386., https://pubmed.ncbi.nlm.nih.gov/24623521/
571. Mandapathil, M, Roessler, M, Werner, JA, Silver, CE, Rinaldo, A, Ferlito, A, Salvage surgery for head and neck squamous cell carcinoma., Eur Arch Otorhinolaryngol, 2014. 271 (7)(7): p. 1845-50., https://pubmed.ncbi.nlm.nih.gov/24756615/
572. Goodwin, WJ, Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?, Laryngoscope, 2000. 110 (3 Pt 2 Suppl 93)(3 Pt 2 Suppl 93): p. 1-18., https://pubmed.ncbi.nlm.nih.gov/10714711/
573. Bots, WTC, van den Bosch, S, Zwijnenburg, EM, Dijkema, T, van den Broek, GB, Weijs, WLJ, et.al. Reirradiation of head and neck cancer: Long-term disease control and toxicity., Head Neck, 2017. 39 (6)(6): p. 1122-1130., https://pubmed.ncbi.nlm.nih.gov/28263446/
574. Ward, MC, Riaz, N, Caudell, JJ, Dunlap, NE, Isrow, D, Zakem, SJ, et.al. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative., Int J Radiat Oncol Biol Phys, 2018. 100 (3)(3): p. 586-594., https://pubmed.ncbi.nlm.nih.gov/28865925/
575. Ward, MC, Koyfman, SA, Bakst, RL, Margalit, DN, Beadle, BM, Beitler, JJ, et.al. Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria., Int J Radiat Oncol Biol Phys, 2022. 113 (4)(4): p. 759-786., https://pubmed.ncbi.nlm.nih.gov/35398456/
576. Vargo, JA, Ward, MC, Caudell, JJ, Riaz, N, Dunlap, NE, Isrow, D, et.al. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer., Int J Radiat Oncol Biol Phys, 2018. 100 (3)(3): p. 595-605., https://pubmed.ncbi.nlm.nih.gov/28899556/
577. Caudell, JJ, Ward, MC, Riaz, N, Zakem, SJ, Awan, MJ, Dunlap, NE, et.al. Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis., Int J Radiat Oncol Biol Phys, 2018. 100 (3)(3): p. 606-617., https://pubmed.ncbi.nlm.nih.gov/29413274/
578. Choi, SH, Chang, JS, Choi, J, Park, SH, Keum, KC, Park, KR, et.al. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer., Anticancer Res, 2018. 38 (5)(5): p. 3165-3173., https://pubmed.ncbi.nlm.nih.gov/29715158/
579. Zbären, P, Nuyens, M, Curschmann, J, Stauffer, E, Histologic characteristics and tumor spread of recurrent glottic carcinoma: analysis on whole-organ sections and comparison with tumor spread of primary glottic carcinomas., Head Neck, 2007. 29 (1)(1): p. 26-32., https://pubmed.ncbi.nlm.nih.gov/17103406/
580. Lee, HJ, Jang, YJ, Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids., Int J Mol Sci, 2018. 19 (3)(3):, https://pubmed.ncbi.nlm.nih.gov/29498630/
581. Ueda, K, Yasuda, Y, Furuya, E, Oba, S, Inadequate blood supply persists in keloids., Scand J Plast Reconstr Surg Hand Surg, 2004. 38 (5)(5): p. 267-71., https://pubmed.ncbi.nlm.nih.gov/15513596/
582. Zhao, B, Guan, H, Liu, JQ, Zheng, Z, Zhou, Q, Zhang, J, et.al. Hypoxia drives the transition of human dermal fibroblasts to a myofibroblast-like phenotype via the TGF-β1/Smad3 pathway., Int J Mol Med, 2017. 39 (1)(1): p. 153-159., https://pubmed.ncbi.nlm.nih.gov/27909731/
583. Dietz, A, Wiegand, S, Bläker, H, Budach, W, [Therapy of tumor recurrences or secondary carcinomas in pretreated area is not compatible with the primary therapy in non-previously treated tissue - an overview]., Laryngorhinootologie, 2023. 102 (12)(12): p. 908-915., https://pubmed.ncbi.nlm.nih.gov/37696291/
584. Lee, J, Shin, IS, Kim, WC, Yoon, WS, Koom, WS, Rim, CH, Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: Meta-analysis and systematic review., Head Neck, 2020. 42 (9)(9): p. 2473-2485., https://pubmed.ncbi.nlm.nih.gov/32437021/
585. Kao, SS, Ooi, EH, Survival outcomes following salvage surgery for oropharyngeal squamous cell carcinoma: systematic review., J Laryngol Otol, 2018. 132 (4)(4): p. 299-313., https://pubmed.ncbi.nlm.nih.gov/28502256/
586. Chung, EJ, Lee, SH, Baek, SH, Bae, WJ, Chang, YJ, Rho, YS, Clinical outcome and prognostic factors after salvage surgery for isolated regional squamous cell carcinoma recurrences., Head Neck, 2015. 37 (11)(11): p. 1612-7., https://pubmed.ncbi.nlm.nih.gov/24931743/
587. Jayaram, SC, Muzaffar, SJ, Ahmed, I, Dhanda, J, Paleri, V, Mehanna, H, Efficacy, outcomes, and complication rates of different surgical and nonsurgical treatment modalities for recurrent/residual oropharyngeal carcinoma: A systematic review and meta-analysis., Head Neck, 2016. 38 (12)(12): p. 1855-1861., https://pubmed.ncbi.nlm.nih.gov/27405247/
588. Joseph, AW, Guo, T, Hur, K, Xie, Y, Yin, L, Califano, JA, et.al. Disease-free survival after salvage therapy for recurrent oropharyngeal squamous cell carcinoma., Head Neck, 2016. 38 Suppl 1 (): p. E1501-9., https://pubmed.ncbi.nlm.nih.gov/26558328/
589. Guo, T, Qualliotine, JR, Ha, PK, Califano, JA, Kim, Y, Saunders, JR, et.al. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer., Cancer, 2015. 121 (12)(12): p. 1977-84., https://pubmed.ncbi.nlm.nih.gov/25782027/
590. Patel, SN, Cohen, MA, Givi, B, Dixon, BJ, Gilbert, RW, Gullane, PJ, et.al. Salvage surgery for locally recurrent oropharyngeal cancer., Head Neck, 2016. 38 Suppl 1 (): p. E658-64., https://pubmed.ncbi.nlm.nih.gov/25867012/
591. Lee, J, Kim, TH, Kim, YS, Kim, M, Park, JW, Kim, SH, et.al. Intensity-Modulated Radiotherapy-Based Reirradiation for Head and Neck Cancer: A Multi-institutional Study by Korean Radiation Oncology Group (KROG 1707)., Cancer Res Treat, 2020. 52 (4)(4): p. 1031-1040., https://pubmed.ncbi.nlm.nih.gov/32632081/
592. Vander Poorten, V, Meulemans, J, Beitler, JJ, Piazza, C, Kowalski, LP, Mäkitie, AA, et.al. Salvage surgery for residual or recurrent laryngeal squamous cell carcinoma after (Chemo)radiotherapy: Oncological outcomes and prognostic factors., Eur J Surg Oncol, 2021. 47 (11)(11): p. 2711-2721., https://pubmed.ncbi.nlm.nih.gov/34059377/
593. Meulemans, J, Demarsin, H, Debacker, J, Batailde, G, Mennes, T, Laenen, A, et.al. Functional Outcomes and Complications After Salvage Total Laryngectomy for Residual, Recurrent, and Second Primary Squamous Cell Carcinoma of the Larynx and Hypopharynx: A Multicenter Retrospective Cohort Study., Front Oncol, 2020. 10 (): p. 1390., https://pubmed.ncbi.nlm.nih.gov/32983968/
594. Kwon, D, Genden, EM, de Bree, R, Rodrigo, JP, Rinaldo, A, Sanabria, A, et.al. Overcoming wound complications in head and neck salvage surgery., Auris Nasus Larynx, 2018. 45 (6)(6): p. 1135-1142., https://pubmed.ncbi.nlm.nih.gov/29692326/
595. Dequanter, D, Jacobs, D, Shahla, M, Paulus, P, Aubert, C, Lothaire, P, The effect of hyperbaric oxygen therapy on treatment of wound complications after oral, pharyngeal and laryngeal salvage surgery., Undersea Hyperb Med, 2013. 40 (5)(5): p. 381-5., https://pubmed.ncbi.nlm.nih.gov/24224281/
596. Reiter, M, Harréus, U, Vacuum assisted closure in the management of wound healing disorders in the head and neck: a retrospective analysis of 23 cases., Am J Otolaryngol, 2013. 34 (5)(5): p. 411-5., https://pubmed.ncbi.nlm.nih.gov/23558358/
597. Fung, K, Teknos, TN, Vandenberg, CD, Lyden, TH, Bradford, CR, Hogikyan, ND, et.al. Prevention of wound complications following salvage laryngectomy using free vascularized tissue., Head Neck, 2007. 29 (5)(5): p. 425-30., https://pubmed.ncbi.nlm.nih.gov/17274047/
598. Yeh, DH, Sahovaler, A, Fung, K, Reconstruction after salvage laryngectomy., Oral Oncol, 2017. 75 (): p. 22-27., https://pubmed.ncbi.nlm.nih.gov/29224818/
599. Baek, CH, Park, W, Choi, N, Gu, S, Sohn, I, Chung, MK, Free flap outcome of salvage surgery compared to primary surgery for head and neck defects: A propensity score analysis., Oral Oncol, 2016. 62 (): p. 85-89., https://pubmed.ncbi.nlm.nih.gov/27865376/
600. Khan, NA, Medina, JE, Sanclement, JA, Krempl, GA, Fistula rates after salvage laryngectomy: comparing pectoralis myofascial and myocutaneous flaps., Laryngoscope, 2014. 124 (7)(7): p. 1615-7., https://pubmed.ncbi.nlm.nih.gov/24122869/
601. Patel, UA, Moore, BA, Wax, M, Rosenthal, E, Sweeny, L, Militsakh, ON, et.al. Impact of pharyngeal closure technique on fistula after salvage laryngectomy., JAMA Otolaryngol Head Neck Surg, 2013. 139 (11)(11): p. 1156-62., https://pubmed.ncbi.nlm.nih.gov/23576219/
602. Jing, SS, O'Neill, T, Clibbon, JJ, A comparison between free gracilis muscle flap and pedicled pectoralis major flap reconstructions following salvage laryngectomy., J Plast Reconstr Aesthet Surg, 2014. 67 (1)(1): p. 17-22., https://pubmed.ncbi.nlm.nih.gov/24095742/
603. Piazza, C, Paderno, A, Del Bon, F, Grammatica, A, Montalto, N, Bresciani, L, et.al. Fascio-cutaneous-free flaps as primary reconstruction in salvage total laryngectomy., Eur Arch Otorhinolaryngol, 2021. 278 (1)(1): p. 219-226., https://pubmed.ncbi.nlm.nih.gov/32583182/
604. Shah, JP, Loree, TR, Kowalski, L, Conservation surgery for radiation-failure carcinoma of the glottic larynx., Head Neck, 1990. 12 (4)(4): p. 326-31., https://pubmed.ncbi.nlm.nih.gov/2361863/
605. Paleri, V, Drinnan, M, van den Brekel, MW, Hinni, ML, Bradley, PJ, Wolf, GT, et.al. Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review., Laryngoscope, 2014. 124 (8)(8): p. 1848-53., https://pubmed.ncbi.nlm.nih.gov/24474684/
606. Sayles, M, Grant, DG, Preventing pharyngo-cutaneous fistula in total laryngectomy: a systematic review and meta-analysis., Laryngoscope, 2014. 124 (5)(5): p. 1150-63., https://pubmed.ncbi.nlm.nih.gov/24122657/
607. Schwaab, G, Mamelle, G, Lartigau, E, Parise, O, Wibault, P, Luboinski, B, Surgical salvage treatment of T1/T2 glottic carcinoma after failure of radiotherapy., Am J Surg, 1994. 168 (5)(5): p. 474-5., https://pubmed.ncbi.nlm.nih.gov/7977978/
608. Putten, L, Bree, R, Doornaert, PA, Buter, J, Eerenstein, SE, Rietveld, DH, et.al. Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review., Acta Otorhinolaryngol Ital, 2015. 35 (3)(3): p. 162-72., https://pubmed.ncbi.nlm.nih.gov/26246660/
609. Janot, F, de Raucourt, D, Benhamou, E, Ferron, C, Dolivet, G, Bensadoun, RJ, et.al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma., J Clin Oncol, 2008. 26 (34)(34): p. 5518-23., https://pubmed.ncbi.nlm.nih.gov/18936479/
610. Caudell, JJ, Ward, MC, Riaz, N, Zakem, SJ, Awan, MJ, Dunlap, NE, et.al. Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis., Int J Radiat Oncol Biol Phys, 2018. 100 (3)(3): p. 606-617., https://pubmed.ncbi.nlm.nih.gov/29413274/
611. Lee, J, Kim, WC, Yoon, WS, Koom, WS, Rim, CH, Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: A meta-analysis and systematic review., Oral Oncol, 2020. 107 (): p. 104757., https://pubmed.ncbi.nlm.nih.gov/32388412/
612. Dionisi, F, Fiorica, F, D'Angelo, E, Maddalo, M, Giacomelli, I, Tornari, E, et.al. Organs at risk's tolerance and dose limits for head and neck cancer re-irradiation: A literature review., Oral Oncol, 2019. 98 (): p. 35-47., https://pubmed.ncbi.nlm.nih.gov/31536844/
613. Rühle, A, Sprave, T, Kalckreuth, T, Stoian, R, Haehl, E, Zamboglou, C, et.al. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer., Radiat Oncol, 2020. 15 (1)(1): p. 81., https://pubmed.ncbi.nlm.nih.gov/32299456/
614. Lee, A, Woods, R, Mahfouz, A, Kitpanit, S, Cartano, O, Mohamed, N, et.al. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma., JAMA Netw Open, 2023. 6 (1)(1): p. e2250607., https://pubmed.ncbi.nlm.nih.gov/36689229/
615. Kreinbrink, PJ, Lewis, LM, Redmond, KP, Takiar, V, Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence., Curr Treat Options Oncol, 2022. 23 (3)(3): p. 295-310., https://pubmed.ncbi.nlm.nih.gov/35226310/
616. Yamazaki, H, Ogita, M, Himei, K, Nakamura, S, Kotsuma, T, Yoshida, K, et.al. Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: A multi-institutional matched-cohort analysis., Radiother Oncol, 2015. 115 (1)(1): p. 67-71., https://pubmed.ncbi.nlm.nih.gov/25827266/
617. Ohizumi, Y, Tamai, Y, Imamiya, S, Akiba, T, Complications following re-irradiation for head and neck cancer., Am J Otolaryngol, 2002. 23 (4)(4): p. 215-21., https://pubmed.ncbi.nlm.nih.gov/12105786/
618. Akbaba, S, Held, T, Lang, K, Hoerner-Rieber, J, Zaoui, K, Forster, T, et.al. Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience., Radiat Oncol, 2019. 14 (1)(1): p. 34., https://pubmed.ncbi.nlm.nih.gov/30782197/
619. Forastiere, AA, Metch, B, Schuller, DE, Ensley, JF, Hutchins, LF, Triozzi, P, et.al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study., J Clin Oncol, 1992. 10 (8)(8): p. 1245-51., https://pubmed.ncbi.nlm.nih.gov/1634913/
620. Burtness, B, Harrington, KJ, Greil, R, Soulières, D, Tahara, M, de Castro, G, et.al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study., Lancet, 2019. 394 (10212)(10212): p. 1915-1928., https://pubmed.ncbi.nlm.nih.gov/31679945/
621. Klinghammer, K, Lorini, L, Nevens, D, Simon, C, Machiels, JP, Bossi, P, Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group., Front Oncol, 2022. 12 (): p. 730785., https://pubmed.ncbi.nlm.nih.gov/35155222/
622. Guigay, J, Aupérin, A, Fayette, J, Saada-Bouzid, E, Lafond, C, Taberna, M, et.al. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial., Lancet Oncol, 2021. 22 (4)(4): p. 463-475., https://pubmed.ncbi.nlm.nih.gov/33684370/
623. Vermorken, JB, Mesia, R, Rivera, F, Remenar, E, Kawecki, A, Rottey, S, et.al. Platinum-based chemotherapy plus cetuximab in head and neck cancer., N Engl J Med, 2008. 359 (11)(11): p. 1116-27., https://pubmed.ncbi.nlm.nih.gov/18784101/
624. Vermorken, JB, Psyrri, A, Mesía, R, Peyrade, F, Beier, F, de Blas, B, et.al. Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial., Ann Oncol, 2014. 25 (4)(4): p. 801-807., https://pubmed.ncbi.nlm.nih.gov/24577117/
625. Ferris, RL, Blumenschein, G, Fayette, J, Guigay, J, Colevas, AD, Licitra, L, et.al. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck., N Engl J Med, 2016. 375 (19)(19): p. 1856-1867., https://pubmed.ncbi.nlm.nih.gov/27718784/
626. Mehra, R, Seiwert, TY, Gupta, S, Weiss, J, Gluck, I, Eder, JP, et.al. Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012., Br J Cancer, 2018. 119 (2)(2): p. 153-159., https://pubmed.ncbi.nlm.nih.gov/29955135/
627. Zandberg, DP, Algazi, AP, Jimeno, A, Good, JS, Fayette, J, Bouganim, N, et.al. Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy., Eur J Cancer, 2019. 107 (): p. 142-152., https://pubmed.ncbi.nlm.nih.gov/30576970/
628. Harrington, KJ, Burtness, B, Greil, R, Soulières, D, Tahara, M, de Castro, G, et.al. Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study., J Clin Oncol, 2023. 41 (4)(4): p. 790-802., https://pubmed.ncbi.nlm.nih.gov/36219809/
629. Mesía, R, Rivera, F, Kawecki, A, Rottey, S, Hitt, R, Kienzer, H, et.al. Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck., Ann Oncol, 2010. 21 (10)(10): p. 1967-1973., https://pubmed.ncbi.nlm.nih.gov/20335368/
630. Licitra, L, Mesia, R, Rivera, F, Remenár, É, Hitt, R, Erfán, J, et.al. Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study., Ann Oncol, 2011. 22 (5)(5): p. 1078-1087., https://pubmed.ncbi.nlm.nih.gov/21048039/
631. A phase III randomised trial of cistplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group., Br J Cancer, 1990. 61 (2)(2): p. 311-5., https://pubmed.ncbi.nlm.nih.gov/2178667/
632. Cohen, EEW, Soulières, D, Le Tourneau, C, Dinis, J, Licitra, L, Ahn, MJ, et.al. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study., Lancet, 2019. 393 (10167)(10167): p. 156-167., https://pubmed.ncbi.nlm.nih.gov/30509740/
633. Burtness, B, Goldwasser, MA, Flood, W, Mattar, B, Forastiere, AA, Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study., J Clin Oncol, 2005. 23 (34)(34): p. 8646-54., https://pubmed.ncbi.nlm.nih.gov/16314626/
634. Samlowski, WE, Moon, J, Kuebler, JP, Nichols, CR, Gandara, DR, Ozer, H, et.al. Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncology Group Phase II study., Cancer Invest, 2007. 25 (3)(3): p. 182-8., https://pubmed.ncbi.nlm.nih.gov/17530488/
635. Gibson, MK, Li, Y, Murphy, B, Hussain, MH, DeConti, RC, Ensley, J, et.al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group., J Clin Oncol, 2005. 23 (15)(15): p. 3562-7., https://pubmed.ncbi.nlm.nih.gov/15908667/
636. Herbst, RS, Arquette, M, Shin, DM, Dicke, K, Vokes, EE, Azarnia, N, et.al. Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck., J Clin Oncol, 2005. 23 (24)(24): p. 5578-87., https://pubmed.ncbi.nlm.nih.gov/16009949/
637. Jacobs, C, Lyman, G, Velez-García, E, Sridhar, KS, Knight, W, Hochster, H, et.al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck., J Clin Oncol, 1992. 10 (2)(2): p. 257-63., https://pubmed.ncbi.nlm.nih.gov/1732427/
638. Al-Sarraf, M, Metch, B, Kish, J, Ensley, J, Rinehart, JJ, Schuller, DE, et.al. Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study., Cancer Treat Rep, 1987. 71 (7-8)(7-8): p. 723-6., https://pubmed.ncbi.nlm.nih.gov/3300967/
639. Grau, JJ, Caballero, M, Verger, E, Monzó, M, Blanch, JL, Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients., Acta Otolaryngol, 2009. 129 (11)(11): p. 1294-9., https://pubmed.ncbi.nlm.nih.gov/19863327/
640. Catimel, G, Verweij, J, Mattijssen, V, Hanauske, A, Piccart, M, Wanders, J, et.al. Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group., Ann Oncol, 1994. 5 (6)(6): p. 533-7., https://pubmed.ncbi.nlm.nih.gov/7918125/
641. Guardiola, E, Peyrade, F, Chaigneau, L, Cupissol, D, Tchiknavorian, X, Bompas, E, et.al. Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer., Eur J Cancer, 2004. 40 (14)(14): p. 2071-6., https://pubmed.ncbi.nlm.nih.gov/15341981/
642. Stewart, JS, Cohen, EE, Licitra, L, Van Herpen, CM, Khorprasert, C, Soulieres, D, et.al. Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected]., J Clin Oncol, 2009. 27 (11)(11): p. 1864-71., https://pubmed.ncbi.nlm.nih.gov/19289630/
643. Vermorken, JB, Trigo, J, Hitt, R, Koralewski, P, Diaz-Rubio, E, Rolland, F, et.al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy., J Clin Oncol, 2007. 25 (16)(16): p. 2171-7., https://pubmed.ncbi.nlm.nih.gov/17538161/
644. Fury, MG, Sherman, E, Lisa, D, Agarwal, N, Algazy, K, Brockstein, B, et.al. A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer., J Natl Compr Canc Netw, 2012. 10 (11)(11): p. 1391-8., https://pubmed.ncbi.nlm.nih.gov/23138167/
645. Martinez-Trufero, J, Isla, D, Adansa, JC, Irigoyen, A, Hitt, R, Gil-Arnaiz, I, et.al. Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment., Br J Cancer, 2010. 102 (12)(12): p. 1687-91., https://pubmed.ncbi.nlm.nih.gov/20485287/
646. Machiels, JP, Haddad, RI, Fayette, J, Licitra, LF, Tahara, M, Vermorken, JB, et.al. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial., Lancet Oncol, 2015. 16 (5)(5): p. 583-94., https://pubmed.ncbi.nlm.nih.gov/25892145/
647. S3-Leitlinie Supportive Therapie bei onkologischen PatientInnen. AWMF-Register-Nummer (032-054OL). Langversion 1.3, 2020., https://www.leitlinienprogramm-onkologie.de/leitlinien/supportive-therapie/
648. Dietz, A, Rudat, V, Nollert, J, Helbig, M, Vanselow, B, Weidauer, H, [Chronic laryngeal edema as a late reaction to radiochemotherapy]., HNO, 1998. 46 (8)(8): p. 731-8., https://pubmed.ncbi.nlm.nih.gov/9773329/
649. Dietz, A, Stöhr, M, Zebralla, V, Pirlich, M, Wichmann, G, Wiegand, S, [Immuno oncology treatment in head and neck cancer]., Laryngorhinootologie, 2021. 100 (4)(4): p. 303-321., https://pubmed.ncbi.nlm.nih.gov/33784782/
650. Opdivo : EPAR - Product informationEuropean Medicines Agency, abgerufen am: 12.04.2023., https://www.ema.europa.eu/en/medicines/human/EPAR/opdivo
651. European Medicines Agency, Keytruda Nebenwirkungsprofil, abgerufen am: 28.04.2023., https://www.ema.europa.eu/en/documents/product-information/keytruda-epar-product-information_de.pdf
652. Immuntherapie-bedingte Nebenwirkungen und ihr Management. Eine ESMO-Patientenleitlinie.European Society for Medical Oncology (ESMO), 2017., https://www.esmo.org/content/download/133758/2490221/1/DE-ESMO-Patientenleitlinie-Immuntherapie-bedingte-Nebenwirkungen-und-ihr-Management.pdf
653. Studer, G, Glanzmann, C, Studer, SP, Grätz, KW, Lütolf, UM, Zwahlen, RA, [Recommendations for dental care prior to intensity-modulated radiotherapy (IMRT). Adaptation of the University Hospital Zurich (USZ) guidelines]., Schweiz Monatsschr Zahnmed, 2007. 117 (6)(6): p. 637-47., https://pubmed.ncbi.nlm.nih.gov/17691423/
654. Grötz, KA, [Dental care for patients with antineoplastic radiotherapy of the head and neck]., Strahlenther Onkol, 2003. 179 (4)(4): p. 275-8., https://pubmed.ncbi.nlm.nih.gov/12728932/
655. Ludwig, E, [Dental care in case of head and neck cancer--Part I: Radiotherapy]., Laryngorhinootologie, 2008. 87 (12)(12): p. 885-97; quiz 898-902., https://pubmed.ncbi.nlm.nih.gov/19031347/
656. Epstein, JB, Lunn, R, Le, N, Stevenson-Moore, P, Periodontal attachment loss in patients after head and neck radiation therapy., Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1998. 86 (6)(6): p. 673-7., https://pubmed.ncbi.nlm.nih.gov/9868723/
657. Denis, F, Garaud, P, Bardet, E, Alfonsi, M, Sire, C, Germain, T, et.al. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems., Int J Radiat Oncol Biol Phys, 2003. 55 (1)(1): p. 93-8., https://pubmed.ncbi.nlm.nih.gov/12504040/
658. Allison, PJ, Locker, D, Feine, JS, The relationship between dental status and health-related quality of life in upper aerodigestive tract cancer patients., Oral Oncol, 1999. 35 (2)(2): p. 138-43., https://pubmed.ncbi.nlm.nih.gov/10435147/
659. Granström, G, Radiotherapy, osseointegration and hyperbaric oxygen therapy., Periodontol 2000, 2003. 33 (): p. 145-62., https://pubmed.ncbi.nlm.nih.gov/12950848/
660. Mericske-Stern, R, Perren, R, Raveh, J, Life table analysis and clinical evaluation of oral implants supporting prostheses after resection of malignant tumors., Int J Oral Maxillofac Implants, 1999. 14 (5)(5): p. 673-80., https://pubmed.ncbi.nlm.nih.gov/10531739/
661. McCord, JF, Michelinakis, G, Systematic review of the evidence supporting intra-oral maxillofacial prosthodontic care., Eur J Prosthodont Restor Dent, 2004. 12 (3)(3): p. 129-35., https://pubmed.ncbi.nlm.nih.gov/15521397/
662. Nusser-Mueller-Busch, , R. and R. Horst, Die Manuelle Schlucktherapie – Reset the brain, in FORUM Logopädie, 2011. 25(3): p. 6-13.
663. Seidl, RO, Nusser-Müller-Busch, R, [Posttreatment rehabilitation of swallowing in patients with head and neck cancer]., Laryngorhinootologie, 2007. 86 (12)(12): p. 846-52., https://pubmed.ncbi.nlm.nih.gov/17973200/
664. Keilmann, A, Wach, FS, Konerding, U, [Outcome of Phoniatric Rehabilitation of Dysphagia in Patients with Head and Neck Cancer]., Laryngorhinootologie, 2021. 100 (4)(4): p. 270-277., https://pubmed.ncbi.nlm.nih.gov/33513621/
665. Motzko, Manuela, Mlynczak, Ute, Prinzen, Claudia, Stimm- und Schlucktherapie nach Larynx- und HypopharynxkarzinomenElsevier, Urban & Fischer, 2004., https://shop.elsevier.de/stimm-und-schlucktherapie-nach-larynx-und-hypopharynxkarzinomen-9783437480003.html
666. Bindewald, J, Herrmann, E, Dietz, A, Wulke, C, Meister, E, Wollbrück, D, et.al. [Quality of life and voice intelligibility in laryngeal cancer patients--relevance of the "satisfaction paradox"]., Laryngorhinootologie, 2007. 86 (6)(6): p. 426-30., https://pubmed.ncbi.nlm.nih.gov/17654777/
667. Meyer, A, Dietz, A, Wollbrück, D, Oeken, J, Danker, H, Meister, EF, et.al. [Swallowing disorders after partial laryngectomy. Prevalence and predictors]., HNO, 2012. 60 (10)(10): p. 892-900., https://pubmed.ncbi.nlm.nih.gov/22903464/
668. Seidl, R.O. , R. Nusser-Müller-Busch, Trachealkanülen: Segen und FluchSpringer Verlag, Die Therapie des Facio-Oralen Trakts. F.O.T.T. nach Kay Coombes, 2015. p. 201-219.
669. Meyer, A, Dietz, A, Wollbrück, D, Oeken, J, Danker, H, Meister, EF, et.al. [Swallowing disorders after partial laryngectomy. Prevalence and predictors]., HNO, 2012. 60 (10)(10): p. 892-900., https://pubmed.ncbi.nlm.nih.gov/22903464/
670. Bartolome, Gudrun,, Schröter-Morasch, Heidrun, Schluckstörungen : Diagnostik und RehabilitationElsevier, Urban & Fischer, 2013.
671. Gillespie, MB, Brodsky, MB, Day, TA, Lee, FS, Martin-Harris, B, Swallowing-related quality of life after head and neck cancer treatment., Laryngoscope, 2004. 114 (8)(8): p. 1362-7., https://pubmed.ncbi.nlm.nih.gov/15280708/
672. Waters, TM, Logemann, JA, Pauloski, BR, Rademaker, AW, Lazarus, CL, Newman, LA, et.al. Beyond efficacy and effectiveness: conducting economic analyses during clinical trials., Dysphagia, 2004. 19 (2)(2): p. 109-19., https://pubmed.ncbi.nlm.nih.gov/15382799/
673. Kulbersh, BD, Rosenthal, EL, McGrew, BM, Duncan, RD, McColloch, NL, Carroll, WR, et.al. Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life., Laryngoscope, 2006. 116 (6)(6): p. 883-6., https://pubmed.ncbi.nlm.nih.gov/16735913/
674. Keilmann A, , Rosanowski F, Gesundheitsbezogene Lebensqualität bei Stimm- und Aussprachestörungen, Sprache Stimme Gehör, 2021. 45: p. 136–142.
675. Karlsson, T, Johansson, M, Andréll, P, Finizia, C, Effects of voice rehabilitation on health-related quality of life, communication and voice in laryngeal cancer patients treated with radiotherapy: a randomised controlled trial., Acta Oncol, 2015. 54 (7)(7): p. 1017-24., https://pubmed.ncbi.nlm.nih.gov/25615892/
676. Barnes, Benjamin, Kraywinkel, Klaus, Nowossadeck, Enno, Schönfeld, Ina, Starker, Anne, Wienecke, Antje, et.al. Bericht zum Krebsgeschehen in Deutschland 2016Robert Koch-Institut, 2016., https://edoc.rki.de/handle/176904/3264
677. Rick, O, Kalusche, EM, Dauelsberg, T, König, V, Korsukéwitz, C, Seifart, U, Reintegrating cancer patients into the workplace., Dtsch Arztebl Int, 2012. 109 (42)(42): p. 702-8., https://pubmed.ncbi.nlm.nih.gov/23264814/
678. Mehnert, A, Employment and work-related issues in cancer survivors., Crit Rev Oncol Hematol, 2011. 77 (2)(2): p. 109-30., https://pubmed.ncbi.nlm.nih.gov/20117019/
679. Ladehoff, N, Sturm, K, Mehnert, A, Work-related self-report measures and assessment tools in cancer survivorship: a systematic literature review., Disabil Rehabil, 2013. 35 (2)(2): p. 100-12., https://pubmed.ncbi.nlm.nih.gov/22697459/
680. Mehnert, A, Koch, U, Predictors of employment among cancer survivors after medical rehabilitation--a prospective study., Scand J Work Environ Health, 2013. 39 (1)(1): p. 76-87., https://pubmed.ncbi.nlm.nih.gov/22422040/
681. Broemer, L, Friedrich, M, Wichmann, G, Müller, J, Neumuth, T, Dietz, A, et.al. Exploratory study of functional and psychological factors associated with employment status in patients with head and neck cancer., Head Neck, 2021. 43 (4)(4): p. 1229-1241., https://pubmed.ncbi.nlm.nih.gov/33615608/
682. de Boer, AG, Verbeek, JH, Spelten, ER, Uitterhoeve, AL, Ansink, AC, de Reijke, TM, et.al. Work ability and return-to-work in cancer patients., Br J Cancer, 2008. 98 (8)(8): p. 1342-7., https://pubmed.ncbi.nlm.nih.gov/18349834/
683. Peteet, JR, Cancer and the meaning of work., Gen Hosp Psychiatry, 2000. 22 (3)(3): p. 200-5., https://pubmed.ncbi.nlm.nih.gov/10880715/
684. Luengo-Fernandez, R, Leal, J, Gray, A, Sullivan, R, Economic burden of cancer across the European Union: a population-based cost analysis., Lancet Oncol, 2013. 14 (12)(12): p. 1165-74., https://pubmed.ncbi.nlm.nih.gov/24131614/
685. Zebralla, V, Kaminski, K, Wichmann, G, Dietz, A, Wiegand, S, [Not Available]., Laryngorhinootologie, 2018. 97 (12)(12): p. 838-845., https://pubmed.ncbi.nlm.nih.gov/30536282/
686. Schultz, PN, Beck, ML, Stava, C, Sellin, RV, Cancer survivors. Work related issues., AAOHN J, 2002. 50 (5)(5): p. 220-6., https://pubmed.ncbi.nlm.nih.gov/12033089/
687. Spelten, ER, Sprangers, MA, Verbeek, JH, Factors reported to influence the return to work of cancer survivors: a literature review., Psychooncology, 2002. 11 (2)(2): p. 124-31., https://pubmed.ncbi.nlm.nih.gov/11921328/
688. van der Wouden, JC, Greaves-Otte, JG, Greaves, J, Kruyt, PM, van Leeuwen, O, van der Does, E, Occupational reintegration of long-term cancer survivors., J Occup Med, 1992. 34 (11)(11): p. 1084-9., https://pubmed.ncbi.nlm.nih.gov/1432298/
689. Singer, S, Keszte, J, Dietz, A, Kluge, A, Plontke, S, Heim, M, et.al. [Vocational rehabilitation after total laryngectomy]., Laryngorhinootologie, 2013. 92 (11)(11): p. 737-45., https://pubmed.ncbi.nlm.nih.gov/23709161/
690. Herranz, J, Gavilán, J, Psychosocial adjustment after laryngeal cancer surgery., Ann Otol Rhinol Laryngol, 1999. 108 (10)(10): p. 990-7., https://pubmed.ncbi.nlm.nih.gov/10526855/
691. Sako, K, Cardinale, S, Marchetta, FC, Shedd, DP, Speech and vocational rehabilitation of the laryngectomized patient., J Surg Oncol, 1974. 6 (3)(3): p. 197-202., https://pubmed.ncbi.nlm.nih.gov/4844315/
692. Lapchenko, SN, Kuznetsov, VS, Dormakov, VV, Guziukina, TV, Orlova, ER, [Medico-social and economic aspects of the rehabilitation of patients with laryngeal cancer]., Vestn Otorinolaringol, 1990. (3)(3): p. 11-4., https://pubmed.ncbi.nlm.nih.gov/2382327/
693. Schraub, S, Bontemps, P, Mercier, M, Barthod, L, Fournier, J, [Surveillance and rehabilitation of cancers of upper respiratory and digestive tracts]., Rev Prat, 1995. 45 (7)(7): p. 861-4., https://pubmed.ncbi.nlm.nih.gov/7761755/
694. Lazo, VV, [Possibilities of vocational rehabilitation after laryngectomy for cancer]., Zh Ushn Nos Gorl Bolezn, 1976. (1)(1): p. 29-34., https://pubmed.ncbi.nlm.nih.gov/1024417/
695. Natvig, K, Study No. 4: Social, occupational and personal factors related to vocational rehabilitation., J Otolaryngol, 1983. 12 (6)(6): p. 370-6., https://pubmed.ncbi.nlm.nih.gov/6663663/
696. Bremerich, A, Stoll, W, [Rehabilitation following laryngectomy from the viewpoint of the affected patients]., HNO, 1985. 33 (5)(5): p. 220-3., https://pubmed.ncbi.nlm.nih.gov/4008281/
697. Matzker, J, Genschow, J, [How does the patient with laryngectomy live? Results of a survey of 90 patients]., Z Laryngol Rhinol Otol, 1970. 49 (5)(5): p. 290-300., https://pubmed.ncbi.nlm.nih.gov/5515822/
698. Koch, R, Wittekindt, C, Altendorf-Hofmann, A, Singer, S, Guntinas-Lichius, O, Employment pathways and work-related issues in head and neck cancer survivors., Head Neck, 2015. 37 (4)(4): p. 585-93., https://pubmed.ncbi.nlm.nih.gov/24677561/
699. Handschel, J, Gellrich, NC, Bremerich, A, Krüskemper, G, Return to work and quality of life after therapy and rehabilitation in oral cancer., In Vivo, 2013. 27 (3)(3): p. 401-7., https://pubmed.ncbi.nlm.nih.gov/23606698/
700. Vartanian, JG, Carvalho, AL, Toyota, J, Kowalski, IS, Kowalski, LP, Socioeconomic effects of and risk factors for disability in long-term survivors of head and neck cancer., Arch Otolaryngol Head Neck Surg, 2006. 132 (1)(1): p. 32-5., https://pubmed.ncbi.nlm.nih.gov/16415426/
701. Buckwalter, AE, Karnell, LH, Smith, RB, Christensen, AJ, Funk, GF, Patient-reported factors associated with discontinuing employment following head and neck cancer treatment., Arch Otolaryngol Head Neck Surg, 2007. 133 (5)(5): p. 464-70., https://pubmed.ncbi.nlm.nih.gov/17520760/
702. Verdonck-de Leeuw, IM, van Bleek, WJ, Leemans, CR, de Bree, R, Employment and return to work in head and neck cancer survivors., Oral Oncol, 2010. 46 (1)(1): p. 56-60., https://pubmed.ncbi.nlm.nih.gov/20004135/
703. Pearce, A, Timmons, A, O'Sullivan, E, Gallagher, P, Gooberman-Hill, R, Thomas, AA, et.al. Long-term workforce participation patterns following head and neck cancer., J Cancer Surviv, 2015. 9 (1)(1): p. 30-9., https://pubmed.ncbi.nlm.nih.gov/25060809/
704. Yu, J, Smith, J, Marwah, R, Edkins, O, Return to work in patients with head and neck cancer: Systematic review and meta-analysis., Head Neck, 2022. 44 (12)(12): p. 2904-2924., https://pubmed.ncbi.nlm.nih.gov/36121026/
705. Park, P, Hashmi, M, Occupational Therapy for the Head and Neck Cancer Patient., Cancer Treat Res, 2018. 174 (): p. 225-235., https://pubmed.ncbi.nlm.nih.gov/29435845/
706. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), , Deutsche Krebsgesellschaft (DKG), , Deutsche Krebshilfe (DKH)., S3-Leitlinie Psychoonkologische Diagnostik, Beratung und Behandlung von erwachsenen Krebspatienten, AWMF-Register-Nr.: 032-051OL, 2023. Version 2.0:, http://www.leitlinienprogramm-onkologie.de/leitlinien/psychoonkologie/
707. Singer, S, Herrmann, E, Welzel, C, Klemm, E, Heim, M, Schwarz, R, Comorbid mental disorders in laryngectomees., Onkologie, 2005. 28 (12)(12): p. 631-6., https://pubmed.ncbi.nlm.nih.gov/16330886/
708. Singer, S, Bringmann, H, Hauss, J, Kortmann, RD, Köhler, U, Krauss, O, et.al. [Prevalence of concomitant psychiatric disorders and the desire for psychosocial help in patients with malignant tumors in an acute hospital]., Dtsch Med Wochenschr, 2007. 132 (40)(40): p. 2071-6., https://pubmed.ncbi.nlm.nih.gov/17899501/
709. Wiseman, DA, Short, WB, Pattinson, HA, Taylor, PJ, Nicholson, SF, Elliott, PD, et.al. Oocyte retrieval in an in vitro fertilization-embryo transfer program: comparison of four methods., Radiology, 1989. 173 (1)(1): p. 99-102., https://pubmed.ncbi.nlm.nih.gov/2528782/
710. Kugaya, A, Akechi, T, Okuyama, T, Nakano, T, Mikami, I, Okamura, H, et.al. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer., Cancer, 2000. 88 (12)(12): p. 2817-23., https://pubmed.ncbi.nlm.nih.gov/10870066/
711. Meyer, A, Keszte, J, Wollbrück, D, Dietz, A, Oeken, J, Vogel, HJ, et.al. Psychological distress and need for psycho-oncological support in spouses of total laryngectomised cancer patients-results for the first 3 years after surgery., Support Care Cancer, 2015. 23 (5)(5): p. 1331-9., https://pubmed.ncbi.nlm.nih.gov/25341549/
712. Katz, MR, Kopek, N, Waldron, J, Devins, GM, Tomlinson, G, Screening for depression in head and neck cancer., Psychooncology, 2004. 13 (4)(4): p. 269-80., https://pubmed.ncbi.nlm.nih.gov/15054731/
713. Keller, M, Sommerfeldt, S, Fischer, C, Knight, L, Riesbeck, M, Löwe, B, et.al. Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach., Ann Oncol, 2004. 15 (8)(8): p. 1243-9., https://pubmed.ncbi.nlm.nih.gov/15277265/
714. Singer, S, Brown, A, Einenkel, J, Hauss, J, Hinz, A, Klein, A, et.al. Identifying tumor patients' depression., Support Care Cancer, 2011. 19 (11)(11): p. 1697-703., https://pubmed.ncbi.nlm.nih.gov/20853171/
715. Singer, S, Krauss, O, Keszte, J, Siegl, G, Papsdorf, K, Severi, E, et.al. Predictors of emotional distress in patients with head and neck cancer., Head Neck, 2012. 34 (2)(2): p. 180-7., https://pubmed.ncbi.nlm.nih.gov/21400629/
716. Tschiesner, U, Stier-Jarmer, M, Strieth, S, Singer, S, Dietz, A, Fietkau, R, et.al. [Development of an ICF-based clinical practice guideline for the assessment of function in head and neck cancer]., Laryngorhinootologie, 2013. 92 (5)(5): p. 314-25., https://pubmed.ncbi.nlm.nih.gov/23364863/
717. Zebralla, V, Pohle, N, Singer, S, Neumuth, T, Dietz, A, Stier-Jarmer, M, et.al. [Introduction of the Screening Tool OncoFunction for Functional Follow-up of Head and Neck Patients]., Laryngorhinootologie, 2016. 95 (2)(2): p. 118-24., https://pubmed.ncbi.nlm.nih.gov/26190042/
718. Faller, H, Schuler, M, Richard, M, Heckl, U, Weis, J, Küffner, R, Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis., J Clin Oncol, 2013. 31 (6)(6): p. 782-93., https://pubmed.ncbi.nlm.nih.gov/23319686/
719. Fauser, D, Wienert, J, Zomorodbakhsch, B, Schmielau, J, Biester, I, Krüger, HU, et.al. Work-Related Medical Rehabilitation in Cancer: A Cluster-Randomized Multicenter Study., Dtsch Arztebl Int, 2019. 116 (35-36)(35-36): p. 592-599., https://pubmed.ncbi.nlm.nih.gov/31587707/
720. Berkel, AEM, Bongers, BC, Kotte, H, Weltevreden, P, de Jongh, FHC, Eijsvogel, MMM, et.al. Effects of Community-based Exercise Prehabilitation for Patients Scheduled for Colorectal Surgery With High Risk for Postoperative Complications: Results of a Randomized Clinical Trial., Ann Surg, 2022. 275 (2)(2): p. e299-e306., https://pubmed.ncbi.nlm.nih.gov/33443905/
721. Perry, R, Scott, LJ, Richards, A, Haase, AM, Savović, J, Ness, AR, et.al. Pre-admission interventions to improve outcome after elective surgery-protocol for a systematic review., Syst Rev, 2016. 5 (): p. 88., https://pubmed.ncbi.nlm.nih.gov/27216584/
722. Frank, Florian, Kim, Mia, Nüssler, Natascha, Jacob, Eva-Maria, Outcome von Krebsoperationen: Prähabilitation ist so bedeutsam wie Rehabilitation, Dtsch Arztebl International, 2022. 119(37): p. A-1518., https://www.aerzteblatt.de/archiv/outcome-von-krebsoperationen-praehabilitation-ist-so-bedeutsam-wie-rehabilitation-8a967a26-32f7-4d8b-b738-e3bcea6f6468
723. Carli, F, Gillis, C, Scheede-Bergdahl, C, Promoting a culture of prehabilitation for the surgical cancer patient., Acta Oncol, 2017. 56 (2)(2): p. 128-133., https://pubmed.ncbi.nlm.nih.gov/28067101/
724. Rossi, VC, Moraes, JL, Molento, CF, Speech therapy in head and neck cancer., Braz J Otorhinolaryngol, 2021. 87 (5)(5): p. 495-496., https://pubmed.ncbi.nlm.nih.gov/33648852/
725. Kramer, H., , Pèrez Alvarez, J.C., Prognostisch relevante Faktoren und Therapieergebnisse der stationären Dysphagiebehandlung: ernährungsbezogene und soziale Aspekte, 21. Wissenschaftliche Jahrestagung der DGPP, 2004., http://www.egms.de/en/meetings/dgpp2004/04dgpp47.shtml
726. Kramer, H.,, Pérez Álvarez, , J.C., Hacki, Prognostisch relevante Faktoren und Ernährungsstrategien bei tumorbedingter Dysphagie, 20. Wissenschaftliche Jahrestagung der DGPP, 2003., https://www.egms.de/static/de/meetings/dgpp2003/03dgpp048.shtml
727. Xu, B, Boero, IJ, Hwang, L, Le, QT, Moiseenko, V, Sanghvi, PR, et.al. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer., Cancer, 2015. 121 (8)(8): p. 1303-11., https://pubmed.ncbi.nlm.nih.gov/25537836/
728. Zebralla, V, Wichmann, G, Pirlich, M, Hammermüller, C, Berger, T, Zimmermann, K, et.al. Dysphagia, voice problems, and pain in head and neck cancer patients., Eur Arch Otorhinolaryngol, 2021. 278 (10)(10): p. 3985-3994., https://pubmed.ncbi.nlm.nih.gov/33452920/
729. Loewen, I, Jeffery, CC, Rieger, J, Constantinescu, G, Prehabilitation in head and neck cancer patients: a literature review., J Otolaryngol Head Neck Surg, 2021. 50 (1)(1): p. 2., https://pubmed.ncbi.nlm.nih.gov/33407922/
730. Brady, R, McSharry, L, Lawson, S, Regan, J, The impact of dysphagia prehabilitation on swallowing outcomes post-chemoradiation therapy in head and neck cancer: A systematic review., Eur J Cancer Care (Engl), 2022. 31 (3)(3): p. e13549., https://pubmed.ncbi.nlm.nih.gov/34964185/
731. Loscalzo, M, Psychological approaches to the management of pain in patients with advanced cancer., Hematol Oncol Clin North Am, 1996. 10 (1)(1): p. 139-55., https://pubmed.ncbi.nlm.nih.gov/8821564/
732. Schweinfurth, JM, Boger, GN, Feustel, PJ, Preoperative risk assessment for gastrostomy tube placement in head and neck cancer patients., Head Neck, 2001. 23 (5)(5): p. 376-82., https://pubmed.ncbi.nlm.nih.gov/11295811/
733. Deurloo, EE, Schultze Kool, LJ, Kröger, R, van Coevorden, F, Balm, AJ, Percutaneous radiological gastrostomy in patients with head and neck cancer., Eur J Surg Oncol, 2001. 27 (1)(1): p. 94-7., https://pubmed.ncbi.nlm.nih.gov/11237498/
734. Beaver, ME, Myers, JN, Griffenberg, L, Waugh, K, Percutaneous fluoroscopic gastrostomy tube placement in patients with head and neck cancer., Arch Otolaryngol Head Neck Surg, 1998. 124 (10)(10): p. 1141-4., https://pubmed.ncbi.nlm.nih.gov/9776193/
735. Lee, JH, Machtay, M, Unger, LD, Weinstein, GS, Weber, RS, Chalian, AA, et.al. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck., Arch Otolaryngol Head Neck Surg, 1998. 124 (8)(8): p. 871-5., https://pubmed.ncbi.nlm.nih.gov/9708712/
736. Mekhail, TM, Adelstein, DJ, Rybicki, LA, Larto, MA, Saxton, JP, Lavertu, P, Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?, Cancer, 2001. 91 (9)(9): p. 1785-90., https://pubmed.ncbi.nlm.nih.gov/11335904/
737. Messing, BP, Ward, EC, Lazarus, CL, Kim, M, Zhou, X, Silinonte, J, et.al. Prophylactic Swallow Therapy for Patients with Head and Neck Cancer Undergoing Chemoradiotherapy: A Randomized Trial., Dysphagia, 2017. 32 (4)(4): p. 487-500., https://pubmed.ncbi.nlm.nih.gov/28444488/
738. Brown, T, Banks, M, Hughes, BGM, Lin, C, Kenny, LM, Bauer, JD, Impact of early prophylactic feeding on long term tube dependency outcomes in patients with head and neck cancer., Oral Oncol, 2017. 72 (): p. 17-25., https://pubmed.ncbi.nlm.nih.gov/28797454/
739. Axelsson, L, Silander, E, Nyman, J, Bove, M, Johansson, L, Hammerlid, E, Effect of prophylactic percutaneous endoscopic gastrostomy tube on swallowing in advanced head and neck cancer: A randomized controlled study., Head Neck, 2017. 39 (5)(5): p. 908-915., https://pubmed.ncbi.nlm.nih.gov/28152219/
740. Silander, E, Jacobsson, I, Bertéus-Forslund, H, Hammerlid, E, Energy intake and sources of nutritional support in patients with head and neck cancer--a randomised longitudinal study., Eur J Clin Nutr, 2013. 67 (1)(1): p. 47-52., https://pubmed.ncbi.nlm.nih.gov/23169469/
741. Erweiterte S3-Leitlinie Palliativmedizin für Patienten mit einer nicht-heilbaren Krebserkrankung, AWMF-Registernummer: 128-001OL, September 2020. Langversion 2.2:, https://www.leitlinienprogramm-onkologie.de/leitlinien/palliativmedizin/
742. Bausewein, Claudia, Roller, Susanne, Voltz, Raymond, Leitfaden Palliativmedizin Palliative Care 104(43): p. A-2942., https://www.aerzteblatt.de/int/article.asp?id=57367
743. Haas, I, Hauser, U, Ganzer, U, The dilemma of follow-up in head and neck cancer patients., Eur Arch Otorhinolaryngol, 2001. 258 (4)(4): p. 177-83., https://pubmed.ncbi.nlm.nih.gov/11407449/
744. Boysen, M, Lövdal, O, Tausjö, J, Winther, F, The value of follow-up in patients treated for squamous cell carcinoma of the head and neck., Eur J Cancer, 1992. 28 (2-3)(2-3): p. 426-30., https://pubmed.ncbi.nlm.nih.gov/1591057/
745. Bjordal, K, Ahlner-Elmqvist, M, Hammerlid, E, Boysen, M, Evensen, JF, Biörklund, A, et.al. A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data., Laryngoscope, 2001. 111 (8)(8): p. 1440-52., https://pubmed.ncbi.nlm.nih.gov/11568582/
746. Gao, S, Li, S, Yang, X, Tang, Q, 18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis., Oral Oncol, 2014. 50 (3)(3): p. 163-7., https://pubmed.ncbi.nlm.nih.gov/24368204/
747. Fukuhara, T, Fujiwara, K, Fujii, T, Takeda, K, Matsuda, E, Hasegawa, K, et.al. Usefulness of chest CT scan for head and neck cancer., Auris Nasus Larynx, 2015. 42 (1)(1): p. 49-52., https://pubmed.ncbi.nlm.nih.gov/25239083/
748. Bobeth, C, Tol, KK, Rößler, M, Bierbaum, V, Gerken, M, Günster, C, et.al. [Methodology and Attribution Success of a Data Linkage of Clinical Registry Data with Health Insurance Data]., Gesundheitswesen, 2023. 85 (S 02)(S 02): p. S154-S161., https://pubmed.ncbi.nlm.nih.gov/36940697/
749. Schmitt, J, Klinkhammer-Schalke, M, Bierbaum, V, Gerken, M, Bobeth, C, Rößler, M, et.al. Initial Cancer Treatment in Certified Versus Non-Certified Hospitals., Dtsch Arztebl Int, 2023. 120 (39)(39): p. 647-654., https://pubmed.ncbi.nlm.nih.gov/37583089/
750. Bierbaum, V, Schmitt, J, Klinkhammer-Schalke, M, Schoffer, O, Assessment of the Potential of Concentrating Cancer Care in Hospitals With Certification Through Survival Analysis., Gesundheitswesen, 2023. 85 (S 03)(S 03): p. S197-S204., https://pubmed.ncbi.nlm.nih.gov/37751756/
751. Cheng, CY, Datzmann, T, Hernandez, D, Schmitt, J, Schlander, M, Do certified cancer centers provide more cost-effective care? A health economic analysis of colon cancer care in Germany using administrative data., Int J Cancer, 2021. 149 (10)(10): p. 1744-1754., https://pubmed.ncbi.nlm.nih.gov/34213799/
752. Völkel, V, Gerken, M, Kleihues-van Tol, K, Schoffer, O, Bierbaum, V, Bobeth, C, et.al. Treatment of Colorectal Cancer in Certified Centers: Results of a Large German Registry Study Focusing on Long-Term Survival., Cancers (Basel), 2023. 15 (18)(18):, https://pubmed.ncbi.nlm.nih.gov/37760537/
753. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF), Entwicklung von leitlinienbasierten Qualitätsindikatoren. Methodenpapier für das Leitlinienprogramm Onkologie, Version 3.0, 2021., http://www.leitlinienprogramm-onkologie.de/methodik/informationen-zur-methodik/